CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tert-butyl hydroperoxide
Accession: CHEBI:64090
browse the term
Definition: An alkyl hydroperoxide in which the alkyl group is tert-butyl. It is widely used in a variety of oxidation processes.
Synonyms: related_synonym: 1,1-Dimethylethyl hydroperoxide; 2-Hydroperoxy-2-methylpropane; Dimethylethyl hydroperoxide; Formula=C4H10O2; Hydroperoxyde de butyle tertiaire; InChI=1S/C4H10O2/c1-4(2,3)6-5/h5H,1-3H3; InChIKey=CIHOLLKRGTVIJN-UHFFFAOYSA-N; SMILES=CC(C)(C)OO; TBHP; Tertiary-butyl hydroperoxide; t-Butylhydroperoxide; t-butyl hydroperoxide; tert-Butylhydroperoxide
xref: Beilstein:1098280; CAS:75-91-2
xref_mesh: MESH:D020122
xref: PMID:21418283; PMID:22037478; PMID:22039964; PMID:22326806; PMID:22337620; PMID:22369679; Reaxys:1098280; Wikipedia:Tert-Butyl_hydroperoxide
G
ABCA1
ATP binding cassette subfamily A member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ABCA1 mRNA
CTD
PMID:15336504
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCB1
ATP binding cassette subfamily B member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCB1A mRNA
CTD
PMID:14729362
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCB11
ATP binding cassette subfamily B member 11
multiple interactions affects localization decreases expression
ISO EXP
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein tert-Butylhydroperoxide results in decreased expression of ABCB11 mRNA
CTD
PMID:16452108 PMID:24306262 PMID:34767876
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCC2
ATP binding cassette subfamily C member 2
decreases expression multiple interactions affects localization
EXP ISO
tert-Butylhydroperoxide results in decreased expression of ABCC2 mRNA Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein
CTD
PMID:22956110 PMID:24306262 PMID:34303734
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCD1
ATP binding cassette subfamily D member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCD1 mRNA
CTD
PMID:15003993
NCBI chr X:153,724,856...153,744,755
Ensembl chr X:153,724,856...153,744,755
G
ABHD17A
abhydrolase domain containing 17A, depalmitoylase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ABHD17A mRNA
CTD
PMID:15336504
NCBI chr19:1,876,810...1,885,496
Ensembl chr19:1,876,810...1,885,496
G
ABLIM1
actin binding LIM protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ABLIM1 mRNA
CTD
PMID:15336504
NCBI chr10:114,431,110...114,801,373
Ensembl chr10:114,431,112...114,768,061
G
ABR
ABR activator of RhoGEF and GTPase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABR mRNA
CTD
PMID:15003993
NCBI chr17:1,003,519...1,229,722
Ensembl chr17:1,003,519...1,229,738
G
ACADS
acyl-CoA dehydrogenase short chain
increases expression multiple interactions decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACADS mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein
CTD
PMID:15003993 PMID:26989860
NCBI chr12:120,725,826...120,740,008
Ensembl chr12:120,725,774...120,740,008
G
ACHE
acetylcholinesterase (Yt blood group)
multiple interactions increases expression increases secretion
ISO
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of ACHE protein] tert-Butylhydroperoxide results in increased expression of ACHE mRNA alternative form
CTD
PMID:16903848
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ACKR3
atypical chemokine receptor 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ACKR3 mRNA
CTD
PMID:15336504
NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354
G
ACO1
aconitase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ACO1 mRNA
CTD
PMID:15336504
NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769
G
ACOT1
acyl-CoA thioesterase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACOT1 mRNA
CTD
PMID:14729362
NCBI chr14:73,490,933...73,543,796
Ensembl chr14:73,537,143...73,543,796
G
ACOT7
acyl-CoA thioesterase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACOT7 mRNA
CTD
PMID:15003993
NCBI chr 1:6,264,272...6,393,767
Ensembl chr 1:6,264,269...6,393,767
G
ACSL3
acyl-CoA synthetase long chain family member 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ACSL3 mRNA
CTD
PMID:15336504
NCBI chr 2:222,861,036...222,944,639
Ensembl chr 2:222,860,942...222,944,639
G
ACTB
actin beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ACTB mRNA
CTD
PMID:12419474
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
G
ACTG2
actin gamma 2, smooth muscle
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ACTG2 mRNA
CTD
PMID:15336504
NCBI chr 2:73,893,008...73,919,865
Ensembl chr 2:73,892,314...73,919,865
G
ACTN1
actinin alpha 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ACTN1 mRNA
CTD
PMID:15336504
NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,128...68,979,440
G
ACTR3
actin related protein 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ACTR3 mRNA
CTD
PMID:15336504
NCBI chr 2:113,889,934...113,962,596
Ensembl chr 2:113,890,063...113,962,596
G
ACTR3B
actin related protein 3B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ACTR3B mRNA
CTD
PMID:15336504
NCBI chr 7:152,759,752...152,855,378
Ensembl chr 7:152,759,749...152,855,378
G
ACY3
aminoacylase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACY3 mRNA
CTD
PMID:15003993
NCBI chr11:67,642,555...67,650,730
Ensembl chr11:67,642,555...67,650,730
G
ACYP1
acylphosphatase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ACYP1 mRNA
CTD
PMID:15336504
NCBI chr14:75,053,243...75,069,490
Ensembl chr14:75,053,237...75,069,483
G
ADAM19
ADAM metallopeptidase domain 19
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ADAM19 mRNA
CTD
PMID:15336504
NCBI chr 5:157,477,304...157,575,775
Ensembl chr 5:157,395,534...157,575,775
G
ADAM8
ADAM metallopeptidase domain 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAM8 mRNA
CTD
PMID:15003993
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADAM9
ADAM metallopeptidase domain 9
multiple interactions increases expression affects expression
EXP
[Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADAM9 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA] tert-Butylhydroperoxide affects the expression of ADAM9 mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 8:38,996,973...39,105,261
Ensembl chr 8:38,996,754...39,105,445
G
ADAR
adenosine deaminase RNA specific
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAR mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:154,582,057...154,627,997
Ensembl chr 1:154,581,695...154,628,013
G
ADAT1
adenosine deaminase tRNA specific 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ADAT1 mRNA
CTD
PMID:15963989
NCBI chr16:75,596,868...75,623,281
Ensembl chr16:75,596,868...75,623,300
G
ADCY3
adenylate cyclase 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ADCY3 mRNA
CTD
PMID:12414654
NCBI chr 2:24,819,169...24,920,237
Ensembl chr 2:24,819,169...24,920,237
G
ADCY9
adenylate cyclase 9
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ADCY9 mRNA
CTD
PMID:15336504
NCBI chr16:3,953,387...4,116,442
Ensembl chr16:3,953,387...4,116,442
G
ADD2
adducin 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ADD2 mRNA
CTD
PMID:15336504
NCBI chr 2:70,656,784...70,768,200
Ensembl chr 2:70,607,618...70,768,225
G
ADD3
adducin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ADD3 mRNA
CTD
PMID:15336504
NCBI chr10:109,996,373...110,135,565
Ensembl chr10:109,996,368...110,135,565
G
ADGRG6
adhesion G protein-coupled receptor G6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ADGRG6 mRNA
CTD
PMID:15336504
NCBI chr 6:142,302,007...142,446,261
Ensembl chr 6:142,301,854...142,446,266
G
ADH7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADH7 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 4:99,412,263...99,435,342
Ensembl chr 4:99,412,261...99,435,510
G
ADIPOR2
adiponectin receptor 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ADIPOR2 mRNA
CTD
PMID:15336504
NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
G
ADM
adrenomedullin
multiple interactions increases expression
EXP ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:20847119 PMID:29432895
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
G
ADORA1
adenosine A1 receptor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ADORA1 mRNA
CTD
PMID:12419474
NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
G
ADORA2B
adenosine A2b receptor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ADORA2B mRNA
CTD
PMID:15336504
NCBI chr17:15,850,362...15,975,746
Ensembl chr17:15,945,130...15,975,746
G
AGK
acylglycerol kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AGK mRNA
CTD
PMID:15336504
NCBI chr 7:141,551,410...141,655,244
Ensembl chr 7:141,551,278...141,655,244
G
AGO2
argonaute RISC catalytic component 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AGO2 mRNA
CTD
PMID:15336504
NCBI chr 8:140,520,156...140,642,313
Ensembl chr 8:140,520,156...140,635,633
G
AGPAT1
1-acylglycerol-3-phosphate O-acyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AGPAT1 mRNA
CTD
PMID:15003993
NCBI chr 6:32,168,212...32,178,108
Ensembl chr 6:32,168,212...32,178,096
G
AHSA1
activator of HSP90 ATPase activity 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AHSA1 mRNA
CTD
PMID:15336504
NCBI chr14:77,457,867...77,469,472
Ensembl chr14:77,457,870...77,469,472
G
AIFM1
apoptosis inducing factor mitochondria associated 1
multiple interactions increases expression
EXP
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of AIFM1 protein]
CTD
PMID:25522270
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
G
AIP
aryl hydrocarbon receptor interacting protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AIP mRNA
CTD
PMID:15336504
NCBI chr11:67,483,026...67,491,103
Ensembl chr11:67,468,174...67,491,154
G
AJUBA
ajuba LIM protein
multiple interactions decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AJUBA mRNA]
CTD
PMID:20847119
NCBI chr14:22,971,177...22,982,551
Ensembl chr14:22,971,177...22,982,551
G
AK2
adenylate kinase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AK2 mRNA
CTD
PMID:15336504
NCBI chr 1:33,007,940...33,036,883
Ensembl chr 1:33,007,986...33,080,996
G
AK4
adenylate kinase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AK4 mRNA
CTD
PMID:15003993
NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,147,549...65,232,145
G
AKAP12
A-kinase anchoring protein 12
affects expression
EXP
tert-Butylhydroperoxide affects the expression of AKAP12 mRNA
CTD
PMID:23410634
NCBI chr 6:151,239,967...151,358,559
Ensembl chr 6:151,239,967...151,358,559
G
AKAP9
A-kinase anchoring protein 9
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AKAP9 mRNA
CTD
PMID:15336504
NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AKR1B10 mRNA
CTD
PMID:23410634 PMID:34767876
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKR1C1
aldo-keto reductase family 1 member C1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AKR1C1 mRNA
CTD
PMID:15336504
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
G
AKR1C2
aldo-keto reductase family 1 member C2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AKR1C2 mRNA
CTD
PMID:12414654 PMID:15336504 PMID:23410634
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
G
AKT1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation
EXP
3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of AKT1 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA]
CTD
PMID:29128606 PMID:35690295
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
AKT2
AKT serine/threonine kinase 2
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of AKT2 mRNA tert-Butylhydroperoxide results in increased methylation of AKT2 gene
CTD
PMID:27509014
NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536
G
ALAD
aminolevulinate dehydratase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ALAD mRNA
CTD
PMID:15336504
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
G
ALAS1
5'-aminolevulinate synthase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ALAS1 protein
CTD
PMID:21659532
NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of ALDH1A1 mRNA tert-Butylhydroperoxide affects the expression of ALDH1A1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
ALDH1A3
aldehyde dehydrogenase 1 family member A3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ALDH1A3 mRNA
CTD
PMID:15336504
NCBI chr15:100,879,831...100,916,626
Ensembl chr15:100,877,714...100,916,626
G
ALDH2
aldehyde dehydrogenase 2 family member
increases expression decreases response to substance
EXP ISO
tert-Butylhydroperoxide results in increased expression of ALDH2 mRNA ALDH2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ALDH3A2
aldehyde dehydrogenase 3 family member A2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ALDH3A2 mRNA
CTD
PMID:15336504
NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
G
ALDH4A1
aldehyde dehydrogenase 4 family member A1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ALDH4A1 mRNA
CTD
PMID:15336504
NCBI chr 1:18,871,430...18,902,555
Ensembl chr 1:18,871,430...18,902,724
G
ALDH6A1
aldehyde dehydrogenase 6 family member A1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ALDH6A1 mRNA
CTD
PMID:15336504
NCBI chr14:74,056,847...74,084,453
Ensembl chr14:74,056,847...74,084,492
G
ALDH7A1
aldehyde dehydrogenase 7 family member A1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ALDH7A1 mRNA
CTD
PMID:15336504
NCBI chr 5:126,541,841...126,595,219
Ensembl chr 5:126,531,200...126,595,362
G
ALDOA
aldolase, fructose-bisphosphate A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ALDOA mRNA
CTD
PMID:15003993
NCBI chr16:30,053,151...30,070,414
Ensembl chr16:30,053,090...30,070,420 Ensembl chr16:30,053,090...30,070,420 Ensembl chr16:30,053,090...30,070,420
G
ALOX5
arachidonate 5-lipoxygenase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ALOX5 mRNA
CTD
PMID:15336504
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
AMD1
adenosylmethionine decarboxylase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AMD1 mRNA
CTD
PMID:27509014
NCBI chr 6:110,814,617...110,895,713
Ensembl chr 6:110,874,770...110,898,879
G
AMIGO2
adhesion molecule with Ig like domain 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AMIGO2 mRNA
CTD
PMID:15336504
NCBI chr12:47,075,707...47,079,959
Ensembl chr12:47,075,707...47,079,959
G
AMOTL2
angiomotin like 2
multiple interactions decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AMOTL2 mRNA]
CTD
PMID:20847119
NCBI chr 3:134,355,345...134,375,417
Ensembl chr 3:134,355,347...134,375,479
G
AMPD3
adenosine monophosphate deaminase 3
increases expression
EXP ISO
tert-Butylhydroperoxide results in increased expression of AMPD3 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr11:10,450,388...10,507,579
Ensembl chr11:10,308,313...10,507,579
G
AMPH
amphiphysin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AMPH mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 7:38,383,704...38,631,373
Ensembl chr 7:38,383,704...38,631,420
G
ANAPC5
anaphase promoting complex subunit 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ANAPC5 mRNA
CTD
PMID:15336504
NCBI chr12:121,308,245...121,354,209
Ensembl chr12:121,308,245...121,399,896
G
ANGPTL2
angiopoietin like 2
multiple interactions increases expression
EXP ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]
CTD
PMID:15003993 PMID:20847119
NCBI chr 9:127,087,348...127,122,635
Ensembl chr 9:127,087,348...127,122,635
G
ANGPTL7
angiopoietin like 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ANGPTL7 mRNA
CTD
PMID:15336504
NCBI chr 1:11,189,355...11,195,981
Ensembl chr 1:11,189,355...11,195,981
G
ANKMY2
ankyrin repeat and MYND domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ANKMY2 mRNA
CTD
PMID:15336504
NCBI chr 7:16,599,779...16,645,754
Ensembl chr 7:16,599,779...16,645,817
G
ANKRA2
ankyrin repeat family A member 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of ANKRA2 mRNA
CTD
PMID:23410634
NCBI chr 5:73,552,190...73,565,639
Ensembl chr 5:73,552,190...73,565,667
G
ANKRD10
ankyrin repeat domain 10
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ANKRD10 mRNA
CTD
PMID:15336504
NCBI chr13:110,878,540...110,915,069
Ensembl chr13:110,878,540...110,915,069
G
ANKRD2
ankyrin repeat domain 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ANKRD2 mRNA
CTD
PMID:15336504
NCBI chr10:97,572,441...97,583,884
Ensembl chr10:97,572,499...97,583,884
G
ANKRD37
ankyrin repeat domain 37
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]
CTD
PMID:20847119
NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628
G
ANKRD6
ankyrin repeat domain 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ANKRD6 mRNA
CTD
PMID:15336504
NCBI chr 6:89,433,152...89,633,834
Ensembl chr 6:89,433,152...89,633,834
G
ANP32A
acidic nuclear phosphoprotein 32 family member A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ANP32A mRNA
CTD
PMID:15336504
NCBI chr15:68,778,535...68,820,895
Ensembl chr15:68,778,535...68,820,897
G
ANPEP
alanyl aminopeptidase, membrane
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ANPEP mRNA
CTD
PMID:15336504
NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
G
ANXA4
annexin A4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ANXA4 mRNA
CTD
PMID:15336504
NCBI chr 2:69,643,808...69,827,112
Ensembl chr 2:69,644,425...69,827,112
G
ANXA8
annexin A8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANXA8 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:47,467,993...47,991,796
Ensembl chr10:47,460,162...47,484,158
G
AOX1
aldehyde oxidase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AOX1 mRNA
CTD
PMID:15336504
NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,586,014...200,677,064
G
AP3B1
adaptor related protein complex 3 subunit beta 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AP3B1 mRNA
CTD
PMID:15336504
NCBI chr 5:78,000,522...78,294,698
Ensembl chr 5:78,000,522...78,294,762
G
AP3D1
adaptor related protein complex 3 subunit delta 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AP3D1 mRNA
CTD
PMID:15336504
NCBI chr19:2,100,988...2,164,616
Ensembl chr19:2,100,988...2,164,468
G
APAF1
apoptotic peptidase activating factor 1
increases expression multiple interactions
EXP ISO
tert-Butylhydroperoxide results in increased expression of APAF1 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of APAF1 protein] [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]
CTD
PMID:15877105 PMID:17419000 PMID:35690295
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
G
APLP2
amyloid beta precursor like protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of APLP2 mRNA
CTD
PMID:15336504
NCBI chr11:130,069,894...130,144,805
Ensembl chr11:130,068,147...130,144,811
G
APOA5
apolipoprotein A5
affects expression
EXP
tert-Butylhydroperoxide affects the expression of APOA5 mRNA
CTD
PMID:23410634
NCBI chr11:116,789,367...116,792,420
Ensembl chr11:116,789,367...116,792,420
G
APOE
apolipoprotein E
increases expression affects localization
EXP ISO
tert-Butylhydroperoxide results in increased expression of APOE mRNA tert-Butylhydroperoxide affects the localization of APOE protein
CTD
PMID:15336504 PMID:19720132
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
APOLD1
apolipoprotein L domain containing 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of APOLD1 mRNA
CTD
PMID:15336504
NCBI chr12:12,725,917...12,791,466
Ensembl chr12:12,725,917...12,829,975
G
APP
amyloid beta precursor protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of APP mRNA
CTD
PMID:12419474
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
APPL1
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of APPL1 mRNA
CTD
PMID:15336504
NCBI chr 3:57,227,729...57,273,471
Ensembl chr 3:57,227,726...57,278,105
G
APPL2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of APPL2 mRNA
CTD
PMID:15336504
NCBI chr12:105,173,300...105,236,174
Ensembl chr12:105,173,297...105,236,203
G
AQP1
aquaporin 1 (Colton blood group)
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AQP1 mRNA
CTD
PMID:15336504
NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517
G
AQP4
aquaporin 4
multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of and affects the localization of AQP4 protein
CTD
PMID:20648640
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
AQR
aquarius intron-binding spliceosomal factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AQR mRNA
CTD
PMID:15336504
NCBI chr15:34,851,782...34,969,742
Ensembl chr15:34,851,782...34,969,742
G
AREG
amphiregulin
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of AREG mRNA
CTD
PMID:12414654
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
G
ARF6
ADP ribosylation factor 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ARF6 mRNA
CTD
PMID:15336504
NCBI chr14:49,893,082...49,897,054
Ensembl chr14:49,893,079...49,897,054
G
ARG2
arginase 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of ARG2 mRNA
CTD
PMID:23410634
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
ARHGDIA
Rho GDP dissociation inhibitor alpha
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ARHGDIA mRNA
CTD
PMID:12419474
NCBI chr17:81,867,721...81,871,337
Ensembl chr17:81,867,721...81,871,378
G
ARHGEF10
Rho guanine nucleotide exchange factor 10
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ARHGEF10 mRNA
CTD
PMID:15336504
NCBI chr 8:1,823,300...1,958,641
Ensembl chr 8:1,823,926...1,958,641
G
ARHGEF7
Rho guanine nucleotide exchange factor 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ARHGEF7 mRNA
CTD
PMID:15336504
NCBI chr13:111,114,619...111,305,734
Ensembl chr13:111,114,559...111,305,737
G
ARID3A
AT-rich interaction domain 3A
affects expression
EXP
tert-Butylhydroperoxide affects the expression of ARID3A mRNA
CTD
PMID:23410634
NCBI chr19:925,732...975,939
Ensembl chr19:925,781...975,939
G
ARL6IP1
ADP ribosylation factor like GTPase 6 interacting protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ARL6IP1 mRNA
CTD
PMID:15336504
NCBI chr16:18,791,667...18,801,549
Ensembl chr16:18,791,669...18,801,572
G
ARL6IP5
ADP ribosylation factor like GTPase 6 interacting protein 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ARL6IP5 mRNA
CTD
PMID:15336504
NCBI chr 3:69,084,937...69,106,092
Ensembl chr 3:69,084,937...69,106,092
G
ARNT
aryl hydrocarbon receptor nuclear translocator
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA]
CTD
PMID:35690295
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
G
ARPC1A
actin related protein 2/3 complex subunit 1A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ARPC1A mRNA
CTD
PMID:15336504
NCBI chr 7:99,325,898...99,366,262
Ensembl chr 7:99,325,898...99,366,262
G
ASF1A
anti-silencing function 1A histone chaperone
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ASF1A mRNA
CTD
PMID:23410634
NCBI chr 6:118,894,152...118,909,171
Ensembl chr 6:118,894,152...118,909,171
G
ASF1B
anti-silencing function 1B histone chaperone
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ASF1B mRNA
CTD
PMID:15336504
NCBI chr19:14,119,512...14,136,589
Ensembl chr19:14,119,512...14,136,613
G
ASPH
aspartate beta-hydroxylase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ASPH mRNA
CTD
PMID:15336504
NCBI chr 8:61,500,556...61,714,592
Ensembl chr 8:61,500,556...61,714,640
G
ASPSCR1
ASPSCR1 tether for SLC2A4, UBX domain containing
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ASPSCR1 mRNA
CTD
PMID:15336504
NCBI chr17:81,977,629...82,017,406
Ensembl chr17:81,976,807...82,017,406
G
ASS1
argininosuccinate synthase 1
decreases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of ASS1 mRNA; tert-Butylhydroperoxide results in decreased expression of ASS1 protein
CTD
PMID:15336504 PMID:24394546
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
G
ASXL1
ASXL transcriptional regulator 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ASXL1 mRNA
CTD
PMID:15336504
NCBI chr20:32,358,331...32,439,319
Ensembl chr20:32,358,330...32,439,319
G
ATAD2
ATPase family AAA domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA
CTD
PMID:15336504
NCBI chr 8:123,319,850...123,416,350
Ensembl chr 8:123,319,850...123,416,350
G
ATF3
activating transcription factor 3
multiple interactions increases expression decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA] tert-Butylhydroperoxide results in decreased expression of ATF3 mRNA
CTD
PMID:12414654 PMID:20196124 PMID:20847119
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
G
ATG4B
autophagy related 4B cysteine peptidase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ATG4B mRNA
CTD
PMID:15336504
NCBI chr 2:241,637,693...241,673,857
Ensembl chr 2:241,637,213...241,673,857
G
ATG5
autophagy related 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ATG5 mRNA
CTD
PMID:15336504
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
G
ATP13A3
ATPase 13A3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ATP13A3 mRNA
CTD
PMID:15336504
NCBI chr 3:194,402,677...194,494,334
Ensembl chr 3:194,402,672...194,498,364
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ATP2A2 mRNA
CTD
PMID:15336504
NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
G
ATP2B1
ATPase plasma membrane Ca2+ transporting 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ATP2B1 mRNA
CTD
PMID:15336504
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,366
G
ATP6V1A
ATPase H+ transporting V1 subunit A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ATP6V1A mRNA
CTD
PMID:15336504
NCBI chr 3:113,747,035...113,812,056
Ensembl chr 3:113,746,770...113,812,056
G
ATP6V1C1
ATPase H+ transporting V1 subunit C1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ATP6V1C1 mRNA
CTD
PMID:15336504
NCBI chr 8:103,021,083...103,073,051
Ensembl chr 8:103,021,063...103,073,051
G
ATR
ATR serine/threonine kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ATR mRNA
CTD
PMID:12419474
NCBI chr 3:142,449,235...142,578,733
Ensembl chr 3:142,449,007...142,578,733
G
ATXN1
ataxin 1
affects localization multiple interactions decreases expression
EXP
tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form]; Buthionine Sulfoximine promotes the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form] tert-Butylhydroperoxide results in decreased expression of ATXN1 mRNA
CTD
PMID:12893416 PMID:15336504
NCBI chr 6:16,299,112...16,761,460
Ensembl chr 6:16,299,112...16,761,491
G
ATXN3
ataxin 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ATXN3 mRNA
CTD
PMID:15336504
NCBI chr14:92,044,775...92,106,582
Ensembl chr14:92,044,496...92,106,621
G
AURKA
aurora kinase A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AURKA mRNA
CTD
PMID:15003993
NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
G
AURKB
aurora kinase B
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AURKB mRNA tert-Butylhydroperoxide results in increased expression of AURKB mRNA
CTD
PMID:12414654 PMID:29432895
NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
G
AUTS2
activator of transcription and developmental regulator AUTS2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AUTS2 mRNA
CTD
PMID:15336504
NCBI chr 7:69,598,475...70,793,506
Ensembl chr 7:69,598,296...70,793,506
G
AZIN1
antizyme inhibitor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of AZIN1 mRNA
CTD
PMID:15336504
NCBI chr 8:102,826,302...102,864,200
Ensembl chr 8:102,826,111...102,893,864
G
BABAM1
BRISC and BRCA1 A complex member 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BABAM1 mRNA
CTD
PMID:15336504
NCBI chr19:17,267,443...17,279,337
Ensembl chr19:17,267,376...17,281,249
G
BABAM2
BRISC and BRCA1 A complex member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BABAM2 mRNA
CTD
PMID:15003993
NCBI chr 2:27,888,709...28,338,901
Ensembl chr 2:27,889,941...28,338,901
G
BACE2
beta-secretase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BACE2 mRNA
CTD
PMID:15336504
NCBI chr21:41,168,160...41,282,530
Ensembl chr21:41,167,801...41,282,530
G
BAD
BCL2 associated agonist of cell death
decreases expression increases expression multiple interactions
EXP ISO
tert-Butylhydroperoxide results in decreased expression of BAD mRNA tert-Butylhydroperoxide results in increased expression of BAD protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAD protein]
CTD
PMID:12419474 PMID:15569404 PMID:17419000
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAK1
BCL2 antagonist/killer 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BAK1 mRNA
CTD
PMID:12419474
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
G
BAMBI
BMP and activin membrane bound inhibitor
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of BAMBI mRNA tert-Butylhydroperoxide affects the expression of BAMBI mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr10:28,677,521...28,682,932
Ensembl chr10:28,677,510...28,682,932
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions decreases expression increases expression affects localization
EXP ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] tert-Butylhydroperoxide results in decreased expression of BAX mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]
CTD
PMID:12419474 PMID:15569404 PMID:17419000 PMID:18552516 PMID:20510348 PMID:23994092 PMID:25522270 PMID:26989860 PMID:28063877 PMID:29111459 PMID:35690295 More...
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BAZ1B
bromodomain adjacent to zinc finger domain 1B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BAZ1B mRNA
CTD
PMID:15336504
NCBI chr 7:73,440,406...73,522,293
Ensembl chr 7:73,440,406...73,522,293
G
BBLN
bublin coiled coil protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BBLN mRNA
CTD
PMID:15336504
NCBI chr 9:128,160,265...128,163,924
Ensembl chr 9:128,160,265...128,163,924
G
BCL2
BCL2 apoptosis regulator
multiple interactions decreases expression affects localization
ISO EXP
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] tert-Butylhydroperoxide results in decreased expression of BCL2 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA; Genistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]
CTD
PMID:12782109 PMID:15288519 PMID:15569404 PMID:17419000 PMID:19772912 PMID:20510348 PMID:22659508 PMID:23994092 PMID:25522270 PMID:26989860 PMID:27050144 PMID:29111459 PMID:29128606 PMID:35690295 More...
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
multiple interactions decreases expression
ISO EXP
Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] tert-Butylhydroperoxide results in decreased expression of BCL2L1 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein
CTD
PMID:12419474 PMID:15569404 PMID:26102008 PMID:27050144
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BCL2L13
BCL2 like 13
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BCL2L13 mRNA
CTD
PMID:15336504
NCBI chr22:17,628,877...17,730,855
Ensembl chr22:17,628,855...17,730,855
G
BDH1
3-hydroxybutyrate dehydrogenase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BDH1 mRNA
CTD
PMID:29432895
NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
G
BDNF
brain derived neurotrophic factor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of BDNF mRNA
CTD
PMID:15336504
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BEX1
brain expressed X-linked 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of BEX1 mRNA
CTD
PMID:15336504
NCBI chr X:103,062,651...103,064,171
Ensembl chr X:103,062,651...103,064,171
G
BEX4
brain expressed X-linked 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of BEX4 mRNA
CTD
PMID:15336504
NCBI chr X:103,215,092...103,217,246
Ensembl chr X:103,215,108...103,217,246
G
BHMT
betaine--homocysteine S-methyltransferase
increases methylation decreases expression
EXP
tert-Butylhydroperoxide results in increased methylation of BHMT gene tert-Butylhydroperoxide results in decreased expression of BHMT mRNA
CTD
PMID:27509014
NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
G
BICD1
BICD cargo adaptor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BICD1 mRNA
CTD
PMID:15336504
NCBI chr12:32,106,847...32,383,633
Ensembl chr12:32,106,835...32,383,633
G
BIK
BCL2 interacting killer
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of BIK mRNA
CTD
PMID:23410634
NCBI chr22:43,110,750...43,129,712
Ensembl chr22:43,110,750...43,129,712
G
BIRC5
baculoviral IAP repeat containing 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BIRC5 mRNA
CTD
PMID:15003993
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
BLNK
B cell linker
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BLNK mRNA
CTD
PMID:14729362
NCBI chr10:96,189,171...96,271,569
Ensembl chr10:96,189,171...96,271,587
G
BMAL2
basic helix-loop-helix ARNT like 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BMAL2 mRNA
CTD
PMID:15336504
NCBI chr12:27,332,836...27,425,286
Ensembl chr12:27,332,836...27,425,289
G
BMERB1
bMERB domain containing 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BMERB1 mRNA
CTD
PMID:15336504
NCBI chr16:15,434,588...15,588,259
Ensembl chr16:15,434,475...15,625,028
G
BMP1
bone morphogenetic protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BMP1 mRNA
CTD
PMID:12419474
NCBI chr 8:22,165,372...22,212,326
Ensembl chr 8:22,165,140...22,212,326
G
BMP4
bone morphogenetic protein 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BMP4 mRNA
CTD
PMID:12419474
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
BNIP3
BCL2 interacting protein 3
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of BNIP3 mRNA tert-Butylhydroperoxide results in increased expression of BNIP3 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
G
BORA
BORA aurora kinase A activator
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BORA mRNA
CTD
PMID:15336504
NCBI chr13:72,727,923...72,756,196
Ensembl chr13:72,727,749...72,756,198
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BRAF mRNA
CTD
PMID:12419474
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
G
BRD3
bromodomain containing 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BRD3 mRNA
CTD
PMID:15336504
NCBI chr 9:134,030,305...134,068,548
Ensembl chr 9:134,030,305...134,068,535
G
BRD3OS
BRD3 opposite strand
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BRD3OS mRNA
CTD
PMID:15336504
NCBI chr 9:134,025,481...134,031,587
Ensembl chr 9:134,025,481...134,034,666
G
BSCL2
BSCL2 lipid droplet biogenesis associated, seipin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BSCL2 mRNA
CTD
PMID:22003191
NCBI chr11:62,690,262...62,709,537
Ensembl chr11:62,689,289...62,709,845
G
BST1
bone marrow stromal cell antigen 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BST1 mRNA
CTD
PMID:15336504
NCBI chr 4:15,703,065...15,774,173
Ensembl chr 4:15,703,065...15,738,313
G
BST2
bone marrow stromal cell antigen 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BST2 mRNA
CTD
PMID:15336504
NCBI chr19:17,402,939...17,405,630
Ensembl chr19:17,402,939...17,405,630
G
BTBD2
BTB domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BTBD2 mRNA
CTD
PMID:15336504
NCBI chr19:1,985,448...2,015,714
Ensembl chr19:1,985,438...2,034,881
G
BTD
biotinidase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BTD mRNA
CTD
PMID:15336504
NCBI chr 3:15,601,361...15,722,516
Ensembl chr 3:15,601,341...15,722,311
G
BTF3
basic transcription factor 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of BTF3 mRNA
CTD
PMID:15336504
NCBI chr 5:73,498,442...73,505,667
Ensembl chr 5:73,498,408...73,505,667
G
BTG1
BTG anti-proliferation factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTG1 mRNA
CTD
PMID:15003993
NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
G
BTG2
BTG anti-proliferation factor 2
increases expression
EXP ISO
tert-Butylhydroperoxide results in increased expression of BTG2 mRNA
CTD
PMID:12414654 PMID:21382384
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
BTN3A1
butyrophilin subfamily 3 member A1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BTN3A1 mRNA
CTD
PMID:15336504
NCBI chr 6:26,402,275...26,415,208
Ensembl chr 6:26,402,237...26,415,208
G
BTN3A3
butyrophilin subfamily 3 member A3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BTN3A3 mRNA
CTD
PMID:15336504
NCBI chr 6:26,440,504...26,453,415
Ensembl chr 6:26,440,472...26,453,415
G
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
affects expression
EXP
tert-Butylhydroperoxide affects the expression of BUB1 mRNA
CTD
PMID:23410634
NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
G
BUD23
BUD23 rRNA methyltransferase and ribosome maturation factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of BUD23 mRNA
CTD
PMID:15336504
NCBI chr 7:73,683,597...73,698,212
Ensembl chr 7:73,683,597...73,698,212
G
BZW1
basic leucine zipper and W2 domains 1
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]
CTD
PMID:20847119
NCBI chr 2:200,811,589...200,827,338
Ensembl chr 2:200,810,594...200,827,338
G
C11orf68
chromosome 11 open reading frame 68
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of C11ORF68 mRNA
CTD
PMID:15336504
NCBI chr11:65,916,810...65,919,062
Ensembl chr11:65,916,810...65,919,062
G
C17orf100
chromosome 17 open reading frame 100
affects expression
EXP
tert-Butylhydroperoxide affects the expression of C17ORF100 mRNA
CTD
PMID:23410634
NCBI chr17:6,651,762...6,653,476
Ensembl chr17:6,651,762...6,693,202
G
C1orf115
chromosome 1 open reading frame 115
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of C1ORF115 mRNA
CTD
PMID:15336504
NCBI chr 1:220,690,363...220,699,153
Ensembl chr 1:220,690,363...220,699,153
G
C1R
complement C1r
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of C1R mRNA
CTD
PMID:15336504
NCBI chr12:7,080,219...7,092,445
Ensembl chr12:7,080,214...7,092,540
G
C2CD2
C2 calcium dependent domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of C2CD2 mRNA
CTD
PMID:15336504
NCBI chr21:41,885,112...41,954,018
Ensembl chr21:41,885,112...41,954,018
G
C5
complement C5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of C5 mRNA
CTD
PMID:15336504
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
C6orf62
chromosome 6 open reading frame 62
affects expression
EXP
tert-Butylhydroperoxide affects the expression of C6ORF62 mRNA
CTD
PMID:23410634
NCBI chr 6:24,704,861...24,720,836
Ensembl chr 6:24,704,861...24,720,825
G
C8orf76
chromosome 8 open reading frame 76
affects expression
EXP
tert-Butylhydroperoxide affects the expression of C8ORF76 mRNA
CTD
PMID:23410634
NCBI chr 8:123,219,967...123,241,377
Ensembl chr 8:123,219,967...123,241,377
G
CA8
carbonic anhydrase 8
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CA8 mRNA
CTD
PMID:15336504
NCBI chr 8:60,185,412...60,281,400
Ensembl chr 8:60,185,412...60,281,400
G
CADM1
cell adhesion molecule 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CADM1 mRNA
CTD
PMID:15336504
NCBI chr11:115,169,236...115,504,415
Ensembl chr11:115,169,218...115,504,957
G
CADM4
cell adhesion molecule 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CADM4 mRNA
CTD
PMID:15336504
NCBI chr19:43,622,368...43,641,984
Ensembl chr19:43,622,368...43,639,850
G
CALHM2
calcium homeostasis modulator family member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CALHM2 mRNA
CTD
PMID:15336504
NCBI chr10:103,446,786...103,452,370
Ensembl chr10:103,446,786...103,452,402
G
CALM1
calmodulin 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CALM1 mRNA
CTD
PMID:15336504
NCBI chr14:90,396,502...90,408,268
Ensembl chr14:90,396,502...90,408,268
G
CALM3
calmodulin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALM3 mRNA
CTD
PMID:15003993
NCBI chr19:46,601,074...46,610,782
Ensembl chr19:46,601,074...46,610,782
G
CALML4
calmodulin like 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALML4 mRNA
CTD
PMID:15003993
NCBI chr15:68,190,705...68,206,110
Ensembl chr15:68,190,705...68,206,079
G
CALR
calreticulin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CALR mRNA
CTD
PMID:15336504
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CALU
calumenin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CALU mRNA
CTD
PMID:15336504
NCBI chr 7:128,739,359...128,773,400
Ensembl chr 7:128,739,292...128,773,400
G
CAMK2N1
calcium/calmodulin dependent protein kinase II inhibitor 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CAMK2N1 mRNA
CTD
PMID:15336504
NCBI chr 1:20,482,391...20,486,210
Ensembl chr 1:20,482,391...20,486,210
G
CAMLG
calcium modulating ligand
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAML mRNA
CTD
PMID:14729362
NCBI chr 5:134,738,548...134,752,157
Ensembl chr 5:134,738,495...134,752,157
G
CAMP
cathelicidin antimicrobial peptide
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAMP mRNA
CTD
PMID:22659508
NCBI chr 3:48,223,495...48,225,485
Ensembl chr 3:48,223,347...48,225,491
G
CAND1
cullin associated and neddylation dissociated 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAND1 mRNA
CTD
PMID:15336504
NCBI chr12:67,269,358...67,319,953
Ensembl chr12:67,269,358...67,319,953
G
CAPN1
calpain 1
increases response to substance increases expression
EXP ISO
CAPN1 protein results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CAPN1 mRNA
CTD
PMID:12842444 PMID:15003993
NCBI chr11:65,181,373...65,212,006
Ensembl chr11:65,180,566...65,212,006
G
CAPN2
calpain 2
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAPN2 mRNA tert-Butylhydroperoxide affects the expression of CAPN2 mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr 1:223,701,597...223,776,018
Ensembl chr 1:223,701,593...223,776,018
G
CAPN5
calpain 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAPN5 mRNA
CTD
PMID:15003993
NCBI chr11:77,066,971...77,126,155
Ensembl chr11:77,066,961...77,126,155
G
CAPN7
calpain 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAPN7 mRNA
CTD
PMID:15336504
NCBI chr 3:15,206,246...15,252,916
Ensembl chr 3:15,206,152...15,252,916
G
CAPNS1
calpain small subunit 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAPNS1 mRNA
CTD
PMID:12419474
NCBI chr19:36,140,066...36,150,353
Ensembl chr19:36,139,953...36,150,353
G
CAPRIN2
caprin family member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAPRIN2 mRNA
CTD
PMID:15336504
NCBI chr12:30,709,553...30,754,951
Ensembl chr12:30,709,552...30,823,302
G
CARS2
cysteinyl-tRNA synthetase 2, mitochondrial
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CARS2 mRNA
CTD
PMID:15336504
NCBI chr13:110,641,410...110,713,522
Ensembl chr13:110,641,412...110,713,603
G
CASK
calcium/calmodulin dependent serine protein kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CASK mRNA
CTD
PMID:12419474
NCBI chr X:41,514,934...41,923,554
Ensembl chr X:41,514,934...41,923,554
G
CASP3
caspase 3
multiple interactions increases activity increases expression increases cleavage decreases expression decreases activity
EXP ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA; acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; KN 93 inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; zinc protoporphyrin inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]] tert-Butylhydroperoxide results in increased expression of CASP3 protein; tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form caffeoylquinic acid analog inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; tert-Butylhydroperoxide results in increased expression of and results in increased cleavage of CASP3 protein acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] tert-butylhydroperoxide decreases activity of Casp3 protein in hepatocyte cytosol
CTD RGD
PMID:12406338 PMID:15496407 PMID:15569404 PMID:15611089 PMID:15877105 PMID:16753784 PMID:17419000 PMID:19647727 PMID:19772912 PMID:20510348 PMID:20847119 PMID:26102008 PMID:26989860 PMID:27511913 PMID:28025122 PMID:28063877 PMID:28733231 PMID:35690295 PMID:18316105 More...
RGD:2311460
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP6
caspase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CASP6 mRNA
CTD
PMID:15003993
NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583
G
CASP7
caspase 7
multiple interactions increases cleavage decreases activity
EXP ISO
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein] tert-butylhydroperoxide decreases activity of Casp7 protein in hepatocyte cytosol
CTD RGD
PMID:27050144 PMID:18316105
RGD:2311460
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CASP8
caspase 8
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]
CTD
PMID:35690295
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
increases cleavage increases expression multiple interactions decreases activity
ISO EXP
tert-Butylhydroperoxide results in increased cleavage of CASP9 protein tert-Butylhydroperoxide results in increased expression of CASP9 protein Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein] Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] Tert-butylhydroperoxide decreases activity of Casp9 protein in hepatocyte cytosol
CTD RGD
PMID:15877105 PMID:17003459 PMID:19772912 PMID:20510348 PMID:27050144 PMID:18316105 More...
RGD:2311460
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CAST
calpastatin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAST mRNA
CTD
PMID:15336504
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,525,267...96,779,595 Ensembl chr 5:96,525,267...96,779,595
G
CAT
catalase
affects response to substance decreases response to substance multiple interactions decreases activity decreases expression increases expression increases activity
EXP ISO
CAT protein affects the susceptibility to tert-Butylhydroperoxide CAT protein results in decreased susceptibility to tert-Butylhydroperoxide [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CAT mRNA; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CAT protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CAT protein] tert-Butylhydroperoxide results in decreased activity of CAT protein tert-Butylhydroperoxide results in decreased expression of CAT mRNA; tert-Butylhydroperoxide results in decreased expression of CAT protein CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of CAT protein] tert-Butylhydroperoxide results in increased expression of CAT mRNA CAT protein results in increased susceptibility to [tert-Butylhydroperoxide co-treated with Desoxycorticosterone co-treated with tempol]
CTD
PMID:10754530 PMID:11178967 PMID:12423650 PMID:12628296 PMID:12646410 PMID:14729362 PMID:15003993 PMID:15105052 PMID:15207383 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16753784 PMID:16928893 PMID:17003459 PMID:20100471 PMID:34303734 PMID:35690295 More...
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CAV1
caveolin 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CAV1 mRNA
CTD
PMID:15963989
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
G
CAV2
caveolin 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAV2 mRNA
CTD
PMID:15336504
NCBI chr 7:116,499,738...116,508,541
Ensembl chr 7:116,287,380...116,508,541
G
CAVIN2
caveolae associated protein 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of CAVIN2 mRNA
CTD
PMID:23410634
NCBI chr 2:191,834,310...191,847,088
Ensembl chr 2:191,834,310...191,847,088
G
CBFB
core-binding factor subunit beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CBFB mRNA
CTD
PMID:15336504
NCBI chr16:67,029,149...67,101,058
Ensembl chr16:67,028,984...67,101,058
G
CBR3
carbonyl reductase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CBR3 mRNA
CTD
PMID:21382384
NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562
G
CBS
cystathionine beta-synthase
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of CBS mRNA tert-Butylhydroperoxide results in increased methylation of CBS gene
CTD
PMID:15336504 PMID:27509014
NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943
G
CCDC25
coiled-coil domain containing 25
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CCDC25 mRNA
CTD
PMID:15336504
NCBI chr 8:27,733,316...27,772,640
Ensembl chr 8:27,733,316...27,772,653
G
CCDC86
coiled-coil domain containing 86
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CCDC86 mRNA
CTD
PMID:15336504
NCBI chr11:60,842,113...60,851,081
Ensembl chr11:60,842,113...60,851,081
G
CCDC93
coiled-coil domain containing 93
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CCDC93 mRNA
CTD
PMID:15336504
NCBI chr 2:117,915,481...118,014,070
Ensembl chr 2:117,915,478...118,014,133
G
CCL2
C-C motif chemokine ligand 2
multiple interactions decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA]
CTD
PMID:20847119
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL5
C-C motif chemokine ligand 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCL5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCN1
cellular communication network factor 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CCN1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CCN2
cellular communication network factor 2
multiple interactions decreases expression affects expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA] tert-Butylhydroperoxide affects the expression of CCN2 mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCN3
cellular communication network factor 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CCN3 mRNA
CTD
PMID:15336504
NCBI chr 8:119,416,446...119,424,434
Ensembl chr 8:119,416,446...119,424,434
G
CCNA2
cyclin A2
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of CCNA2 mRNA tert-Butylhydroperoxide affects the expression of CCNA2 mRNA
CTD
PMID:12414654 PMID:12419474 PMID:15336504 PMID:23410634
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCNB2
cyclin B2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNB2 mRNA
CTD
PMID:15003993
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
G
CCNE1
cyclin E1
multiple interactions
EXP
ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CCNE1 protein]
CTD
PMID:15606011
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
G
CCNE2
cyclin E2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CCNE2 mRNA
CTD
PMID:15336504
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
G
CCNF
cyclin F
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNF mRNA
CTD
PMID:15003993
NCBI chr16:2,429,447...2,458,854
Ensembl chr16:2,429,394...2,458,854
G
CCNG2
cyclin G2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CCNG2 mRNA
CTD
PMID:15336504
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
G
CCNJ
cyclin J
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CCNJ mRNA
CTD
PMID:15336504
NCBI chr10:96,043,068...96,060,870
Ensembl chr10:96,043,394...96,060,870
G
CCNK
cyclin K
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CCNK mRNA
CTD
PMID:12419474
NCBI chr14:99,481,409...99,512,440
Ensembl chr14:99,481,169...99,535,044
G
CCS
copper chaperone for superoxide dismutase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCS mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr11:66,593,185...66,606,019
Ensembl chr11:66,593,153...66,606,019
G
CD24
CD24 molecule
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CD24 mRNA
CTD
PMID:15336504
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
CD320
CD320 molecule
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CD320 mRNA
CTD
PMID:15336504
NCBI chr19:8,302,127...8,308,358
Ensembl chr19:8,302,127...8,308,358
G
CD46
CD46 molecule
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CD46 mRNA
CTD
PMID:15336504
NCBI chr 1:207,752,038...207,795,516
Ensembl chr 1:207,752,037...207,795,513
G
CD47
CD47 molecule
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CD47 mRNA
CTD
PMID:12419474
NCBI chr 3:108,043,091...108,091,031
Ensembl chr 3:108,043,091...108,091,862
G
CD55
CD55 molecule (Cromer blood group)
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CD55 mRNA
CTD
PMID:15336504
NCBI chr 1:207,321,678...207,360,966
Ensembl chr 1:207,321,519...207,386,804
G
CD68
CD68 molecule
increases expression decreases response to substance
EXP ISO
tert-Butylhydroperoxide results in increased expression of CD68 mRNA CD68 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
G
CD82
CD82 molecule
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CD82 mRNA
CTD
PMID:15336504
NCBI chr11:44,564,409...44,620,358
Ensembl chr11:44,564,427...44,620,358
G
CD9
CD9 molecule
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of CD9 mRNA tert-Butylhydroperoxide affects the expression of CD9 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
G
CD99
CD99 molecule (Xg blood group)
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CD99 mRNA
CTD
PMID:15336504
NCBI chr X:2,691,295...2,741,309 NCBI chr Y:2,691,295...2,741,309
Ensembl chr Y:2,691,187...2,741,309 Ensembl chr X:2,691,187...2,741,309
G
CDC16
cell division cycle 16
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDC16 mRNA
CTD
PMID:15336504
NCBI chr13:114,234,897...114,272,723
Ensembl chr13:114,234,887...114,272,723
G
CDC25B
cell division cycle 25B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDC25B mRNA
CTD
PMID:15336504
NCBI chr20:3,786,951...3,806,115
Ensembl chr20:3,786,772...3,806,121
G
CDC25C
cell division cycle 25C
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of CDC25C mRNA tert-Butylhydroperoxide results in increased expression of CDC25C mRNA
CTD
PMID:12419474 PMID:14729362 PMID:15003993
NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355
G
CDC27
cell division cycle 27
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDC27 mRNA
CTD
PMID:15336504
NCBI chr17:47,117,703...47,189,295
Ensembl chr17:47,117,703...47,189,422
G
CDC37L1
cell division cycle 37 like 1, HSP90 cochaperone
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDC37L1 mRNA
CTD
PMID:15963989
NCBI chr 9:4,679,569...4,708,399
Ensembl chr 9:4,679,559...4,708,399
G
CDC42
cell division cycle 42
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDC42 mRNA
CTD
PMID:15336504
NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360
G
CDC42EP2
CDC42 effector protein 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDC42EP2 mRNA
CTD
PMID:15336504
NCBI chr11:65,314,866...65,322,417
Ensembl chr11:65,314,866...65,322,417
G
CDC42EP3
CDC42 effector protein 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDC42EP3 mRNA
CTD
PMID:15336504
NCBI chr 2:37,641,944...37,672,949
Ensembl chr 2:37,641,882...37,738,468
G
CDC42EP4
CDC42 effector protein 4
affects expression
EXP
tert-Butylhydroperoxide affects the expression of CDC42EP4 mRNA
CTD
PMID:23410634
NCBI chr17:73,283,624...73,312,001
Ensembl chr17:73,283,624...73,312,005
G
CDC42SE1
CDC42 small effector 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDC42SE1 mRNA
CTD
PMID:15336504
NCBI chr 1:151,050,985...151,059,622
Ensembl chr 1:151,050,971...151,070,325
G
CDC5L
cell division cycle 5 like
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDC5L mRNA
CTD
PMID:15336504
NCBI chr 6:44,387,706...44,450,425
Ensembl chr 6:44,387,706...44,450,425
G
CDCA3
cell division cycle associated 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDCA3 mRNA
CTD
PMID:15336504
NCBI chr12:6,844,798...6,851,286
Ensembl chr12:6,844,793...6,851,292
G
CDCP1
CUB domain containing protein 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDCP1 mRNA
CTD
PMID:15336504
NCBI chr 3:45,082,277...45,146,482
Ensembl chr 3:45,082,277...45,146,422
G
CDH11
cadherin 11
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDH11 mRNA
CTD
PMID:12419474
NCBI chr16:64,943,753...65,123,744
Ensembl chr16:64,943,753...65,126,112
G
CDH3
cadherin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDH3 mRNA
CTD
PMID:12419474
NCBI chr16:68,645,310...68,733,771
Ensembl chr16:68,636,189...68,727,468
G
CDH5
cadherin 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDH5 mRNA
CTD
PMID:22659508
NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784
G
CDK1
cyclin dependent kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDK1 mRNA
CTD
PMID:15003993
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDK10
cyclin dependent kinase 10
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDK10 mRNA
CTD
PMID:12419474
NCBI chr16:89,686,689...89,696,354
Ensembl chr16:89,680,737...89,696,354
G
CDK2
cyclin dependent kinase 2
decreases activity multiple interactions decreases expression
EXP
tert-Butylhydroperoxide results in decreased activity of CDK2 protein ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDK2 protein] tert-Butylhydroperoxide results in decreased expression of CDK2 mRNA
CTD
PMID:12766906 PMID:15336504 PMID:15606011
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of CDKN1A mRNA; tert-Butylhydroperoxide results in increased expression of CDKN1A protein [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA; ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDKN1A protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]
CTD
PMID:12414654 PMID:12766906 PMID:12782109 PMID:15336504 PMID:15606011 PMID:18619952 PMID:22563892 PMID:35690295 More...
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1B
cyclin dependent kinase inhibitor 1B
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA
CTD
PMID:35690295
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CDKN1C
cyclin dependent kinase inhibitor 1C
multiple interactions decreases expression increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA] tert-Butylhydroperoxide results in decreased expression of CDKN1C mRNA
CTD
PMID:12419474 PMID:20847119
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
G
CDKN2B
cyclin dependent kinase inhibitor 2B
decreases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of CDKN2B mRNA
CTD
PMID:12419474 PMID:14729362
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
G
CDKN2C
cyclin dependent kinase inhibitor 2C
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CDKN2C mRNA
CTD
PMID:15336504
NCBI chr 1:50,968,706...50,974,634
Ensembl chr 1:50,960,745...50,974,634
G
CDKN3
cyclin dependent kinase inhibitor 3
increases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of CDKN3 mRNA
CTD
PMID:15003993 PMID:27509014
NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
G
CEBPA
CCAAT enhancer binding protein alpha
affects expression
EXP
tert-Butylhydroperoxide affects the expression of CEBPA mRNA
CTD
PMID:23410634
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
G
CEBPB
CCAAT enhancer binding protein beta
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CEBPB mRNA
CTD
PMID:15336504
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
G
CELF2
CUGBP Elav-like family member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CELF2 mRNA
CTD
PMID:15336504
NCBI chr10:10,462,550...11,336,675
Ensembl chr10:10,798,397...11,336,675
G
CELSR2
cadherin EGF LAG seven-pass G-type receptor 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CELSR2 mRNA
CTD
PMID:15336504
NCBI chr 1:109,249,539...109,275,751
Ensembl chr 1:109,249,539...109,275,751
G
CENPA
centromere protein A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CENPA mRNA
CTD
PMID:12414654
NCBI chr 2:26,786,056...26,794,589
Ensembl chr 2:26,764,289...26,801,067
G
CENPM
centromere protein M
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CENPM mRNA
CTD
PMID:15336504
NCBI chr22:41,927,196...41,947,152
Ensembl chr22:41,938,737...41,947,152
G
CEP170
centrosomal protein 170
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CEP170 mRNA
CTD
PMID:15336504
NCBI chr 1:243,124,428...243,255,785
Ensembl chr 1:243,124,428...243,255,793
G
CEP170B
centrosomal protein 170B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CEP170B mRNA
CTD
PMID:15336504
NCBI chr14:104,864,513...104,896,747
Ensembl chr14:104,865,268...104,896,747
G
CEP192
centrosomal protein 192
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CEP192 mRNA
CTD
PMID:15336504
NCBI chr18:12,991,362...13,125,036
Ensembl chr18:12,991,362...13,125,052
G
CEP43
centrosomal protein 43
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CEP43 mRNA
CTD
PMID:15336504
NCBI chr 6:166,999,397...167,052,718
Ensembl chr 6:166,999,174...167,052,718
G
CEP57
centrosomal protein 57
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CEP57 mRNA
CTD
PMID:15336504
NCBI chr11:95,790,498...95,832,693
Ensembl chr11:95,789,965...95,832,693
G
CEP89
centrosomal protein 89
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP89 mRNA
CTD
PMID:15003993
NCBI chr19:32,875,925...32,971,958
Ensembl chr19:32,875,925...32,971,991
G
CFB
complement factor B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CFB mRNA
CTD
PMID:15336504
NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,086
G
CFI
complement factor I
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CFI mRNA
CTD
PMID:15336504
NCBI chr 4:109,730,982...109,801,999
Ensembl chr 4:109,731,008...109,802,150
G
CHAF1A
chromatin assembly factor 1 subunit A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CHAF1A mRNA
CTD
PMID:15336504
NCBI chr19:4,402,640...4,450,830
Ensembl chr19:4,402,640...4,445,018
G
CHDH
choline dehydrogenase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CHDH mRNA
CTD
PMID:27509014
NCBI chr 3:53,812,335...53,846,419
Ensembl chr 3:53,812,335...53,846,419
G
CHEK1
checkpoint kinase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CHEK1 mRNA
CTD
PMID:12414654
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
G
CHKA
choline kinase alpha
affects expression
EXP
tert-Butylhydroperoxide affects the expression of CHKA mRNA
CTD
PMID:23410634
NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444
G
CHMP2A
charged multivesicular body protein 2A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CHMP2A mRNA
CTD
PMID:15336504
NCBI chr19:58,551,566...58,555,105
Ensembl chr19:58,551,452...58,555,105
G
CHORDC1
cysteine and histidine rich domain containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CHORDC1 mRNA
CTD
PMID:15336504
NCBI chr11:90,200,429...90,223,049
Ensembl chr11:90,200,429...90,223,077
G
CHRDL1
chordin like 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CHRDL1 mRNA
CTD
PMID:15336504
NCBI chr X:110,673,856...110,795,817
Ensembl chr X:110,673,856...110,795,819
G
CHST15
carbohydrate sulfotransferase 15
affects expression
EXP
tert-Butylhydroperoxide affects the expression of CHST15 mRNA
CTD
PMID:23410634
NCBI chr10:124,007,668...124,093,598
Ensembl chr10:124,007,668...124,093,598
G
CHST2
carbohydrate sulfotransferase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CHST2 mRNA
CTD
PMID:15336504
NCBI chr 3:143,119,771...143,124,014
Ensembl chr 3:143,119,771...143,124,014
G
CLASP1
cytoplasmic linker associated protein 1
decreases methylation decreases expression
EXP
tert-Butylhydroperoxide results in decreased methylation of CLASP1 intron tert-Butylhydroperoxide results in decreased expression of CLASP1 mRNA
CTD
PMID:29432895
NCBI chr 2:121,337,776...121,649,462
Ensembl chr 2:121,337,776...121,649,476
G
CLCN3
chloride voltage-gated channel 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLCN3 mRNA
CTD
PMID:15003993
NCBI chr 4:169,620,578...169,723,673
Ensembl chr 4:169,612,633...169,723,673
G
CLIC3
chloride intracellular channel 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CLIC3 mRNA
CTD
PMID:15336504
NCBI chr 9:136,994,608...136,996,568
Ensembl chr 9:136,994,608...136,996,568
G
CLN3
CLN3 lysosomal/endosomal transmembrane protein, battenin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CLN3 mRNA
CTD
PMID:15336504
NCBI chr16:28,466,653...28,492,082
Ensembl chr16:28,474,111...28,495,575
G
CLN6
CLN6 transmembrane ER protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CLN6 mRNA
CTD
PMID:15003993
NCBI chr15:68,206,992...68,257,211
Ensembl chr15:68,206,992...68,257,211
G
CLSTN1
calsyntenin 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CLSTN1 mRNA
CTD
PMID:15336504
NCBI chr 1:9,728,926...9,824,526
Ensembl chr 1:9,728,926...9,823,984
G
CLU
clusterin
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CLU mRNA
CTD
PMID:15963989
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CMTM1
CKLF like MARVEL transmembrane domain containing 1
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of CMTM1 gene
CTD
PMID:29432895
NCBI chr16:66,566,439...66,579,135
Ensembl chr16:66,566,393...66,579,137
G
CNDP2
carnosine dipeptidase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CNDP2 mRNA
CTD
PMID:15003993
NCBI chr18:74,496,363...74,523,454
Ensembl chr18:74,495,816...74,523,454
G
CNNM3
cyclin and CBS domain divalent metal cation transport mediator 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CNNM3 mRNA
CTD
PMID:15336504
NCBI chr 2:96,816,268...96,837,466
Ensembl chr 2:96,816,245...96,835,382
G
CNOT8
CCR4-NOT transcription complex subunit 8
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CNOT8 mRNA
CTD
PMID:15336504
NCBI chr 5:154,858,249...154,876,792
Ensembl chr 5:154,857,553...154,876,792
G
COG5
component of oligomeric golgi complex 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COG5 mRNA
CTD
PMID:15336504
NCBI chr 7:107,201,372...107,563,920
Ensembl chr 7:107,201,372...107,564,261
G
COG8
component of oligomeric golgi complex 8
multiple interactions decreases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of COG8 mRNA]
CTD
PMID:20847119
NCBI chr16:69,326,428...69,339,564
Ensembl chr16:69,320,140...69,339,583
G
COL13A1
collagen type XIII alpha 1 chain
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of COL13A1 mRNA
CTD
PMID:15336504
NCBI chr10:69,801,906...69,959,144
Ensembl chr10:69,801,880...69,964,275
G
COL1A2
collagen type I alpha 2 chain
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COL1A2 mRNA
CTD
PMID:15336504
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
G
COL3A1
collagen type III alpha 1 chain
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COL3A1 mRNA
CTD
PMID:15336504
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
COL4A1
collagen type IV alpha 1 chain
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COL4A1 mRNA
CTD
PMID:15336504
NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,202
G
COL4A2
collagen type IV alpha 2 chain
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COL4A2 mRNA
CTD
PMID:15336504
NCBI chr13:110,307,284...110,513,209
Ensembl chr13:110,305,812...110,513,209
G
COL5A1
collagen type V alpha 1 chain
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COL5A1 mRNA
CTD
PMID:15336504
NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843
G
COL5A2
collagen type V alpha 2 chain
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COL5A2 mRNA
CTD
PMID:15336504
NCBI chr 2:189,031,898...189,441,111
Ensembl chr 2:189,031,898...189,225,312
G
COL6A1
collagen type VI alpha 1 chain
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of COL6A1 mRNA
CTD
PMID:15336504
NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,770...46,005,050
G
COL6A2
collagen type VI alpha 2 chain
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of COL6A2 mRNA
CTD
PMID:15336504
NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848
G
COL7A1
collagen type VII alpha 1 chain
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of COL7A1 mRNA
CTD
PMID:15336504
NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,329
G
COL8A2
collagen type VIII alpha 2 chain
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COL8A2 mRNA
CTD
PMID:15336504
NCBI chr 1:36,095,239...36,125,222
Ensembl chr 1:36,095,239...36,125,222
G
COMT
catechol-O-methyltransferase
decreases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of COMT mRNA tert-Butylhydroperoxide results in decreased expression of COMT protein
CTD
PMID:12419474 PMID:24394546
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
G
COPA
COPI coat complex subunit alpha
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COPA mRNA
CTD
PMID:15336504
NCBI chr 1:160,288,594...160,343,250
Ensembl chr 1:160,288,594...160,343,566
G
COPB1
COPI coat complex subunit beta 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of COPB1 mRNA
CTD
PMID:15336504
NCBI chr11:14,457,512...14,499,811
Ensembl chr11:14,443,440...14,500,027
G
COPE
COPI coat complex subunit epsilon
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COPE mRNA
CTD
PMID:15336504
NCBI chr19:18,899,514...18,919,387
Ensembl chr19:18,899,514...18,919,387
G
COPS6
COP9 signalosome subunit 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COPS6 mRNA
CTD
PMID:15336504
NCBI chr 7:100,088,969...100,092,187
Ensembl chr 7:100,088,969...100,092,187
G
COPS8
COP9 signalosome subunit 8
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of COPS8 mRNA
CTD
PMID:15336504
NCBI chr 2:237,085,889...237,100,474
Ensembl chr 2:237,085,882...237,100,474
G
COX7A1
cytochrome c oxidase subunit 7A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COX7A1 mRNA
CTD
PMID:15003993
NCBI chr19:36,150,922...36,152,447
Ensembl chr19:36,150,922...36,152,449
G
CP
ceruloplasmin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CP mRNA
CTD
PMID:14729362
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
G
CPE
carboxypeptidase E
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CPE mRNA tert-Butylhydroperoxide results in increased expression of CPE mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 4:165,379,008...165,498,547
Ensembl chr 4:165,361,194...165,498,547
G
CPM
carboxypeptidase M
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CPM mRNA
CTD
PMID:15336504
NCBI chr12:68,842,197...68,963,469
Ensembl chr12:68,842,197...68,971,570
G
CPNE1
copine 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CPNE1 mRNA
CTD
PMID:15336504
NCBI chr20:35,626,044...35,664,900
Ensembl chr20:35,626,031...35,664,956
G
CPQ
carboxypeptidase Q
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CPQ mRNA
CTD
PMID:15336504
NCBI chr 8:96,645,242...97,143,501
Ensembl chr 8:96,645,242...97,149,654
G
CRAT
carnitine O-acetyltransferase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CRAT mRNA
CTD
PMID:15336504
NCBI chr 9:129,094,794...129,110,793
Ensembl chr 9:129,094,142...129,111,189
G
CREB1
cAMP responsive element binding protein 1
decreases expression multiple interactions increases phosphorylation
EXP
tert-Butylhydroperoxide results in decreased expression of CREB1 mRNA U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of CREB1 protein]
CTD
PMID:12419474 PMID:17003459
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CRIP1
cysteine rich protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CRIP1 mRNA
CTD
PMID:15003993
NCBI chr14:105,486,886...105,488,947
Ensembl chr14:105,486,317...105,488,947
G
CRISPLD2
cysteine rich secretory protein LCCL domain containing 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CRISPLD2 mRNA
CTD
PMID:15336504
NCBI chr16:84,819,985...84,909,508
Ensembl chr16:84,819,985...84,920,768
G
CRYAB
crystallin alpha B
multiple interactions increases expression decreases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA] tert-Butylhydroperoxide results in decreased expression of CRYAB mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
G
CRYZ
crystallin zeta
decreases response to substance increases expression
ISO
CRYZ protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CRYZ mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 1:74,705,486...74,733,050
Ensembl chr 1:74,705,482...74,733,408
G
CSF1
colony stimulating factor 1
decreases response to substance
EXP
CSF1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:16446085
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
G
CSNK1D
casein kinase 1 delta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CSNK1D mRNA
CTD
PMID:15336504
NCBI chr17:82,239,019...82,273,750
Ensembl chr17:82,239,023...82,273,700
G
CSPG4
chondroitin sulfate proteoglycan 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CSPG4 mRNA
CTD
PMID:15336504
NCBI chr15:75,674,322...75,713,466
Ensembl chr15:75,674,322...75,712,848
G
CTDSPL
CTD small phosphatase like
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CTDSPL mRNA
CTD
PMID:15336504
NCBI chr 3:37,861,880...37,984,469
Ensembl chr 3:37,861,880...37,984,469
G
CTH
cystathionine gamma-lyase
increases activity
ISO
tert-Butylhydroperoxide results in increased activity of CTH protein
CTD
PMID:18184479
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
G
CTNNA1
catenin alpha 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CTNNA1 mRNA
CTD
PMID:12419474
NCBI chr 5:138,753,425...138,935,034
Ensembl chr 5:138,610,967...138,935,034
G
CTNNB1
catenin beta 1
multiple interactions increases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]
CTD
PMID:20847119
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CTSB
cathepsin B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CTSB mRNA
CTD
PMID:15336504
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CTSL
cathepsin L
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CTSL mRNA tert-Butylhydroperoxide results in increased expression of CTSL mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
CTTN
cortactin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CTTN mRNA
CTD
PMID:12419474
NCBI chr11:70,398,529...70,436,575
Ensembl chr11:70,398,404...70,436,584
G
CUL4A
cullin 4A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CUL4A mRNA
CTD
PMID:15336504
NCBI chr13:113,208,193...113,267,108
Ensembl chr13:113,208,193...113,267,108
G
CUX1
cut like homeobox 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CUX1 mRNA
CTD
PMID:12419474
NCBI chr 7:101,816,007...102,283,958
Ensembl chr 7:101,815,904...102,283,958
G
CXADR
CXADR Ig-like cell adhesion molecule
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CXADR mRNA
CTD
PMID:15336504
NCBI chr21:17,513,043...17,636,262
Ensembl chr21:17,513,043...17,593,579
G
CXCL1
C-X-C motif chemokine ligand 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA
CTD
PMID:15336504
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL10 mRNA
CTD
PMID:15003993
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CXCL2 mRNA
CTD
PMID:15336504
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL3
C-X-C motif chemokine ligand 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CXCL3 mRNA
CTD
PMID:15336504
NCBI chr 4:74,036,589...74,038,689
Ensembl chr 4:74,036,589...74,038,807
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions increases expression increases secretion affects expression
EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of CXCL8 protein]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of CXCL8 protein]; [Catechin co-treated with tert-Butylhydroperoxide co-treated with Hydrocortisone] results in decreased secretion of CXCL8 protein; [Grape Seed Extract co-treated with tert-Butylhydroperoxide co-treated with Hydrocortisone] results in decreased secretion of CXCL8 protein; [tert-Butylhydroperoxide co-treated with Hydrocortisone] results in decreased secretion of CXCL8 protein; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; W 7 inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of CXCL8 protein] tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA; tert-Butylhydroperoxide results in increased expression of CXCL8 protein tert-Butylhydroperoxide affects the expression of CXCL8 mRNA
CTD
PMID:15336504 PMID:17129690 PMID:23410634 PMID:28063877 PMID:29111459 PMID:29935159 More...
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCR4
C-X-C motif chemokine receptor 4
multiple interactions increases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]
CTD
PMID:20847119
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
CXXC5
CXXC finger protein 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CXXC5 mRNA
CTD
PMID:29432895
NCBI chr 5:139,647,299...139,683,882
Ensembl chr 5:139,647,299...139,683,882
G
CYB561
cytochrome b561
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CYB561 mRNA
CTD
PMID:15336504
NCBI chr17:63,432,304...63,446,639
Ensembl chr17:63,432,304...63,446,354
G
CYB5D2
cytochrome b5 domain containing 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of CYB5D2 mRNA
CTD
PMID:23410634
NCBI chr17:4,143,168...4,157,701
Ensembl chr17:4,143,168...4,187,310
G
CYB5R2
cytochrome b5 reductase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CYB5R2 mRNA
CTD
PMID:15336504
NCBI chr11:7,665,095...7,674,267
Ensembl chr11:7,665,100...7,677,222
G
CYBC1
cytochrome b-245 chaperone 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CYBC1 mRNA
CTD
PMID:15336504
NCBI chr17:82,442,586...82,450,752
Ensembl chr17:82,440,912...82,450,829
G
CYCS
cytochrome c, somatic
multiple interactions affects localization
EXP
hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein]
CTD
PMID:18552516
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
CYGB
cytoglobin
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CYGB mRNA
CTD
PMID:27509014
NCBI chr17:76,527,356...76,551,193
Ensembl chr17:76,527,356...76,551,175
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CYP1B1 mRNA
CTD
PMID:12414654
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of CYP24A1 mRNA
CTD
PMID:23410634
NCBI chr20:54,143,538...54,173,986
Ensembl chr20:54,153,446...54,173,986
G
CYRIA
CYFIP related Rac1 interactor A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CYRIA mRNA
CTD
PMID:15336504
NCBI chr 2:16,549,459...16,665,834
Ensembl chr 2:16,549,459...16,666,331
G
DAP3
death associated protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DAP3 mRNA
CTD
PMID:14729362
NCBI chr 1:155,687,948...155,739,010
Ensembl chr 1:155,687,960...155,739,010
G
DAPK1
death associated protein kinase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DAPK1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634
G
DARS1
aspartyl-tRNA synthetase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DARS1 mRNA
CTD
PMID:15336504
NCBI chr 2:135,905,881...135,985,684
Ensembl chr 2:135,905,881...135,986,100
G
DAZAP2
DAZ associated protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DAZAP2 mRNA
CTD
PMID:15336504
NCBI chr12:51,238,826...51,246,717
Ensembl chr12:51,238,724...51,271,362
G
DBI
diazepam binding inhibitor, acyl-CoA binding protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DBI mRNA
CTD
PMID:15336504
NCBI chr 2:119,366,977...119,372,543
Ensembl chr 2:119,366,924...119,372,550
G
DCAF7
DDB1 and CUL4 associated factor 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DCAF7 mRNA
CTD
PMID:15336504
NCBI chr17:63,550,477...63,594,266
Ensembl chr17:63,550,222...63,594,286
G
DCTN5
dynactin subunit 5
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of DCTN5 gene
CTD
PMID:29432895
NCBI chr16:23,641,466...23,677,472
Ensembl chr16:23,641,466...23,677,472
G
DDB2
damage specific DNA binding protein 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DDB2 mRNA
CTD
PMID:15336504
NCBI chr11:47,214,454...47,239,217
Ensembl chr11:47,214,465...47,239,217
G
DDIT3
DNA damage inducible transcript 3
increases expression multiple interactions
EXP ISO
tert-Butylhydroperoxide results in increased expression of DDIT3 mRNA; tert-Butylhydroperoxide results in increased expression of DDIT3 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]
CTD
PMID:12414654 PMID:22659508 PMID:24394546
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DDIT4
DNA damage inducible transcript 4
affects expression
EXP
tert-Butylhydroperoxide affects the expression of DDIT4 mRNA
CTD
PMID:23410634
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
G
DDR1
discoidin domain receptor tyrosine kinase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DDR1 mRNA
CTD
PMID:15336504
NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
G
DDX11
DEAD/H-box helicase 11
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DDX11 mRNA
CTD
PMID:15336504
NCBI chr12:31,073,860...31,104,799
Ensembl chr12:31,073,860...31,104,799
G
DDX21
DExD-box helicase 21
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DDX21 mRNA
CTD
PMID:15336504
NCBI chr10:68,956,170...68,985,068
Ensembl chr10:68,956,135...68,985,068
G
DDX42
DEAD-box helicase 42
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DDX42 mRNA
CTD
PMID:12414654
NCBI chr17:63,773,800...63,819,317
Ensembl chr17:63,773,603...63,819,317
G
DDX43
DEAD-box helicase 43
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DDX43 mRNA
CTD
PMID:15336504
NCBI chr 6:73,394,828...73,417,566
Ensembl chr 6:73,394,828...73,417,566
G
DDX50
DExD-box helicase 50
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDX50 mRNA
CTD
PMID:15003993
NCBI chr10:68,901,315...68,946,847
Ensembl chr10:68,901,286...68,946,847
G
DDX52
DExD-box helicase 52
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DDX52 mRNA
CTD
PMID:15336504
NCBI chr17:37,609,739...37,643,446
Ensembl chr17:37,609,739...37,643,446
G
DDX56
DEAD-box helicase 56
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DDX56 mRNA
CTD
PMID:15336504
NCBI chr 7:44,565,804...44,573,908
Ensembl chr 7:44,565,804...44,575,051
G
DDX6
DEAD-box helicase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX6 mRNA
CTD
PMID:15003993
NCBI chr11:118,747,763...118,791,744
Ensembl chr11:118,747,763...118,791,164
G
DENND3
DENN domain containing 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DENND3 mRNA
CTD
PMID:15336504
NCBI chr 8:141,128,589...141,195,804
Ensembl chr 8:141,117,278...141,195,808
G
DEPP1
DEPP autophagy regulator 1
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]
CTD
PMID:20847119
NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809
G
DERL1
derlin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DERL1 mRNA
CTD
PMID:15003993
NCBI chr 8:123,013,170...123,042,302
Ensembl chr 8:123,013,170...123,042,302
G
DFFB
DNA fragmentation factor subunit beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DFFB mRNA
CTD
PMID:12419474
NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429
G
DGAT2
diacylglycerol O-acyltransferase 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of DGAT2 mRNA
CTD
PMID:23410634
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
G
DHPS
deoxyhypusine synthase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DHPS mRNA
CTD
PMID:15336504
NCBI chr19:12,672,470...12,681,880
Ensembl chr19:12,675,717...12,681,880
G
DHX9
DExH-box helicase 9
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DHX9 mRNA
CTD
PMID:15336504
NCBI chr 1:182,839,347...182,887,982
Ensembl chr 1:182,839,347...182,887,982
G
DIMT1
DIM1 rRNA methyltransferase and ribosome maturation factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DIMT1 mRNA
CTD
PMID:15336504
NCBI chr 5:62,387,254...62,403,905
Ensembl chr 5:62,347,284...62,403,943
G
DIP2C
disco interacting protein 2 homolog C
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DIP2C mRNA
CTD
PMID:15336504
NCBI chr10:274,201...689,668
Ensembl chr10:274,201...689,668
G
DKK1
dickkopf WNT signaling pathway inhibitor 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DKK1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
G
DLG1
discs large MAGUK scaffold protein 1
multiple interactions increases expression
EXP
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DLG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DLG1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]
CTD
PMID:20847119
NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330
G
DLG3
discs large MAGUK scaffold protein 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DLG3 mRNA
CTD
PMID:15336504
NCBI chr X:70,444,835...70,505,490
Ensembl chr X:70,444,835...70,505,490
G
DLGAP4
DLG associated protein 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DLGAP4 mRNA
CTD
PMID:15336504
NCBI chr20:36,306,339...36,528,633
Ensembl chr20:36,306,336...36,528,637
G
DLGAP5
DLG associated protein 5
increases expression affects expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of DLGAP5 mRNA tert-Butylhydroperoxide affects the expression of DLGAP5 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr14:55,148,135...55,191,585
Ensembl chr14:55,148,112...55,191,608
G
DLX2
distal-less homeobox 2
increases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of DLX2 mRNA
CTD
PMID:14729362 PMID:29432895
NCBI chr 2:172,099,438...172,102,900
Ensembl chr 2:172,099,438...172,102,900
G
DMPK
DM1 protein kinase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DMPK mRNA
CTD
PMID:15003993
NCBI chr19:45,769,709...45,782,490
Ensembl chr19:45,769,709...45,782,552
G
DNAAF2
dynein axonemal assembly factor 2
multiple interactions decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]
CTD
PMID:20847119
NCBI chr14:49,625,174...49,635,244
Ensembl chr14:49,625,174...49,635,244
G
DNAJB1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DNAJB1 mRNA
CTD
PMID:15336504
NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391
G
DNAJB11
DnaJ heat shock protein family (Hsp40) member B11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB11 mRNA
CTD
PMID:15003993
NCBI chr 3:186,570,720...186,585,793
Ensembl chr 3:186,567,403...186,585,800
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DNAJB4 mRNA
CTD
PMID:15336504
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
DNAJB7
DnaJ heat shock protein family (Hsp40) member B7
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of DNAJB7 intron
CTD
PMID:29432895
NCBI chr22:40,859,549...40,862,113
Ensembl chr22:40,859,549...40,862,113
G
DNASE2
deoxyribonuclease 2, lysosomal
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DNASE2 mRNA
CTD
PMID:15336504
NCBI chr19:12,875,209...12,881,449
Ensembl chr19:12,875,209...12,881,595
G
DNM2
dynamin 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DNM2 mRNA
CTD
PMID:15336504
NCBI chr19:10,718,079...10,831,903
Ensembl chr19:10,718,055...10,833,488
G
DNMBP
dynamin binding protein
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DNMBP mRNA
CTD
PMID:15336504
NCBI chr10:99,875,571...100,009,947
Ensembl chr10:99,875,577...100,009,947
G
DNPH1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DNPH1 mRNA
CTD
PMID:12419474
NCBI chr 6:43,225,629...43,229,481
Ensembl chr 6:43,225,629...43,229,481
G
DOCK2
dedicator of cytokinesis 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DOCK2 mRNA
CTD
PMID:15336504
NCBI chr 5:169,637,275...170,083,382
Ensembl chr 5:169,637,268...170,083,382
G
DOCK4
dedicator of cytokinesis 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DOCK4 mRNA
CTD
PMID:15336504
NCBI chr 7:111,726,110...112,206,399
Ensembl chr 7:111,726,110...112,206,407
G
DPP4
dipeptidyl peptidase 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DPP4 mRNA
CTD
PMID:15336504
NCBI chr 2:161,992,245...162,074,215
Ensembl chr 2:161,992,245...162,074,394
G
DPY19L1
dpy-19 like C-mannosyltransferase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DPY19L1 mRNA
CTD
PMID:15336504
NCBI chr 7:34,928,881...35,038,041
Ensembl chr 7:34,927,292...35,038,271
G
DPYSL3
dihydropyrimidinase like 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DPYSL3 mRNA
CTD
PMID:15336504
NCBI chr 5:147,390,808...147,510,068
Ensembl chr 5:147,390,808...147,510,068
G
DRAP1
DR1 associated protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DRAP1 mRNA
CTD
PMID:15003993
NCBI chr11:65,919,426...65,921,563
Ensembl chr11:65,919,274...65,921,563
G
DSC3
desmocollin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DSC3 mRNA
CTD
PMID:15336504
NCBI chr18:30,989,365...31,042,742
Ensembl chr18:30,989,365...31,042,815
G
DST
dystonin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DST mRNA
CTD
PMID:12419474
NCBI chr 6:56,457,996...56,954,830
Ensembl chr 6:56,457,987...56,954,830
G
DTX2P1-UPK3BP1-PMS2P11
DTX2P1-UPK3BP1-PMS2P11 readthrough, transcribed pseudogene
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DTX2P1-UPK3BP1-PMS2P11 mRNA
CTD
PMID:15336504
NCBI chr 7:76,980,822...77,023,761
Ensembl chr 7:76,959,835...77,043,775
G
DUSP1
dual specificity phosphatase 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of DUSP1 mRNA
CTD
PMID:23410634
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP10
dual specificity phosphatase 10
multiple interactions increases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]
CTD
PMID:15336504 PMID:20847119
NCBI chr 1:221,701,424...221,742,089
Ensembl chr 1:221,701,424...221,742,089
G
DUSP5
dual specificity phosphatase 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of DUSP5 mRNA
CTD
PMID:15336504
NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533
G
DUSP6
dual specificity phosphatase 6
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DUSP6 mRNA tert-Butylhydroperoxide results in increased expression of DUSP6 mRNA
CTD
PMID:15336504 PMID:17003459
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
DUSP9
dual specificity phosphatase 9
affects expression
EXP
tert-Butylhydroperoxide affects the expression of DUSP9 mRNA
CTD
PMID:23410634
NCBI chr X:153,642,441...153,651,326
Ensembl chr X:153,642,492...153,651,326
G
DUT
deoxyuridine triphosphatase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DUT mRNA
CTD
PMID:15336504
NCBI chr15:48,331,095...48,343,373
Ensembl chr15:48,331,011...48,343,373
G
DVL3
dishevelled segment polarity protein 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DVL3 mRNA
CTD
PMID:29432895
NCBI chr 3:184,155,377...184,173,614
Ensembl chr 3:184,155,377...184,173,614
G
DYNLL1
dynein light chain LC8-type 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DYNLL1 mRNA
CTD
PMID:12419474
NCBI chr12:120,469,842...120,498,493
Ensembl chr12:120,469,850...120,498,493
G
DYNLRB1
dynein light chain roadblock-type 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of DYNLRB1 mRNA
CTD
PMID:15336504
NCBI chr20:34,515,602...34,540,958
Ensembl chr20:34,516,395...34,540,958
G
E2F1
E2F transcription factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of E2F1 mRNA
CTD
PMID:12419474
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
ECH1
enoyl-CoA hydratase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ECH1 mRNA
CTD
PMID:15003993
NCBI chr19:38,815,422...38,831,794
Ensembl chr19:38,815,422...38,831,841
G
ECHDC2
enoyl-CoA hydratase domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ECHDC2 mRNA
CTD
PMID:15336504
NCBI chr 1:52,895,910...52,921,774
Ensembl chr 1:52,895,910...52,927,212
G
ECHS1
enoyl-CoA hydratase, short chain 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECHS1 protein
CTD
PMID:24394546
NCBI chr10:133,362,485...133,373,354
Ensembl chr10:133,362,485...133,373,354
G
ECI1
enoyl-CoA delta isomerase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ECI1 mRNA
CTD
PMID:15336504
NCBI chr16:2,239,402...2,251,587
Ensembl chr16:2,239,402...2,252,300
G
ECSIT
ECSIT signaling integrator
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ECSIT mRNA
CTD
PMID:15336504
NCBI chr19:11,505,929...11,529,134
Ensembl chr19:11,505,929...11,529,172
G
EDIL3
EGF like repeats and discoidin domains 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EDIL3 mRNA
CTD
PMID:15336504
NCBI chr 5:83,940,554...84,384,880
Ensembl chr 5:83,940,554...84,384,880
G
EDN1
endothelin 1
increases expression affects expression
EXP
tert-Butylhydroperoxide results in increased expression of EDN1 mRNA tert-Butylhydroperoxide affects the expression of EDN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EEF2
eukaryotic translation elongation factor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EEF2 protein
CTD
PMID:16469450
NCBI chr19:3,976,056...3,985,463
Ensembl chr19:3,976,056...3,985,463
G
EFEMP1
EGF containing fibulin extracellular matrix protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EFEMP1 mRNA
CTD
PMID:15336504
NCBI chr 2:55,865,967...55,923,782
Ensembl chr 2:55,865,967...55,924,139
G
EFHD1
EF-hand domain family member D1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EFHD1 mRNA
CTD
PMID:15336504
NCBI chr 2:232,606,057...232,682,776
Ensembl chr 2:232,606,057...232,682,776
G
EFNA4
ephrin A4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EFNA4 mRNA
CTD
PMID:12419474
NCBI chr 1:155,063,740...155,069,553
Ensembl chr 1:155,063,737...155,069,553
G
EFS
embryonal Fyn-associated substrate
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of EFS mRNA
CTD
PMID:15336504
NCBI chr14:23,356,406...23,365,172
Ensembl chr14:23,356,403...23,365,752
G
EGFR
epidermal growth factor receptor
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA]
CTD
PMID:35690295
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGR1
early growth response 1
increases expression affects expression
EXP
tert-Butylhydroperoxide results in increased expression of EGR1 mRNA tert-Butylhydroperoxide affects the expression of EGR1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EIF2AK2
eukaryotic translation initiation factor 2 alpha kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF2AK2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,522
G
EIF2B4
eukaryotic translation initiation factor 2B subunit delta
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of EIF2B4 mRNA
CTD
PMID:15336504
NCBI chr 2:27,364,352...27,370,338
Ensembl chr 2:27,364,352...27,370,338
G
EIF3M
eukaryotic translation initiation factor 3 subunit M
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of EIF3M mRNA
CTD
PMID:15336504
NCBI chr11:32,583,831...32,606,264
Ensembl chr11:32,583,798...32,606,264
G
EIF5
eukaryotic translation initiation factor 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of EIF5 mRNA
CTD
PMID:15336504
NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025
G
EIF5B
eukaryotic translation initiation factor 5B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of EIF5B mRNA
CTD
PMID:15336504
NCBI chr 2:99,337,389...99,401,326
Ensembl chr 2:99,337,389...99,401,326
G
ELAVL1
ELAV like RNA binding protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ELAVL1 mRNA
CTD
PMID:15336504
NCBI chr19:7,958,573...8,005,641
Ensembl chr19:7,958,573...8,005,659
G
ELF1
E74 like ETS transcription factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ELF1 mRNA
CTD
PMID:15336504
NCBI chr13:40,931,919...41,061,386
Ensembl chr13:40,931,924...41,061,440
G
ELF5
E74 like ETS transcription factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ELF5 mRNA
CTD
PMID:15003993
NCBI chr11:34,478,791...34,513,794
Ensembl chr11:34,478,791...34,525,193
G
ELOB
elongin B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ELOB mRNA
CTD
PMID:15336504
NCBI chr16:2,771,414...2,777,280
Ensembl chr16:2,771,414...2,777,289
G
EME1
essential meiotic structure-specific endonuclease 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of EME1 mRNA
CTD
PMID:27509014
NCBI chr17:50,373,229...50,381,483
Ensembl chr17:50,373,220...50,381,483
G
EMILIN1
elastin microfibril interfacer 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of EMILIN1 mRNA
CTD
PMID:23410634
NCBI chr 2:27,078,615...27,086,403
Ensembl chr 2:27,078,615...27,086,403
G
EML1
EMAP like 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of EML1 mRNA
CTD
PMID:15336504
NCBI chr14:99,737,722...99,942,060
Ensembl chr14:99,737,693...99,942,060
G
EML4
EMAP like 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EML4 mRNA
CTD
PMID:15336504
NCBI chr 2:42,169,353...42,332,548
Ensembl chr 2:42,169,353...42,332,548
G
EMP3
epithelial membrane protein 3 (MAM blood group)
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EMP3 mRNA
CTD
PMID:15003993
NCBI chr19:48,325,552...48,330,553
Ensembl chr19:48,321,509...48,330,553
G
ENG
endoglin
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ENG mRNA
CTD
PMID:15336504
NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,811,130...127,854,773
G
EPB41L2
erythrocyte membrane protein band 4.1 like 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EPB41L2 mRNA
CTD
PMID:15336504
NCBI chr 6:130,839,347...131,063,245
Ensembl chr 6:130,839,347...131,063,322
G
EPB42
erythrocyte membrane protein band 4.2
increases degradation
EXP
tert-Butylhydroperoxide results in increased degradation of EPB42 protein
CTD
PMID:15040847
NCBI chr15:43,197,227...43,225,737
Ensembl chr15:43,197,227...43,221,018
G
EPHB2
EPH receptor B2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of EPHB2 mRNA
CTD
PMID:15336504
NCBI chr 1:22,710,838...22,921,500
Ensembl chr 1:22,710,839...22,921,500
G
EPHB4
EPH receptor B4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EPHB4 mRNA
CTD
PMID:15336504
NCBI chr 7:100,802,565...100,827,523
Ensembl chr 7:100,802,565...100,827,523
G
EPHX1
epoxide hydrolase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHX1 mRNA
CTD
PMID:21382384
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
EPHX2
epoxide hydrolase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHX2 mRNA
CTD
PMID:14729362
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
ERBB2
erb-b2 receptor tyrosine kinase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ERBB2 mRNA
CTD
PMID:15336504
NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
G
ERBB4
erb-b2 receptor tyrosine kinase 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ERBB4 mRNA
CTD
PMID:12419474
NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
G
ERBIN
erbb2 interacting protein
multiple interactions increases expression
EXP
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of ERBIN mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]
CTD
PMID:20847119
NCBI chr 5:65,926,575...66,082,546
Ensembl chr 5:65,883,128...66,082,546
G
ERCC5
ERCC excision repair 5, endonuclease
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ERCC5 mRNA
CTD
PMID:12419474
NCBI chr13:102,846,032...102,875,995
Ensembl chr13:102,845,831...102,875,995
G
ERN1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
EXP
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]
CTD
PMID:24394546
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
G
ERP29
endoplasmic reticulum protein 29
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ERP29 mRNA
CTD
PMID:15336504
NCBI chr12:112,013,426...112,023,449
Ensembl chr12:112,013,348...112,023,449
G
ESM1
endothelial cell specific molecule 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ESM1 mRNA
CTD
PMID:15336504
NCBI chr 5:54,977,867...54,985,593
Ensembl chr 5:54,977,867...55,022,671
G
ESS2
ess-2 splicing factor homolog
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ESS2 mRNA
CTD
PMID:15336504
NCBI chr22:19,130,279...19,144,651
Ensembl chr22:19,130,279...19,144,684
G
ETF1
eukaryotic translation termination factor 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ETF1 mRNA
CTD
PMID:15336504
NCBI chr 5:138,506,095...138,543,236
Ensembl chr 5:138,506,095...138,543,236
G
ETFA
electron transfer flavoprotein subunit alpha
multiple interactions increases expression decreases expression
EXP ISO
ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; pyrazolanthrone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ETFA protein] tert-Butylhydroperoxide results in decreased expression of ETFA protein
CTD
PMID:24394546
NCBI chr15:76,215,353...76,311,469
Ensembl chr15:76,188,555...76,311,730
G
ETFB
electron transfer flavoprotein subunit beta
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of ETFB mRNA tert-Butylhydroperoxide results in increased methylation of ETFB gene
CTD
PMID:15336504 PMID:29432895
NCBI chr19:51,345,155...51,366,388
Ensembl chr19:51,345,169...51,366,388
G
ETS1
ETS proto-oncogene 1, transcription factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ETS1 mRNA
CTD
PMID:12419474
NCBI chr11:128,458,765...128,587,558
Ensembl chr11:128,458,761...128,587,558
G
ETS2
ETS proto-oncogene 2, transcription factor
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ETS2 mRNA tert-Butylhydroperoxide results in increased expression of ETS2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr21:38,805,183...38,824,955
Ensembl chr21:38,805,183...38,824,955
G
ETV3
ETS variant transcription factor 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ETV3 mRNA
CTD
PMID:12419474
NCBI chr 1:157,121,191...157,138,395
Ensembl chr 1:157,121,191...157,138,474
G
ETV4
ETS variant transcription factor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETV4 mRNA
CTD
PMID:15003993
NCBI chr17:43,527,846...43,546,340
Ensembl chr17:43,527,844...43,579,620
G
ETV5
ETS variant transcription factor 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ETV5 mRNA
CTD
PMID:15336504
NCBI chr 3:186,046,314...186,109,089
Ensembl chr 3:186,046,314...186,110,318
G
EXO1
exonuclease 1
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]
CTD
PMID:35690295
NCBI chr 1:241,847,986...241,889,939
Ensembl chr 1:241,847,967...241,895,148
G
EXOC7
exocyst complex component 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EXOC7 mRNA
CTD
PMID:15336504
NCBI chr17:76,081,016...76,103,787
Ensembl chr17:76,081,016...76,121,576
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EZH2 mRNA
CTD
PMID:15336504
NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
G
EZR
ezrin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EZR mRNA
CTD
PMID:12419474
NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
G
F2RL1
F2R like trypsin receptor 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of F2RL1 mRNA
CTD
PMID:23410634
NCBI chr 5:76,819,030...76,835,315
Ensembl chr 5:76,818,933...76,835,315
G
FAH
fumarylacetoacetate hydrolase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAH protein
CTD
PMID:24394546
NCBI chr15:80,152,789...80,186,949
Ensembl chr15:80,152,490...80,186,946
G
FAM110B
family with sequence similarity 110 member B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FAM110B mRNA
CTD
PMID:29432895
NCBI chr 8:57,994,523...58,148,784
Ensembl chr 8:57,994,523...58,204,279
G
FAM111A
FAM111 trypsin like peptidase A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FAM111A mRNA
CTD
PMID:15336504
NCBI chr11:59,142,856...59,155,039
Ensembl chr11:59,142,748...59,155,039
G
FAM13B
family with sequence similarity 13 member B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM13B mRNA
CTD
PMID:15003993
NCBI chr 5:137,937,960...138,052,178
Ensembl chr 5:137,937,960...138,051,961
G
FAM171A1
family with sequence similarity 171 member A1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FAM171A1 mRNA
CTD
PMID:29432895
NCBI chr10:15,211,643...15,374,554
Ensembl chr10:15,211,643...15,371,289
G
FAM210A
family with sequence similarity 210 member A
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]
CTD
PMID:20847119
NCBI chr18:13,663,347...13,726,558
Ensembl chr18:13,663,347...13,726,663
G
FANCI
FA complementation group I
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FANCI mRNA
CTD
PMID:15336504
NCBI chr15:89,243,979...89,317,259
Ensembl chr15:89,243,945...89,317,261
G
FARP1
FERM, ARH/RhoGEF and pleckstrin domain protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FARP1 mRNA
CTD
PMID:15336504
NCBI chr13:98,142,589...98,455,176
Ensembl chr13:98,142,562...98,455,176
G
FAS
Fas cell surface death receptor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FAS mRNA
CTD
PMID:12414654 PMID:27509014
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASTK
Fas activated serine/threonine kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FASTK mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 7:151,076,624...151,080,809
Ensembl chr 7:151,076,624...151,080,866
G
FBLN1
fibulin 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FBLN1 mRNA
CTD
PMID:15336504
NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
G
FBXO30
F-box protein 30
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FBXO30 mRNA
CTD
PMID:23410634
NCBI chr 6:145,793,502...145,814,795
Ensembl chr 6:145,793,502...145,814,795
G
FDPS
farnesyl diphosphate synthase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FDPS mRNA
CTD
PMID:15336504
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
G
FDX1
ferredoxin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FDX1 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr11:110,429,331...110,464,884
Ensembl chr11:110,429,948...110,464,884
G
FDXR
ferredoxin reductase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FDXR mRNA
CTD
PMID:12414654 PMID:27509014
NCBI chr17:74,862,497...74,872,994
Ensembl chr17:74,862,497...74,873,031
G
FEN1
flap structure-specific endonuclease 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FEN1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr11:61,792,911...61,797,238
Ensembl chr11:61,792,911...61,797,238
G
FERMT2
FERM domain containing kindlin 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FERMT2 mRNA
CTD
PMID:15336504
NCBI chr14:52,857,273...52,951,050
Ensembl chr14:52,857,268...52,952,435
G
FGG
fibrinogen gamma chain
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FGG mRNA
CTD
PMID:12414654
NCBI chr 4:154,604,136...154,612,656
Ensembl chr 4:154,604,134...154,612,967
G
FH
fumarate hydratase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FH mRNA
CTD
PMID:15336504
NCBI chr 1:241,497,603...241,519,755
Ensembl chr 1:241,497,511...241,519,799
G
FHL1
four and a half LIM domains 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FHL1 mRNA
CTD
PMID:15336504
NCBI chr X:136,146,702...136,211,359
Ensembl chr X:136,146,702...136,211,359
G
FHL2
four and a half LIM domains 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FHL2 mRNA
CTD
PMID:15336504
NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513
G
FHOD3
formin homology 2 domain containing 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FHOD3 mRNA
CTD
PMID:15336504
NCBI chr18:36,297,713...36,780,220
Ensembl chr18:36,297,713...36,780,220
G
FIBP
FGF1 intracellular binding protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FIBP mRNA
CTD
PMID:15336504
NCBI chr11:65,883,740...65,888,471
Ensembl chr11:65,883,740...65,888,531
G
FIS1
fission, mitochondrial 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FIS1 mRNA
CTD
PMID:15336504
NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316
G
FJX1
four-jointed box kinase 1
multiple interactions decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA]
CTD
PMID:20847119
NCBI chr11:35,618,460...35,620,865
Ensembl chr11:35,618,460...35,620,865
G
FKBP1A
FKBP prolyl isomerase 1A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FKBP1A mRNA
CTD
PMID:15336504
NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164
G
FKBP8
FKBP prolyl isomerase 8
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FKBP8 mRNA
CTD
PMID:15336504
NCBI chr19:18,531,763...18,543,573
Ensembl chr19:18,531,751...18,544,077
G
FLNB
filamin B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FLNB mRNA
CTD
PMID:15336504
NCBI chr 3:58,008,422...58,172,251
Ensembl chr 3:58,008,398...58,172,251
G
FMO1
flavin containing dimethylaniline monoxygenase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FMO1 mRNA
CTD
PMID:12419474
NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978
G
FN1
fibronectin 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FN1 mRNA
CTD
PMID:15963989
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FOLR1
folate receptor alpha
increases expression decreases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of FOLR1 mRNA tert-Butylhydroperoxide results in decreased expression of FOLR1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:22956110
NCBI chr11:72,189,709...72,196,323
Ensembl chr11:72,189,558...72,196,323
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions increases expression increases methylation
EXP ISO
tert-Butylhydroperoxide results in decreased expression of FOS mRNA CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA] tert-Butylhydroperoxide results in increased methylation of FOS gene
CTD
PMID:12419474 PMID:15105052 PMID:27509014
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FOSL1 mRNA
CTD
PMID:15336504
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FOXD1
forkhead box D1
decreases expression increases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of FOXD1 mRNA tert-Butylhydroperoxide results in increased expression of FOXD1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 5:73,446,266...73,448,777
Ensembl chr 5:73,444,827...73,448,777
G
FOXM1
forkhead box M1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FOXM1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr12:2,857,680...2,877,174
Ensembl chr12:2,857,680...2,877,174
G
FTL
ferritin light chain
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FTL mRNA
CTD
PMID:12414654 PMID:15963989
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
FUBP1
far upstream element binding protein 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of FUBP1 mRNA
CTD
PMID:15336504
NCBI chr 1:77,944,055...77,979,501
Ensembl chr 1:77,944,055...77,979,110
G
FXYD5
FXYD domain containing ion transport regulator 5
increases expression
EXP ISO
tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr19:35,154,735...35,169,881
Ensembl chr19:35,154,730...35,169,881
G
FYCO1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FYCO1 mRNA
CTD
PMID:15336504
NCBI chr 3:45,917,903...45,995,824
Ensembl chr 3:45,917,903...45,995,824
G
FZD1
frizzled class receptor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FZD1 mRNA
CTD
PMID:29432895
NCBI chr 7:91,264,433...91,271,326
Ensembl chr 7:91,264,433...91,271,326
G
FZR1
fizzy and cell division cycle 20 related 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FZR1 mRNA
CTD
PMID:15336504
NCBI chr19:3,506,311...3,538,334
Ensembl chr19:3,506,311...3,538,334
G
G0S2
G0/G1 switch 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of G0S2 mRNA
CTD
PMID:15336504
NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390
G
G6PD
glucose-6-phosphate dehydrogenase
decreases activity increases activity
EXP ISO
tert-Butylhydroperoxide results in decreased activity of G6PD protein tert-Butylhydroperoxide results in increased activity of G6PD protein
CTD
PMID:12628296 PMID:15336504 PMID:16928893
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GADD45B
growth arrest and DNA damage inducible beta
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of GADD45B mRNA tert-Butylhydroperoxide affects the expression of GADD45B mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GAK
cyclin G associated kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GAK mRNA
CTD
PMID:12419474
NCBI chr 4:849,277...932,316
Ensembl chr 4:849,276...932,373
G
GALM
galactose mutarotase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALM mRNA
CTD
PMID:15003993
NCBI chr 2:38,666,114...38,734,765
Ensembl chr 2:38,666,081...38,741,237
G
GALNS
galactosamine (N-acetyl)-6-sulfatase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GALNS mRNA
CTD
PMID:15336504
NCBI chr16:88,813,734...88,856,947
Ensembl chr16:88,813,734...88,856,970
G
GALNT1
polypeptide N-acetylgalactosaminyltransferase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GALNT1 mRNA
CTD
PMID:15336504
NCBI chr18:35,580,922...35,711,834
Ensembl chr18:35,581,117...35,711,834
G
GALNT3
polypeptide N-acetylgalactosaminyltransferase 3
increases methylation decreases methylation
EXP
tert-Butylhydroperoxide results in increased methylation of GALNT3 intron tert-Butylhydroperoxide results in decreased methylation of GALNT3 intron
CTD
PMID:29432895
NCBI chr 2:165,747,588...165,794,692
Ensembl chr 2:165,747,588...165,846,201
G
GALNT6
polypeptide N-acetylgalactosaminyltransferase 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GALNT6 mRNA
CTD
PMID:15336504
NCBI chr12:51,351,252...51,391,673
Ensembl chr12:51,351,247...51,392,867
G
GANAB
glucosidase II alpha subunit
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GANAB mRNA
CTD
PMID:15336504
NCBI chr11:62,624,829...62,646,613
Ensembl chr11:62,624,826...62,646,726
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GAPDH protein
CTD
PMID:11295360
NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
G
GARS1
glycyl-tRNA synthetase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GARS1 mRNA
CTD
PMID:15003993
NCBI chr 7:30,594,735...30,634,033
Ensembl chr 7:30,580,533...30,634,033
G
GAS2
growth arrest specific 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GAS2 mRNA
CTD
PMID:14729362
NCBI chr11:22,626,002...22,813,055
Ensembl chr11:22,625,509...22,813,001
G
GAS2L1
growth arrest specific 2 like 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GAS2L1 mRNA
CTD
PMID:29432895
NCBI chr22:29,306,650...29,312,787
Ensembl chr22:29,306,618...29,312,787
G
GATA6
GATA binding protein 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GATA6 mRNA
CTD
PMID:15336504
NCBI chr18:22,169,589...22,202,528
Ensembl chr18:22,169,589...22,202,528
G
GATD3
glutamine amidotransferase class 1 domain containing 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GATD3 mRNA
CTD
PMID:15336504
NCBI chr21:44,133,683...44,145,711
Ensembl chr21:44,133,610...44,210,114
G
GBP2
guanylate binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:89,106,132...89,126,114
Ensembl chr 1:89,106,132...89,150,456
G
GBP4
guanylate binding protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:89,181,144...89,198,942
Ensembl chr 1:89,181,144...89,198,942
G
GBP6
guanylate binding protein family member 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP6 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:89,364,059...89,388,160
Ensembl chr 1:89,364,059...89,388,160
G
GCHFR
GTP cyclohydrolase I feedback regulator
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GCHFR mRNA
CTD
PMID:15336504
NCBI chr15:40,764,068...40,767,708
Ensembl chr15:40,764,068...40,767,708
G
GCLC
glutamate-cysteine ligase catalytic subunit
multiple interactions decreases response to substance increases expression decreases expression
EXP ISO
[Linoleic Acids, Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide GCLC protein results in decreased susceptibility to tert-Butylhydroperoxide [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLC mRNA tert-Butylhydroperoxide results in decreased expression of GCLC mRNA
CTD
PMID:12425961 PMID:17092368 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568 More...
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
multiple interactions increases expression
ISO EXP
[Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLM mRNA
CTD
PMID:12414654 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GCNT1
glucosaminyl (N-acetyl) transferase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GCNT1 mRNA
CTD
PMID:15336504
NCBI chr 9:76,393,869...76,507,416
Ensembl chr 9:76,419,850...76,651,203
G
GCNT3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GCNT3 mRNA
CTD
PMID:23410634
NCBI chr15:59,549,039...59,622,723
Ensembl chr15:59,594,875...59,640,239
G
GDF15
growth differentiation factor 15
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GDF15 mRNA
CTD
PMID:12414654
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GDPD5
glycerophosphodiester phosphodiesterase domain containing 5
affects expression
EXP
tert-Butylhydroperoxide affects the expression of GDPD5 mRNA
CTD
PMID:23410634
NCBI chr11:75,434,640...75,525,941
Ensembl chr11:75,434,640...75,525,941
G
GEM
GTP binding protein overexpressed in skeletal muscle
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GEM mRNA]
CTD
PMID:20847119
NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350
G
GEMIN4
gem nuclear organelle associated protein 4
multiple interactions decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of GEMIN4 mRNA]
CTD
PMID:20847119
NCBI chr17:744,421...754,410
Ensembl chr17:744,421...753,999
G
GFAP
glial fibrillary acidic protein
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GFAP protein tert-Butylhydroperoxide results in increased expression of GFAP protein
CTD
PMID:24394546
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
G
GFER
growth factor, augmenter of liver regeneration
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GFER mRNA
CTD
PMID:15336504
NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749
G
GFPT2
glutamine-fructose-6-phosphate transaminase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GFPT2 mRNA
CTD
PMID:15336504
NCBI chr 5:180,300,698...180,353,336
Ensembl chr 5:180,300,698...180,353,336
G
GFRA1
GDNF family receptor alpha 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GFRA1 mRNA
CTD
PMID:15336504
NCBI chr10:116,056,925...116,274,705
Ensembl chr10:116,056,925...116,276,803
G
GINS2
GINS complex subunit 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GINS2 mRNA
CTD
PMID:15336504
NCBI chr16:85,676,198...85,688,954
Ensembl chr16:85,676,198...85,690,073
G
GJA1
gap junction protein alpha 1
decreases expression decreases response to substance
EXP
tert-Butylhydroperoxide results in decreased expression of GJA1 mRNA; tert-Butylhydroperoxide results in decreased expression of GJA1 protein GJA1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15336504 PMID:18235030
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GJB2
gap junction protein beta 2
decreases response to substance
EXP
GJB2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:18235030
NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938
G
GLA
galactosidase alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLA mRNA
CTD
PMID:14729362
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
G
GLG1
golgi glycoprotein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GLG1 mRNA
CTD
PMID:15336504
NCBI chr16:74,447,440...74,607,114
Ensembl chr16:74,447,427...74,607,144
G
GLIPR1
GLI pathogenesis related 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GLIPR1 mRNA
CTD
PMID:15336504
NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863
G
GLOD4
glyoxalase domain containing 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLOD4 mRNA
CTD
PMID:15003993
NCBI chr17:759,330...785,895
Ensembl chr17:757,097...782,294
G
GLRX
glutaredoxin
multiple interactions increases expression
ISO EXP
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] tert-Butylhydroperoxide results in increased expression of GLRX mRNA
CTD
PMID:12414654 PMID:12680778
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GLRX3
glutaredoxin 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GLRX3 mRNA
CTD
PMID:15336504
NCBI chr10:130,136,391...130,180,377
Ensembl chr10:130,136,391...130,184,521
G
GLYR1
glyoxylate reductase 1 homolog
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GLYR1 mRNA
CTD
PMID:15336504
NCBI chr16:4,803,203...4,847,288
Ensembl chr16:4,803,203...4,847,288
G
GMPR2
guanosine monophosphate reductase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GMPR2 mRNA
CTD
PMID:15336504
NCBI chr14:24,232,622...24,239,242
Ensembl chr14:24,232,422...24,239,242
G
GNA11
G protein subunit alpha 11
increases expression decreases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of GNA11 mRNA tert-Butylhydroperoxide results in decreased expression of GNA11 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr19:3,094,362...3,123,999
Ensembl chr19:3,094,362...3,123,999
G
GNAI1
G protein subunit alpha i1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of GNAI1 mRNA
CTD
PMID:23410634
NCBI chr 7:80,134,831...80,226,181
Ensembl chr 7:79,768,028...80,226,181
G
GNAS
GNAS complex locus
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GNAS mRNA
CTD
PMID:12419474
NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
G
GNB5
G protein subunit beta 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GNB5 mRNA
CTD
PMID:15336504
NCBI chr15:52,115,100...52,191,392
Ensembl chr15:52,115,100...52,191,392
G
GNPNAT1
glucosamine-phosphate N-acetyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNPNAT1 mRNA
CTD
PMID:15003993
NCBI chr14:52,775,193...52,791,607
Ensembl chr14:52,775,193...52,791,668
G
GNS
glucosamine (N-acetyl)-6-sulfatase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GNS mRNA
CTD
PMID:15336504
NCBI chr12:64,713,449...64,759,406
Ensembl chr12:64,713,445...64,759,431
G
GOSR2
golgi SNAP receptor complex member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GOSR2 mRNA
CTD
PMID:15003993
NCBI chr17:46,923,160...46,975,890
Ensembl chr17:46,923,075...46,975,524
G
GOT1
glutamic-oxaloacetic transaminase 1
multiple interactions increases activity increases expression
ISO
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GOT1 protein]
CTD
PMID:15095147 PMID:15212457 PMID:15645217
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
GPAT3
glycerol-3-phosphate acyltransferase 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GPAT3 mRNA
CTD
PMID:23410634
NCBI chr 4:83,535,587...83,605,875
Ensembl chr 4:83,535,914...83,605,875
G
GPC1
glypican 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPC1 mRNA
CTD
PMID:15003993
NCBI chr 2:240,435,663...240,468,076
Ensembl chr 2:240,435,663...240,468,076
G
GPER1
G protein-coupled estrogen receptor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GPER1 mRNA
CTD
PMID:15336504
NCBI chr 7:1,087,118...1,093,810
Ensembl chr 7:1,082,208...1,093,815
G
GPI
glucose-6-phosphate isomerase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPI1 mRNA
CTD
PMID:15003993
NCBI chr19:34,359,718...34,402,413
Ensembl chr19:34,359,480...34,402,413
G
GPNMB
glycoprotein nmb
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GPNMB mRNA
CTD
PMID:15336504
NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108
G
GPR107
G protein-coupled receptor 107
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GPR107 mRNA
CTD
PMID:15336504
NCBI chr 9:130,053,906...130,140,164
Ensembl chr 9:130,053,426...130,140,169
G
GPR161
G protein-coupled receptor 161
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GPR161 mRNA
CTD
PMID:15336504
NCBI chr 1:168,079,542...168,137,667
Ensembl chr 1:168,079,542...168,137,667
G
GPR4
G protein-coupled receptor 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GPR4 mRNA
CTD
PMID:15336504
NCBI chr19:45,589,764...45,602,212
Ensembl chr19:45,589,764...45,602,212
G
GPRC5B
G protein-coupled receptor class C group 5 member B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GPRC5B mRNA
CTD
PMID:15336504 PMID:29432895
NCBI chr16:19,856,691...19,885,634
Ensembl chr16:19,856,691...19,886,167
G
GPSM2
G protein signaling modulator 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GPSM2 mRNA
CTD
PMID:15336504
NCBI chr 1:108,876,985...108,934,545
Ensembl chr 1:108,875,350...108,934,545
G
GPSM3
G protein signaling modulator 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GPSM3 mRNA
CTD
PMID:15336504
NCBI chr 6:32,190,766...32,195,523
Ensembl chr 6:32,190,766...32,195,523
G
GPT
glutamic--pyruvic transaminase
multiple interactions increases activity increases expression
ISO
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GPT protein] rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]
CTD
PMID:15015760 PMID:15095147 PMID:15212457 PMID:15645217 PMID:28025122
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX1
glutathione peroxidase 1
increases reduction decreases response to substance increases response to substance increases expression
EXP ISO
GPX1 protein results in increased reduction of tert-Butylhydroperoxide GPX1 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GPX1 mRNA
CTD
PMID:8428933 PMID:9741587 PMID:15182862 PMID:19720132
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX2
glutathione peroxidase 2
increases reduction decreases expression increases expression
EXP
GPX2 protein results in increased reduction of tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of GPX2 mRNA tert-Butylhydroperoxide results in increased expression of GPX2 mRNA
CTD
PMID:8428933 PMID:10806356 PMID:12414654 PMID:12419474
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GPX4
glutathione peroxidase 4
multiple interactions decreases response to substance increases response to substance
EXP ISO
GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] GPX4 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX4 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:12566075 PMID:15496407
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
GRB2
growth factor receptor bound protein 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GRB2 mRNA
CTD
PMID:15336504
NCBI chr17:75,318,076...75,405,678
Ensembl chr17:75,318,076...75,405,709
G
GREM1
gremlin 1, DAN family BMP antagonist
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GREM1 mRNA
CTD
PMID:15336504
NCBI chr15:32,718,004...32,745,106
Ensembl chr15:32,718,004...32,745,106
G
GRHPR
glyoxylate and hydroxypyruvate reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRHPR mRNA
CTD
PMID:15003993
NCBI chr 9:37,422,435...37,439,494
Ensembl chr 9:37,422,666...37,436,990
G
GRIN2C
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GRIN2C mRNA
CTD
PMID:12414654
NCBI chr17:74,842,023...74,861,532
Ensembl chr17:74,842,023...74,861,504
G
GRPEL1
GrpE like 1, mitochondrial
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GRPEL1 mRNA
CTD
PMID:15336504
NCBI chr 4:7,058,895...7,068,064
Ensembl chr 4:7,058,671...7,068,085
G
GSK3B
glycogen synthase kinase 3 beta
increases expression decreases phosphorylation multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of GSK3B mRNA tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein]
CTD
PMID:15336504 PMID:29128606
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSN
gelsolin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSN mRNA
CTD
PMID:15003993
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
G
GSPT1
G1 to S phase transition 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of GSPT1 mRNA
CTD
PMID:15336504
NCBI chr16:11,868,128...11,916,654
Ensembl chr16:11,868,128...11,916,082
G
GSPT2
G1 to S phase transition 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSPT2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr X:51,743,442...51,746,232
Ensembl chr X:51,743,442...51,746,232
G
GSR
glutathione-disulfide reductase
multiple interactions decreases expression increases activity decreases activity decreases methylation increases expression
EXP ISO
Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GSR protein] tert-Butylhydroperoxide results in decreased expression of GSR mRNA Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of GSR protein] tert-Butylhydroperoxide results in decreased methylation of GSR gene tert-Butylhydroperoxide results in increased expression of GSR mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15212457 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16928893 PMID:17427263 PMID:23410634 PMID:27509014 More...
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTA2
glutathione S-transferase alpha 2
decreases metabolic processing increases metabolic processing
EXP
GSTA2 protein polymorphism results in decreased metabolism of tert-Butylhydroperoxide GSTA2 protein results in increased metabolism of tert-Butylhydroperoxide
CTD
PMID:3138230 PMID:15128049
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTA3
glutathione S-transferase alpha 3
decreases response to substance increases expression
ISO
GSTA3 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GSTA3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698
G
GSTA4
glutathione S-transferase alpha 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GSTA4 mRNA
CTD
PMID:15336504 PMID:31627909
NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304
G
GSTK1
glutathione S-transferase kappa 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GSTK1 mRNA
CTD
PMID:15336504
NCBI chr 7:143,263,441...143,269,115
Ensembl chr 7:143,244,093...143,270,854
G
GSTM2
glutathione S-transferase mu 2
decreases expression decreases response to substance increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in decreased expression of GSTM2 protein GSTM2 protein results in decreased susceptibility to tert-Butylhydroperoxide; GSTM5 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in increased expression of GSTM5 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:24394546
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTM4
glutathione S-transferase mu 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GSTM4 mRNA
CTD
PMID:15336504
NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496
G
GSTP1
glutathione S-transferase pi 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA
CTD
PMID:15336504
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GSTT1
glutathione S-transferase theta 1
affects metabolic processing
ISO
GSTT1 protein affects the metabolism of tert-Butylhydroperoxide
CTD
PMID:9854036
G
GSTZ1
glutathione S-transferase zeta 1
affects metabolic processing
EXP
GSTZ1 protein affects the metabolism of tert-Butylhydroperoxide
CTD
PMID:9396740
NCBI chr14:77,321,036...77,331,597
Ensembl chr14:77,320,996...77,331,597
G
GTF2F1
general transcription factor IIF subunit 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GTF2F1 mRNA
CTD
PMID:15336504
NCBI chr19:6,379,572...6,393,164
Ensembl chr19:6,379,572...6,393,981
G
GTF2I
general transcription factor IIi
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GTF2I mRNA
CTD
PMID:15336504
NCBI chr 7:74,657,718...74,760,692
Ensembl chr 7:74,650,231...74,760,692
G
GTF2IRD1
GTF2I repeat domain containing 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GTF2IRD1 mRNA
CTD
PMID:15336504
NCBI chr 7:74,453,906...74,602,605
Ensembl chr 7:74,453,790...74,602,605
G
GTF3A
general transcription factor IIIA
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GTF3A mRNA
CTD
PMID:15336504
NCBI chr13:27,424,619...27,435,823
Ensembl chr13:27,424,619...27,435,823
G
GULP1
GULP PTB domain containing engulfment adaptor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GULP1 mRNA
CTD
PMID:15336504
NCBI chr 2:188,291,874...188,595,926
Ensembl chr 2:188,291,669...188,595,931
G
GUSB
glucuronidase beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GUSB mRNA
CTD
PMID:15336504
NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215
G
GYG2
glycogenin 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GYG2 mRNA
CTD
PMID:15336504
NCBI chr X:2,828,930...2,882,818
Ensembl chr X:2,828,822...2,882,818
G
GYS1
glycogen synthase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GYS1 mRNA
CTD
PMID:15003993
NCBI chr19:48,968,130...48,993,309
Ensembl chr19:48,968,130...48,993,310
G
H1-10
H1.10 linker histone
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of H1-10 mRNA
CTD
PMID:15336504
NCBI chr 3:129,314,771...129,316,286
Ensembl chr 3:129,314,771...129,316,286
G
H2AX
H2A.X variant histone
decreases expression increases phosphorylation
EXP
tert-Butylhydroperoxide results in decreased expression of H2AX mRNA tert-Butylhydroperoxide results in increased phosphorylation of H2AX protein
CTD
PMID:15336504 PMID:33207735
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
G
H2AZ2
H2A.Z variant histone 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of H2AZ2 mRNA
CTD
PMID:15336504
NCBI chr 7:44,826,889...44,848,126
Ensembl chr 7:44,826,791...44,848,087
G
H2BC12
H2B clustered histone 12
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of H2BC12 mRNA
CTD
PMID:15336504
NCBI chr 6:27,138,293...27,146,858
Ensembl chr 6:27,146,361...27,146,855
G
H2BC5
H2B clustered histone 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of H2BC5 mRNA
CTD
PMID:15336504
NCBI chr 6:26,158,121...26,171,349
Ensembl chr 6:26,158,122...26,171,349
G
H3-4
H3.4 histone, cluster member
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of H3-4 mRNA tert-Butylhydroperoxide results in increased methylation of H3-4 gene
CTD
PMID:27509014
NCBI chr 1:228,424,845...228,425,360
Ensembl chr 1:228,424,845...228,425,360
G
H4C3
H4 clustered histone 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of H4C3 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 6:26,103,933...26,104,337
Ensembl chr 6:26,103,933...26,104,337
G
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
increases activity increases expression
ISO
tert-Butylhydroperoxide results in increased activity of H6PD protein tert-Butylhydroperoxide results in increased expression of H6PD mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 1:9,234,774...9,271,337
Ensembl chr 1:9,234,774...9,271,337
G
HADH
hydroxyacyl-CoA dehydrogenase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HADH mRNA
CTD
PMID:15336504
NCBI chr 4:107,989,889...108,035,171
Ensembl chr 4:107,989,714...108,035,241
G
HAMP
hepcidin antimicrobial peptide
affects expression
EXP
tert-Butylhydroperoxide affects the expression of HAMP mRNA
CTD
PMID:23410634
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
G
HAS2
hyaluronan synthase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HAS2 mRNA
CTD
PMID:15336504
NCBI chr 8:121,612,116...121,641,440
Ensembl chr 8:121,612,116...121,641,440
G
HAUS7
HAUS augmin like complex subunit 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HAUS7 mRNA
CTD
PMID:15336504
NCBI chr X:153,447,668...153,495,465
Ensembl chr X:153,447,668...153,495,516
G
HBEGF
heparin binding EGF like growth factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HBEGF mRNA
CTD
PMID:12419474
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
G
HBP1
HMG-box transcription factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HBP1 mRNA
CTD
PMID:15336504
NCBI chr 7:107,169,003...107,202,522
Ensembl chr 7:107,168,961...107,202,522
G
HDAC1
histone deacetylase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HDAC1 mRNA
CTD
PMID:12419474
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
G
HDAC11
histone deacetylase 11
affects expression
EXP
tert-Butylhydroperoxide affects the expression of HDAC11 mRNA
CTD
PMID:23410634
NCBI chr 3:13,480,306...13,506,416
Ensembl chr 3:13,479,724...13,506,424
G
HDAC7
histone deacetylase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HDAC7 mRNA
CTD
PMID:15003993
NCBI chr12:47,782,722...47,821,344
Ensembl chr12:47,782,722...47,833,132
G
HEATR1
HEAT repeat containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HEATR1 mRNA
CTD
PMID:15336504
NCBI chr 1:236,549,005...236,604,516
Ensembl chr 1:236,549,005...236,604,516
G
HEG1
heart development protein with EGF like domains 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HEG1 mRNA
CTD
PMID:15336504
NCBI chr 3:124,965,710...125,055,997
Ensembl chr 3:124,965,710...125,055,997
G
HEPH
hephaestin
decreases response to substance decreases expression increases expression
ISO EXP
HEPH protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of HEPH mRNA tert-Butylhydroperoxide results in increased expression of HEPH mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr X:66,162,671...66,268,863
Ensembl chr X:66,162,671...66,268,867
G
HES1
hes family bHLH transcription factor 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HES1 mRNA
CTD
PMID:15336504
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
G
HES6
hes family bHLH transcription factor 6
affects expression
EXP
tert-Butylhydroperoxide affects the expression of HES6 mRNA
CTD
PMID:23410634
NCBI chr 2:238,238,267...238,240,038
Ensembl chr 2:238,238,267...238,240,662
G
HGFAC
HGF activator
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HGFAC mRNA
CTD
PMID:12419474
NCBI chr 4:3,441,005...3,449,486
Ensembl chr 4:3,441,968...3,449,486
G
HIF1A
hypoxia inducible factor 1 subunit alpha
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA; [HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA]
CTD
PMID:15611089 PMID:35690295
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HIKESHI
heat shock protein nuclear import factor hikeshi
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HIKESHI mRNA
CTD
PMID:15003993
NCBI chr11:86,302,240...86,345,943
Ensembl chr11:86,302,211...86,345,943
G
HILPDA
hypoxia inducible lipid droplet associated
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]
CTD
PMID:20847119
NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418
G
HIVEP1
HIVEP zinc finger 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HIVEP1 mRNA
CTD
PMID:15003993
NCBI chr 6:12,007,693...12,212,048
Ensembl chr 6:12,008,762...12,164,999
G
HK1
hexokinase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HK1 mRNA
CTD
PMID:15336504
NCBI chr10:69,270,000...69,401,882
Ensembl chr10:69,269,984...69,401,884
G
HLA-B
major histocompatibility complex, class I, B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HLA-B mRNA
CTD
PMID:15336504
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-C
major histocompatibility complex, class I, C
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HLA-C mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 6:31,268,749...31,272,092
Ensembl chr 6:31,268,749...31,272,130
G
HLA-DMB
major histocompatibility complex, class II, DM beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2-DMB1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,028
G
HLA-DPA1
major histocompatibility complex, class II, DP alpha 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HLA-DPA1 mRNA
CTD
PMID:15336504
NCBI chr 6:33,064,569...33,080,748
Ensembl chr 6:33,064,569...33,080,775
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HLA-DPB1 mRNA
CTD
PMID:15336504
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
HLA-E
major histocompatibility complex, class I, E
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HLA-E mRNA
CTD
PMID:15336504
NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194
G
HMGA1
high mobility group AT-hook 1
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HMGA1 mRNA tert-Butylhydroperoxide results in increased expression of HMGA1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231
G
HMGA2
high mobility group AT-hook 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGA2 mRNA
CTD
PMID:14729362
NCBI chr12:65,824,460...65,966,291
Ensembl chr12:65,824,460...65,966,291
G
HMGB1
high mobility group box 1
multiple interactions increases expression
EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein] tert-Butylhydroperoxide results in increased expression of HMGB1 protein
CTD
PMID:28063877 PMID:29111459
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HMGCR mRNA
CTD
PMID:12414654
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMGN5
high mobility group nucleosome binding domain 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGN5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr X:81,113,699...81,201,913
Ensembl chr X:81,113,699...81,201,913
G
HMOX1
heme oxygenase 1
decreases response to substance multiple interactions increases expression affects expression decreases expression
EXP ISO
HMOX1 protein results in decreased susceptibility to tert-Butylhydroperoxide [Apigenin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [chrysin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA] tert-Butylhydroperoxide affects the expression of HMOX1 mRNA [Biological Products results in increased expression of HMOX1 protein] inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; [Biological Products results in increased expression of HMOX1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA] tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in decreased expression of HMOX1 protein tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in increased expression of HMOX1 protein
CTD
PMID:12414654 PMID:15336504 PMID:15589375 PMID:16636651 PMID:17295091 PMID:18812229 PMID:22864849 PMID:22954530 PMID:23266269 PMID:27050144 PMID:27509014 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135 More...
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HMOX2
heme oxygenase 2
decreases response to substance decreases expression increases methylation
EXP
HMOX2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of HMOX2 mRNA tert-Butylhydroperoxide results in increased methylation of HMOX2 gene
CTD
PMID:15589375 PMID:27509014
NCBI chr16:4,474,736...4,510,347
Ensembl chr16:4,474,690...4,510,347
G
HNRNPA3
heterogeneous nuclear ribonucleoprotein A3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HNRNPA3 mRNA
CTD
PMID:15336504
NCBI chr 2:177,212,794...177,223,959
Ensembl chr 2:177,212,694...177,223,959
G
HNRNPDL
heterogeneous nuclear ribonucleoprotein D like
multiple interactions decreases expression increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of HNRNPDL mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA] tert-Butylhydroperoxide results in decreased expression of HNRNPDL mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr 4:82,422,564...82,430,462
Ensembl chr 4:82,422,565...82,430,462
G
HOOK2
hook microtubule tethering protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HOOK2 mRNA
CTD
PMID:15336504
NCBI chr19:12,763,003...12,792,350
Ensembl chr19:12,763,003...12,872,740
G
HOXD1
homeobox D1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of HOXD1 mRNA
CTD
PMID:23410634
NCBI chr 2:176,188,668...176,190,907
Ensembl chr 2:176,188,668...176,190,907
G
HP1BP3
heterochromatin protein 1 binding protein 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HP1BP3 mRNA
CTD
PMID:15336504
NCBI chr 1:20,740,266...20,787,307
Ensembl chr 1:20,740,266...20,787,323
G
HPS1
HPS1 biogenesis of lysosomal organelles complex 3 subunit 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HPS1 mRNA
CTD
PMID:15336504
NCBI chr10:98,413,948...98,446,935
Ensembl chr10:98,410,939...98,446,963
G
HS3ST3A1
heparan sulfate-glucosamine 3-sulfotransferase 3A1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HS3ST3A1 mRNA
CTD
PMID:15336504
NCBI chr17:13,494,032...13,601,929
Ensembl chr17:13,494,032...13,601,929
G
HSBP1
heat shock factor binding protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HSBP1 mRNA
CTD
PMID:15336504
NCBI chr16:83,807,978...83,819,737
Ensembl chr16:83,719,311...83,819,737
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
multiple interactions decreases expression
EXP
Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]
CTD
PMID:29935159
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of HSD11B2 mRNA
CTD
PMID:23410634
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
HSD17B10
hydroxysteroid 17-beta dehydrogenase 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD17B10 mRNA
CTD
PMID:15003993
NCBI chr X:53,431,258...53,434,376
Ensembl chr X:53,431,258...53,434,370
G
HSD17B11
hydroxysteroid 17-beta dehydrogenase 11
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HSD17B11 mRNA
CTD
PMID:15336504
NCBI chr 4:87,336,515...87,391,188
Ensembl chr 4:87,336,515...87,391,188
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD17B2 mRNA
CTD
PMID:15003993
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
G
HSD3B7
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD3B7 mRNA
CTD
PMID:15003993
NCBI chr16:30,985,207...30,989,147
Ensembl chr16:30,985,207...30,989,147
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HSP90AA1 mRNA
CTD
PMID:15336504
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSPA13
heat shock protein family A (Hsp70) member 13
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HSPA13 mRNA
CTD
PMID:12419474
NCBI chr21:14,371,115...14,383,146
Ensembl chr21:14,371,115...14,383,484
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HSPA1A mRNA
CTD
PMID:12414654
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA1B
heat shock protein family A (Hsp70) member 1B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HSPA1B mRNA
CTD
PMID:12414654
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
G
HSPA1L
heat shock protein family A (Hsp70) member 1 like
multiple interactions increases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]
CTD
PMID:20847119
NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
G
HSPA2
heat shock protein family A (Hsp70) member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HSPA2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
G
HSPA4
heat shock protein family A (Hsp70) member 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HSPA4 mRNA
CTD
PMID:15336504
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HSPA5 mRNA
CTD
PMID:12766906
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPA6
heat shock protein family A (Hsp70) member 6
increases expression multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of HSPA6 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]
CTD
PMID:12414654 PMID:35690295
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
G
HSPB1
heat shock protein family B (small) member 1
increases expression decreases expression
EXP
tert-Butylhydroperoxide results in increased expression of HSPB1 protein tert-Butylhydroperoxide results in decreased expression of HSPB1 mRNA
CTD
PMID:11295360 PMID:15336504
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
G
HSPB2
heat shock protein family B (small) member 2
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of HSPB2 mRNA tert-Butylhydroperoxide results in increased expression of HSPB2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr11:111,912,734...111,914,093
Ensembl chr11:111,912,734...111,914,093
G
HSPB8
heat shock protein family B (small) member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPB8 mRNA
CTD
PMID:14729362
NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855
G
HSPD1
heat shock protein family D (Hsp60) member 1
increases expression multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of HSPD1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
HSPH1
heat shock protein family H (Hsp110) member 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HSPH1 mRNA
CTD
PMID:15336504
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
G
HTATIP2
HIV-1 Tat interactive protein 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of HTATIP2 mRNA
CTD
PMID:15336504
NCBI chr11:20,363,714...20,383,782
Ensembl chr11:20,363,685...20,383,782
G
HTRA1
HtrA serine peptidase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of HTRA1 mRNA
CTD
PMID:15336504
NCBI chr10:122,461,553...122,514,907
Ensembl chr10:122,458,551...122,514,907
G
ICAM1
intercellular adhesion molecule 1
increases expression multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]
CTD
PMID:15336504 PMID:28063877
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ICMT
isoprenylcysteine carboxyl methyltransferase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ICMT mRNA
CTD
PMID:15336504
NCBI chr 1:6,221,193...6,235,964
Ensembl chr 1:6,221,193...6,235,972
G
ID1
inhibitor of DNA binding 1
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of ID1 mRNA tert-Butylhydroperoxide results in increased expression of ID1 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
ID2
inhibitor of DNA binding 2
multiple interactions increases expression
EXP ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:20847119
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
ID3
inhibitor of DNA binding 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ID3 mRNA
CTD
PMID:15003993
NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
increases activity
ISO
tert-Butylhydroperoxide results in increased activity of IDH1 protein
CTD
PMID:16928893
NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
decreases activity multiple interactions
EXP
tert-Butylhydroperoxide results in decreased activity of IDH2 protein resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]; SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
CTD
PMID:25522270
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
G
IER2
immediate early response 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IER2 mRNA
CTD
PMID:15336504
NCBI chr19:13,150,411...13,154,911
Ensembl chr19:13,150,411...13,154,911
G
IER3
immediate early response 3
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IER3 mRNA tert-Butylhydroperoxide results in increased expression of IER3 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IFI27
interferon alpha inducible protein 27
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of IFI27 mRNA tert-Butylhydroperoxide results in increased expression of IFI27 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695
G
IFI35
interferon induced protein 35
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IFI35 mRNA
CTD
PMID:15336504
NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456
G
IFIH1
interferon induced with helicase C domain 1
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of IFIH1 mRNA tert-Butylhydroperoxide results in increased expression of IFIH1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
G
IFIT1
interferon induced protein with tetratricopeptide repeats 1
decreases expression increases expression decreases response to substance
EXP ISO
tert-Butylhydroperoxide results in decreased expression of IFIT1 mRNA tert-Butylhydroperoxide results in increased expression of IFIT1 mRNA IFIT1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
G
IFIT3
interferon induced protein with tetratricopeptide repeats 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFIT3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:89,327,997...89,340,968
Ensembl chr10:89,327,307...89,377,473
G
IFITM1
interferon induced transmembrane protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IFITM1 mRNA
CTD
PMID:15336504
NCBI chr11:314,040...315,272
Ensembl chr11:310,041...315,272
G
IFITM2
interferon induced transmembrane protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IFITM2 mRNA
CTD
PMID:15336504
NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397
G
IFITM3
interferon induced transmembrane protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFITM3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
G
IFT122
intraflagellar transport 122
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IFT122 mRNA
CTD
PMID:15336504
NCBI chr 3:129,440,224...129,520,507
Ensembl chr 3:129,429,607...129,520,510
G
IGF1
insulin like growth factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGF1 mRNA
CTD
PMID:22659508
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IGF1R mRNA
CTD
PMID:12419474
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IGF2BP1
insulin like growth factor 2 mRNA binding protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGF2BP1 mRNA
CTD
PMID:14729362
NCBI chr17:48,996,558...49,056,145
Ensembl chr17:48,997,385...49,056,145
G
IGFBP2
insulin like growth factor binding protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IGFBP2 mRNA
CTD
PMID:15336504
NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
G
IGFBP3
insulin like growth factor binding protein 3
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IGFBP3 mRNA tert-Butylhydroperoxide results in increased expression of IGFBP3 mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IGFBP4
insulin like growth factor binding protein 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of IGFBP4 mRNA
CTD
PMID:15336504
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
G
IGFBP5
insulin like growth factor binding protein 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of IGFBP5 mRNA
CTD
PMID:12414654
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
G
IGFBP6
insulin like growth factor binding protein 6
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP6 mRNA tert-Butylhydroperoxide results in increased expression of IGFBP6 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr12:53,097,667...53,102,340
Ensembl chr12:53,097,436...53,102,345
G
IGSF8
immunoglobulin superfamily member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGSF8 mRNA
CTD
PMID:14729362
NCBI chr 1:160,091,339...160,099,468
Ensembl chr 1:160,091,340...160,098,943
G
IL11
interleukin 11
increases expression affects expression
EXP
tert-Butylhydroperoxide results in increased expression of IL11 mRNA; tert-Butylhydroperoxide results in increased expression of IL11 protein tert-Butylhydroperoxide affects the expression of IL11 mRNA
CTD
PMID:15336504 PMID:17295091 PMID:23410634
NCBI chr19:55,364,382...55,370,463
Ensembl chr19:55,364,382...55,370,463
G
IL15
interleukin 15
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IL15 mRNA
CTD
PMID:15336504
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL1B
interleukin 1 beta
multiple interactions increases expression increases secretion
EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]; tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] tert-Butylhydroperoxide results in increased expression of IL1B mRNA; tert-Butylhydroperoxide results in increased expression of IL1B protein
CTD
PMID:15336504 PMID:15705740 PMID:28063877 PMID:29111459
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL3
interleukin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IL3 mRNA
CTD
PMID:12419474
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
G
IL4R
interleukin 4 receptor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of IL4R mRNA
CTD
PMID:15336504
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
increases expression multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of IL6 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]
CTD
PMID:15336504 PMID:28063877 PMID:29111459
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6ST
interleukin 6 cytokine family signal transducer
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IL6ST mRNA
CTD
PMID:12419474
NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
G
IL9
interleukin 9
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IL9 mRNA
CTD
PMID:12419474
NCBI chr 5:135,892,246...135,895,841
Ensembl chr 5:135,892,246...135,895,841
G
ILF3
interleukin enhancer binding factor 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ILF3 mRNA
CTD
PMID:15336504
NCBI chr19:10,654,346...10,692,400
Ensembl chr19:10,654,304...10,692,400
G
ILVBL
ilvB acetolactate synthase like
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ILVBL mRNA
CTD
PMID:15336504
NCBI chr19:15,114,987...15,125,786
Ensembl chr19:15,114,984...15,125,786
G
IMPA2
inositol monophosphatase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IMPA2 mRNA
CTD
PMID:15336504
NCBI chr18:11,981,507...12,030,877
Ensembl chr18:11,981,025...12,030,877
G
ING1
inhibitor of growth family member 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ING1 mRNA
CTD
PMID:15336504
NCBI chr13:110,712,623...110,723,339
Ensembl chr13:110,712,736...110,723,339
G
ING3
inhibitor of growth family member 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ING3 mRNA
CTD
PMID:15336504
NCBI chr 7:120,950,777...120,977,216
Ensembl chr 7:120,950,763...120,977,216
G
INHBA
inhibin subunit beta A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of INHBA mRNA
CTD
PMID:15336504
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
G
INHBB
inhibin subunit beta B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of INHBB mRNA
CTD
PMID:12414654
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
G
INPP5B
inositol polyphosphate-5-phosphatase B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of INPP5B mRNA
CTD
PMID:15336504
NCBI chr 1:37,860,697...37,947,057
Ensembl chr 1:37,860,697...37,947,053
G
INSIG1
insulin induced gene 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of INSIG1 mRNA
CTD
PMID:15336504
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
G
INTS7
integrator complex subunit 7
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of INTS7 gene
CTD
PMID:29432895
NCBI chr 1:211,940,403...212,035,557
Ensembl chr 1:211,940,399...212,035,557
G
IPO4
importin 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of IPO4 mRNA
CTD
PMID:15336504
NCBI chr14:24,180,219...24,188,816
Ensembl chr14:24,180,219...24,188,869
G
IPO9
importin 9
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IPO9 mRNA
CTD
PMID:15336504
NCBI chr 1:201,829,157...201,884,291
Ensembl chr 1:201,829,149...201,884,291
G
IRF1
interferon regulatory factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF1 mRNA
CTD
PMID:15003993
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
G
IRF7
interferon regulatory factor 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF7 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
G
IRF9
interferon regulatory factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF9 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr14:24,161,265...24,166,565
Ensembl chr14:24,161,234...24,168,043
G
IRGM
immunity related GTPase M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRGM mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736
G
ISG15
ISG15 ubiquitin like modifier
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ISG15 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:1,013,497...1,014,540
Ensembl chr 1:1,001,138...1,014,540
G
ISG20
interferon stimulated exonuclease gene 20
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ISG20 mRNA
CTD
PMID:15336504
NCBI chr15:88,635,632...88,656,483
Ensembl chr15:88,635,670...88,656,483
G
ITCH
itchy E3 ubiquitin protein ligase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ITCH mRNA
CTD
PMID:15336504
NCBI chr20:34,363,273...34,511,773
Ensembl chr20:34,363,235...34,511,773
G
ITGA2
integrin subunit alpha 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ITGA2 mRNA
CTD
PMID:12766906
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGA3
integrin subunit alpha 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
G
ITGA4
integrin subunit alpha 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ITGA4 mRNA
CTD
PMID:15336504
NCBI chr 2:181,457,205...181,538,940
Ensembl chr 2:181,457,202...181,538,940
G
ITGA5
integrin subunit alpha 5
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of ITGA5 mRNA tert-Butylhydroperoxide results in increased expression of ITGA5 mRNA
CTD
PMID:12419474 PMID:22659508
NCBI chr12:54,395,261...54,419,266
Ensembl chr12:54,395,261...54,419,266
G
ITGA6
integrin subunit alpha 6
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of ITGA6 mRNA tert-Butylhydroperoxide results in increased expression of ITGA6 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 2:172,427,336...172,506,459
Ensembl chr 2:172,234,216...172,506,459
G
ITGA7
integrin subunit alpha 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITGA7 mRNA
CTD
PMID:15336504
NCBI chr12:55,684,568...55,716,400
Ensembl chr12:55,684,568...55,716,404
G
ITGAL
integrin subunit alpha L
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITGAL mRNA
CTD
PMID:12419474
NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567
G
ITGAV
integrin subunit alpha V
multiple interactions increases expression
EXP
[Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ITGAV mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]
CTD
PMID:20847119
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
G
ITGB3
integrin subunit beta 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB3 mRNA
CTD
PMID:22659508
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
ITGB4
integrin subunit beta 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITGB4 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:75,721,459...75,757,818
Ensembl chr17:75,721,328...75,757,818
G
ITGB5
integrin subunit beta 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITGB5 mRNA
CTD
PMID:12419474
NCBI chr 3:124,761,948...124,901,418
Ensembl chr 3:124,761,948...124,901,418
G
ITGB6
integrin subunit beta 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITGB6 mRNA
CTD
PMID:12419474
NCBI chr 2:160,099,671...160,200,272
Ensembl chr 2:160,099,667...160,271,888
G
ITM2B
integral membrane protein 2B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITM2B mRNA
CTD
PMID:15336504
NCBI chr13:48,233,206...48,270,357
Ensembl chr13:48,232,612...48,270,357
G
ITPR3
inositol 1,4,5-trisphosphate receptor type 3
affects expression
EXP
tert-Butylhydroperoxide affects the expression of ITPR3 mRNA
CTD
PMID:23410634
NCBI chr 6:33,621,322...33,696,562
Ensembl chr 6:33,620,365...33,696,574
G
ITSN1
intersectin 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITSN1 mRNA
CTD
PMID:12419474
NCBI chr21:33,642,501...33,899,861
Ensembl chr21:33,642,400...33,899,861
G
JAK2
Janus kinase 2
decreases phosphorylation multiple interactions
EXP
tert-Butylhydroperoxide results in decreased phosphorylation of JAK2 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of JAK2 protein]
CTD
PMID:29128606
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
JAM3
junctional adhesion molecule 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of JAM3 mRNA
CTD
PMID:14729362
NCBI chr11:134,069,072...134,152,001
Ensembl chr11:134,069,071...134,152,001
G
JMJD6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
increases expression decreases methylation
EXP
tert-Butylhydroperoxide results in increased expression of JMJD6 mRNA tert-Butylhydroperoxide results in decreased methylation of JMJD6 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr17:76,712,836...76,726,606
Ensembl chr17:76,712,832...76,726,799
G
JPT2
Jupiter microtubule associated homolog 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of JPT2 mRNA
CTD
PMID:15336504
NCBI chr16:1,678,279...1,702,086
Ensembl chr16:1,678,256...1,702,280
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO EXP
CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]
CTD
PMID:12414654 PMID:15105052 PMID:15336504 PMID:27509014
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of JUND mRNA
CTD
PMID:12419474
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
G
JUP
junction plakoglobin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of JUP mRNA
CTD
PMID:15336504
NCBI chr17:41,754,609...41,786,711
Ensembl chr17:41,754,604...41,786,931
G
KANK1
KN motif and ankyrin repeat domains 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of KANK1 mRNA
CTD
PMID:15336504
NCBI chr 9:470,295...746,103
Ensembl chr 9:470,291...746,105
G
KANK2
KN motif and ankyrin repeat domains 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of KANK2 mRNA
CTD
PMID:15336504
NCBI chr19:11,164,270...11,197,865
Ensembl chr19:11,164,270...11,197,791
G
KAT2A
lysine acetyltransferase 2A
affects expression
EXP
tert-Butylhydroperoxide affects the expression of KAT2A mRNA
CTD
PMID:23410634
NCBI chr17:42,113,111...42,121,367
Ensembl chr17:42,113,111...42,121,367
G
KCNAB2
potassium voltage-gated channel subfamily A regulatory beta subunit 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KCNAB2 mRNA
CTD
PMID:15003993
NCBI chr 1:5,992,676...6,101,180
Ensembl chr 1:5,990,927...6,101,193
G
KCNB2
potassium voltage-gated channel subfamily B member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of KCNB2 mRNA
CTD
PMID:15336504
NCBI chr 8:72,537,225...72,938,349
Ensembl chr 8:72,537,225...72,938,349
G
KCNJ1
potassium inwardly rectifying channel subfamily J member 1
decreases response to substance
ISO
KCNJ1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:22811560
NCBI chr11:128,838,020...128,867,296
Ensembl chr11:128,836,315...128,867,373
G
KCNN4
potassium calcium-activated channel subfamily N member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KCNN4 mRNA
CTD
PMID:15003993
NCBI chr19:43,766,533...43,780,973
Ensembl chr19:43,766,533...43,780,976
G
KCTD21
potassium channel tetramerization domain containing 21
affects expression
EXP
tert-Butylhydroperoxide affects the expression of KCTD21 mRNA
CTD
PMID:23410634
NCBI chr11:78,171,249...78,188,626
Ensembl chr11:78,171,249...78,188,626
G
KDELR3
KDEL endoplasmic reticulum protein retention receptor 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of KDELR3 mRNA
CTD
PMID:15336504
NCBI chr22:38,468,096...38,483,447
Ensembl chr22:38,468,078...38,483,447
G
KDM3A
lysine demethylase 3A
affects expression
EXP
tert-Butylhydroperoxide affects the expression of KDM3A mRNA
CTD
PMID:23410634
NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716
G
KDSR
3-ketodihydrosphingosine reductase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of KDSR mRNA
CTD
PMID:15336504
NCBI chr18:63,327,726...63,367,206
Ensembl chr18:63,327,726...63,367,228
G
KEAP1
kelch like ECH associated protein 1
multiple interactions increases expression
EXP
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein]
CTD
PMID:27050144
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
KHNYN
KH and NYN domain containing
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of KHNYN mRNA
CTD
PMID:15336504
NCBI chr14:24,423,165...24,441,843
Ensembl chr14:24,429,286...24,441,843
G
KIF15
kinesin family member 15
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of KIF15 mRNA tert-Butylhydroperoxide affects the expression of KIF15 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 3:44,761,794...44,868,687
Ensembl chr 3:44,761,721...44,873,376
G
KIF20A
kinesin family member 20A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF20A mRNA
CTD
PMID:15003993
NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
G
KIF23
kinesin family member 23
affects expression
EXP
tert-Butylhydroperoxide affects the expression of KIF23 mRNA
CTD
PMID:23410634
NCBI chr15:69,414,349...69,448,427
Ensembl chr15:69,414,246...69,448,427
G
KIF2C
kinesin family member 2C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF2C mRNA
CTD
PMID:15003993
NCBI chr 1:44,739,837...44,767,767
Ensembl chr 1:44,739,818...44,767,767
G
KIF4A
kinesin family member 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF4 mRNA
CTD
PMID:15003993
NCBI chr X:70,290,104...70,420,886
Ensembl chr X:70,290,104...70,420,886
G
KIF5C
kinesin family member 5C
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of KIF5C mRNA
CTD
PMID:15336504
NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
G
KIFBP
kinesin family binding protein
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of KIFBP mRNA
CTD
PMID:15336504
NCBI chr10:68,988,803...69,016,982
Ensembl chr10:68,988,803...69,043,544
G
KIFC1
kinesin family member C1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of KIFC1 mRNA
CTD
PMID:15336504
NCBI chr 6:33,391,461...33,409,896
Ensembl chr 6:33,391,823...33,409,896
G
KISS1R
KISS1 receptor
affects expression
EXP
tert-Butylhydroperoxide affects the expression of KISS1R mRNA
CTD
PMID:23410634
NCBI chr19:917,333...921,005
Ensembl chr19:917,287...921,005
G
KLF10
KLF transcription factor 10
affects expression
EXP
tert-Butylhydroperoxide affects the expression of KLF10 mRNA
CTD
PMID:23410634
NCBI chr 8:102,648,784...102,655,725
Ensembl chr 8:102,648,784...102,655,725
G
KLF2
KLF transcription factor 2
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]
CTD
PMID:20847119
NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685
G
KLF9
KLF transcription factor 9
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of KLF9 mRNA
CTD
PMID:15336504
NCBI chr 9:70,384,604...70,414,657
Ensembl chr 9:70,384,604...70,414,657
G
KLHDC3
kelch domain containing 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of KLHDC3 mRNA
CTD
PMID:15336504
NCBI chr 6:43,014,249...43,021,294
Ensembl chr 6:43,014,103...43,021,298
G
KMT2D
lysine methyltransferase 2D
decreases expression decreases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of KMT2D mRNA tert-Butylhydroperoxide results in decreased methylation of KMT2D gene
CTD
PMID:27509014
NCBI chr12:49,018,978...49,060,794
Ensembl chr12:49,018,975...49,060,794
G
KMT5B
lysine methyltransferase 5B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of KMT5B mRNA
CTD
PMID:15336504
NCBI chr11:68,154,863...68,213,648
Ensembl chr11:68,154,863...68,213,852
G
KNTC1
kinetochore associated 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of KNTC1 mRNA
CTD
PMID:15336504
NCBI chr12:122,527,249...122,626,396
Ensembl chr12:122,527,246...122,626,396
G
KPNB1
karyopherin subunit beta 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of KPNB1 mRNA
CTD
PMID:15336504
NCBI chr17:47,649,919...47,685,505
Ensembl chr17:47,649,476...47,685,505
G
KTN1
kinectin 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of KTN1 mRNA
CTD
PMID:15336504
NCBI chr14:55,580,207...55,684,584
Ensembl chr14:55,559,072...55,701,526
G
LAIR1
leukocyte associated immunoglobulin like receptor 1
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of LAIR1 intron
CTD
PMID:29432895
NCBI chr19:54,351,384...54,376,088
Ensembl chr19:54,351,384...54,370,558
G
LAMA5
laminin subunit alpha 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LAMA5 mRNA
CTD
PMID:15336504
NCBI chr20:62,309,065...62,367,312
Ensembl chr20:62,307,955...62,367,312
G
LAMB1
laminin subunit beta 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LAMB1 mRNA
CTD
PMID:15336504
NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213
G
LAMB3
laminin subunit beta 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LAMB3 mRNA
CTD
PMID:15336504
NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425
G
LAMC2
laminin subunit gamma 2
increases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of LAMC2 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 1:183,186,264...183,258,968
Ensembl chr 1:183,186,238...183,245,127
G
LAPTM5
lysosomal protein transmembrane 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LAPTM5 mRNA
CTD
PMID:15336504
NCBI chr 1:30,732,469...30,757,774
Ensembl chr 1:30,732,469...30,757,774
G
LAT
linker for activation of T cells
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAT mRNA
CTD
PMID:22659508
NCBI chr16:28,984,803...28,990,784
Ensembl chr16:28,984,826...28,990,784
G
LBR
lamin B receptor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LBR mRNA
CTD
PMID:12414654
NCBI chr 1:225,401,502...225,428,821
Ensembl chr 1:225,401,502...225,428,925
G
LCAT
lecithin-cholesterol acyltransferase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LCAT mRNA
CTD
PMID:12419474
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
G
LCN2
lipocalin 2
decreases secretion
EXP
tert-Butylhydroperoxide results in decreased secretion of LCN2 protein
CTD
PMID:27888128
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
LCP1
lymphocyte cytosolic protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LCP1 mRNA
CTD
PMID:14729362
NCBI chr13:46,125,923...46,182,177
Ensembl chr13:46,125,920...46,211,871
G
LDLR
low density lipoprotein receptor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LDLR mRNA
CTD
PMID:12414654
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LGALS3BP
galectin 3 binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS3BP mRNA
CTD
PMID:14729362
NCBI chr17:78,971,255...78,979,923
Ensembl chr17:78,971,238...78,979,947
G
LGALS8
galectin 8
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LGALS8 mRNA
CTD
PMID:15336504
NCBI chr 1:236,518,214...236,552,981
Ensembl chr 1:236,518,000...236,552,981
G
LGALS9
galectin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS9 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr17:27,631,188...27,649,560
Ensembl chr17:27,629,798...27,649,560
G
LGR5
leucine rich repeat containing G protein-coupled receptor 5
affects expression
EXP
tert-Butylhydroperoxide affects the expression of LGR5 mRNA
CTD
PMID:23410634
NCBI chr12:71,439,129...71,586,310
Ensembl chr12:71,439,798...71,586,310
G
LHX2
LIM homeobox 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LHX2 mRNA
CTD
PMID:15336504
NCBI chr 9:124,011,768...124,033,301
Ensembl chr 9:124,001,670...124,033,301
G
LIF
LIF interleukin 6 family cytokine
increases expression increases methylation
EXP
tert-Butylhydroperoxide results in increased expression of LIF mRNA tert-Butylhydroperoxide results in increased methylation of LIF gene
CTD
PMID:12414654 PMID:15336504 PMID:23410634 PMID:27509014
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
G
LIFR
LIF receptor subunit alpha
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LIFR mRNA
CTD
PMID:15336504
NCBI chr 5:38,474,668...38,608,403
Ensembl chr 5:38,474,668...38,608,354
G
LIG1
DNA ligase 1
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of LIG1 mRNA tert-Butylhydroperoxide results in increased methylation of LIG1 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr19:48,115,445...48,170,344
Ensembl chr19:48,115,445...48,170,603
G
LILRB4
leukocyte immunoglobulin like receptor B4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LILRB4B mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr19:54,662,985...54,668,718
Ensembl chr19:54,643,889...54,670,359
G
LIMCH1
LIM and calponin homology domains 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LIMCH1 mRNA
CTD
PMID:15336504
NCBI chr 4:41,359,607...41,700,044
Ensembl chr 4:41,359,607...41,700,044
G
LIMK1
LIM domain kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMK1 mRNA
CTD
PMID:15003993
NCBI chr 7:74,083,804...74,122,525
Ensembl chr 7:74,082,933...74,122,525
G
LIMS1
LIM zinc finger domain containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LIMS1 mRNA
CTD
PMID:15336504
NCBI chr 2:108,533,671...108,687,246
Ensembl chr 2:108,533,671...108,687,246
G
LIPA
lipase A, lysosomal acid type
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LIPA mRNA
CTD
PMID:15336504
NCBI chr10:89,213,572...89,251,775
Ensembl chr10:89,213,569...89,414,557
G
LITAF
lipopolysaccharide induced TNF factor
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]
CTD
PMID:20847119
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
G
LMBR1
limb development membrane protein 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of LMBR1 mRNA
CTD
PMID:23410634
NCBI chr 7:156,669,012...156,893,183
Ensembl chr 7:156,668,946...156,893,216
G
LMNB1
lamin B1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LMNB1 mRNA
CTD
PMID:15336504
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
G
LMNB2
lamin B2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LMNB2 mRNA
CTD
PMID:15336504
NCBI chr19:2,428,166...2,456,959
Ensembl chr19:2,427,638...2,456,959
G
LNX2
ligand of numb-protein X 2
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of LNX2 intron
CTD
PMID:29432895
NCBI chr13:27,545,913...27,621,107
Ensembl chr13:27,545,913...27,620,529
G
LOX
lysyl oxidase
affects expression
EXP
tert-Butylhydroperoxide affects the expression of LOX mRNA
CTD
PMID:23410634
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LOXL2
lysyl oxidase like 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LOXL2 mRNA
CTD
PMID:15963989
NCBI chr 8:23,296,897...23,404,120
Ensembl chr 8:23,296,897...23,425,328
G
LPCAT1
lysophosphatidylcholine acyltransferase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LPCAT1 mRNA
CTD
PMID:15336504
NCBI chr 5:1,461,427...1,523,960
Ensembl chr 5:1,456,480...1,523,962
G
LPCAT3
lysophosphatidylcholine acyltransferase 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LPCAT3 mRNA
CTD
PMID:15336504
NCBI chr12:6,976,185...7,018,476
Ensembl chr12:6,976,185...7,018,477
G
LPIN1
lipin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPIN1 mRNA
CTD
PMID:14729362
NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409
G
LPIN2
lipin 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LPIN2 mRNA
CTD
PMID:15336504
NCBI chr18:2,916,994...3,013,144
Ensembl chr18:2,885,296...3,013,144
G
LPL
lipoprotein lipase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LPL mRNA
CTD
PMID:15336504
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LPP
LIM domain containing preferred translocation partner in lipoma
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LPP mRNA
CTD
PMID:15336504
NCBI chr 3:188,153,021...188,890,671
Ensembl chr 3:188,153,284...188,890,671
G
LRBA
LPS responsive beige-like anchor protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LRBA mRNA
CTD
PMID:14729362
NCBI chr 4:150,264,435...151,015,727
Ensembl chr 4:150,264,435...151,015,727
G
LRP1
LDL receptor related protein 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of LRP1 mRNA
CTD
PMID:23410634
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
G
LRP6
LDL receptor related protein 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LRP6 mRNA
CTD
PMID:12414654
NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044
G
LRRC1
leucine rich repeat containing 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LRRC1 mRNA
CTD
PMID:15336504
NCBI chr 6:53,795,005...53,924,125
Ensembl chr 6:53,794,497...53,924,125
G
LRRC17
leucine rich repeat containing 17
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LRRC17 mRNA
CTD
PMID:15336504
NCBI chr 7:102,913,000...102,945,111
Ensembl chr 7:102,913,000...102,945,111
G
LRRC23
leucine rich repeat containing 23
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of LRRC23 intron
CTD
PMID:29432895
NCBI chr12:6,904,822...6,914,229
Ensembl chr12:6,873,569...6,914,241
G
LRRC27
leucine rich repeat containing 27
increases methylation
EXP
tert-Butylhydroperoxide results in increased methylation of LRRC27 promoter
CTD
PMID:29432895
NCBI chr10:132,330,063...132,381,508
Ensembl chr10:132,332,154...132,381,508
G
LSM4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LSM4 mRNA
CTD
PMID:15336504
NCBI chr19:18,306,236...18,323,076
Ensembl chr19:18,306,236...18,323,112
G
LSS
lanosterol synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LSS mRNA
CTD
PMID:14729362
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
LTBP2
latent transforming growth factor beta binding protein 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LTBP2 mRNA
CTD
PMID:15336504
NCBI chr14:74,498,183...74,612,237
Ensembl chr14:74,498,183...74,612,378
G
LY6S
lymphocyte antigen 6 family member S
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LY6A mRNA
CTD
PMID:15003993
NCBI chr 8:143,040,839...143,076,471
Ensembl chr 8:143,040,839...143,048,319
G
LY96
lymphocyte antigen 96
multiple interactions
EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079
G
LYN
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of LYN mRNA
CTD
PMID:12419474
NCBI chr 8:55,879,835...56,014,169
Ensembl chr 8:55,879,835...56,014,169
G
LYPD1
LY6/PLAUR domain containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LYPD1 mRNA
CTD
PMID:15336504
NCBI chr 2:132,643,286...132,671,526
Ensembl chr 2:132,643,286...132,671,579
G
LYPLA1
lysophospholipase 1
decreases response to substance
ISO
LYPLA1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15003993
NCBI chr 8:54,046,367...54,101,947
Ensembl chr 8:54,046,367...54,102,017
G
MAB21L1
mab-21 like 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MAB21L1 mRNA
CTD
PMID:15336504
NCBI chr13:35,473,789...35,476,689
Ensembl chr13:35,473,419...35,478,764
G
MAB21L2
mab-21 like 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MAB21L2 mRNA
CTD
PMID:15336504
NCBI chr 4:150,582,151...150,584,693
Ensembl chr 4:150,582,151...150,584,693
G
MACROH2A1
macroH2A.1 histone
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MACROH2A1 mRNA
CTD
PMID:15336504
NCBI chr 5:135,334,381...135,399,887
Ensembl chr 5:135,334,381...135,399,914
G
MAFB
MAF bZIP transcription factor B
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of MAFB mRNA tert-Butylhydroperoxide results in increased methylation of MAFB gene
CTD
PMID:27509014
NCBI chr20:40,685,848...40,689,236
Ensembl chr20:40,685,848...40,689,236
G
MAFF
MAF bZIP transcription factor F
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MAFF mRNA
CTD
PMID:15336504
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
G
MAFG
MAF bZIP transcription factor G
increases expression increases methylation
EXP
tert-Butylhydroperoxide results in increased expression of MAFG mRNA tert-Butylhydroperoxide results in increased methylation of MAFG gene
CTD
PMID:12414654 PMID:27509014
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
G
MAFK
MAF bZIP transcription factor K
increases methylation increases expression
EXP
tert-Butylhydroperoxide results in increased methylation of MAFK gene tert-Butylhydroperoxide results in increased expression of MAFK mRNA
CTD
PMID:27509014
NCBI chr 7:1,530,702...1,543,043
Ensembl chr 7:1,530,702...1,543,043
G
MAL
mal, T cell differentiation protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MAL mRNA
CTD
PMID:15336504
NCBI chr 2:95,025,708...95,053,992
Ensembl chr 2:95,025,677...95,053,992
G
MAMLD1
mastermind like domain containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MAMLD1 mRNA
CTD
PMID:15336504
NCBI chr X:150,361,572...150,514,173
Ensembl chr X:150,361,422...150,514,178
G
MAN2A2
mannosidase alpha class 2A member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MAN2A2 mRNA
CTD
PMID:15336504
NCBI chr15:90,902,382...90,922,585
Ensembl chr15:90,902,218...90,922,584
G
MANSC1
MANSC domain containing 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MANSC1 mRNA
CTD
PMID:15336504
NCBI chr12:12,326,056...12,350,242
Ensembl chr12:12,326,056...12,350,242
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MAP1LC3B mRNA
CTD
PMID:15336504
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
G
MAP2K3
mitogen-activated protein kinase kinase 3
increases expression increases phosphorylation
EXP
tert-Butylhydroperoxide results in increased expression of MAP2K3 mRNA tert-Butylhydroperoxide results in increased phosphorylation of MAP2K3 protein
CTD
PMID:15336504 PMID:17003459
NCBI chr17:21,284,711...21,315,240
Ensembl chr17:21,284,672...21,315,232
G
MAP2K4
mitogen-activated protein kinase kinase 4
increases phosphorylation
EXP
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K4 protein
CTD
PMID:17003459
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
G
MAP2K5
mitogen-activated protein kinase kinase 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MAP2K5 mRNA
CTD
PMID:12419474
NCBI chr15:67,542,703...67,807,114
Ensembl chr15:67,542,703...67,807,117
G
MAP2K6
mitogen-activated protein kinase kinase 6
increases phosphorylation
EXP
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K6 protein
CTD
PMID:17003459
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MAP3K5 mRNA
CTD
PMID:15336504
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
G
MAP3K6
mitogen-activated protein kinase kinase kinase 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MAP3K6 mRNA
CTD
PMID:15336504
NCBI chr 1:27,355,184...27,366,961
Ensembl chr 1:27,355,184...27,366,961
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MAP3K7 mRNA
CTD
PMID:15336504
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MAP4
microtubule associated protein 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MAP4 mRNA
CTD
PMID:15336504
NCBI chr 3:47,850,695...48,088,848
Ensembl chr 3:47,850,690...48,089,272
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation multiple interactions decreases expression increases phosphorylation
EXP ISO
tert-Butylhydroperoxide results in decreased phosphorylation of MAPK1 protein [tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK1 protein; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MAPK1 protein modified form] 7-methyljuglone analog inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein]
CTD
PMID:17003459 PMID:20100471 PMID:20922651
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK12
mitogen-activated protein kinase 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAPK12 mRNA
CTD
PMID:14729362
NCBI chr22:50,252,901...50,261,683
Ensembl chr22:50,245,450...50,261,716
G
MAPK14
mitogen-activated protein kinase 14
decreases expression increases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of MAPK14 mRNA tert-Butylhydroperoxide results in increased expression of MAPK14 mRNA tert-Butylhydroperoxide results in increased methylation of MAPK14 gene
CTD
PMID:15336504 PMID:27509014 PMID:29432895
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions decreases phosphorylation decreases expression increases phosphorylation
EXP ISO
[tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK3 protein; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MAPK3 protein modified form] tert-Butylhydroperoxide results in decreased phosphorylation of MAPK3 protein tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein 7-methyljuglone analog inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:17003459 PMID:20100471 PMID:20922651
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK8
mitogen-activated protein kinase 8
multiple interactions increases phosphorylation
ISO EXP
[phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK8 protein tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]
CTD
PMID:20423716 PMID:28063877
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MAPK9
mitogen-activated protein kinase 9
multiple interactions increases phosphorylation
ISO EXP
[phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]
CTD
PMID:20423716 PMID:28063877
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
G
MAPRE3
microtubule associated protein RP/EB family member 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAPRE3 mRNA
CTD
PMID:15003993
NCBI chr 2:26,970,637...27,027,219
Ensembl chr 2:26,970,637...27,027,219
G
MARCHF2
membrane associated ring-CH-type finger 2
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of MARCHF2 mRNA tert-Butylhydroperoxide results in increased methylation of MARCHF2 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr19:8,413,305...8,439,017
Ensembl chr19:8,413,270...8,439,017
G
MARK3
microtubule affinity regulating kinase 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MARK3 mRNA
CTD
PMID:12419474
NCBI chr14:103,385,415...103,503,831
Ensembl chr14:103,385,377...103,503,831
G
MAS1
MAS1 proto-oncogene, G protein-coupled receptor
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of MAS1 gene
CTD
PMID:29432895
NCBI chr 6:159,888,787...159,917,447
Ensembl chr 6:159,890,988...159,917,447
G
MATN2
matrilin 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MATN2 mRNA
CTD
PMID:15336504
NCBI chr 8:97,869,064...98,036,724
Ensembl chr 8:97,868,840...98,036,724
G
MB21D2
Mab-21 domain containing 2
multiple interactions decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MB21D2 mRNA]
CTD
PMID:20847119
NCBI chr 3:192,796,815...192,917,856
Ensembl chr 3:192,796,815...192,917,856
G
MBD3
methyl-CpG binding domain protein 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MBD3 mRNA
CTD
PMID:15336504
NCBI chr19:1,573,596...1,592,865
Ensembl chr19:1,573,596...1,592,865
G
MBNL2
muscleblind like splicing regulator 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MBNL2 mRNA
CTD
PMID:15336504
NCBI chr13:97,141,834...97,394,120
Ensembl chr13:97,221,434...97,394,120
G
MBTPS1
membrane bound transcription factor peptidase, site 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MBTPS1 mRNA
CTD
PMID:15336504
NCBI chr16:84,053,763...84,116,942
Ensembl chr16:84,053,761...84,116,942
G
MCAM
melanoma cell adhesion molecule
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MCAM mRNA
CTD
PMID:15336504
NCBI chr11:119,308,529...119,317,130
Ensembl chr11:119,308,529...119,321,521
G
MCFD2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCFD2 mRNA
CTD
PMID:15003993
NCBI chr 2:46,901,870...46,941,855
Ensembl chr 2:46,901,870...46,941,855
G
MCL1
MCL1 apoptosis regulator, BCL2 family member
multiple interactions decreases response to substance
EXP
[HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] MCL1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15611089
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
G
MCM2
minichromosome maintenance complex component 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MCM2 mRNA
CTD
PMID:15336504
NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,223...127,622,436
G
MCM3
minichromosome maintenance complex component 3
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of MCM3 mRNA tert-Butylhydroperoxide affects the expression of MCM3 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 6:52,264,015...52,284,742
Ensembl chr 6:52,264,014...52,284,881
G
MCM4
minichromosome maintenance complex component 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MCM4 mRNA
CTD
PMID:12419474
NCBI chr 8:47,960,941...47,978,160
Ensembl chr 8:47,960,185...47,978,160
G
MCM5
minichromosome maintenance complex component 5
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of MCM5 mRNA tert-Butylhydroperoxide affects the expression of MCM5 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
G
MCM6
minichromosome maintenance complex component 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MCM6 mRNA
CTD
PMID:15336504
NCBI chr 2:135,839,626...135,876,443
Ensembl chr 2:135,839,626...135,876,443
G
MCM7
minichromosome maintenance complex component 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MCM7 mRNA
CTD
PMID:15336504
NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,233...100,101,940
G
MCRS1
microspherule protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MCRS1 mRNA
CTD
PMID:15336504
NCBI chr12:49,558,299...49,568,142
Ensembl chr12:49,556,544...49,568,145
G
MDM2
MDM2 proto-oncogene
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MDM2 mRNA
CTD
PMID:27509014
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
ME1
malic enzyme 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ME1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
MECP2
methyl-CpG binding protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MECP2 mRNA
CTD
PMID:15336504
NCBI chr X:154,021,573...154,097,717
Ensembl chr X:154,021,573...154,137,103
G
MED16
mediator complex subunit 16
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MED16 mRNA
CTD
PMID:15336504
NCBI chr19:867,963...893,187
Ensembl chr19:867,630...893,218
G
MED21
mediator complex subunit 21
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MED21 mRNA
CTD
PMID:15336504
NCBI chr12:27,022,558...27,038,951
Ensembl chr12:27,022,546...27,066,343
G
MEGF9
multiple EGF like domains 9
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MEGF9 mRNA
CTD
PMID:15336504
NCBI chr 9:120,600,811...120,714,470
Ensembl chr 9:120,600,811...120,714,470
G
MEST
mesoderm specific transcript
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MEST mRNA
CTD
PMID:15336504
NCBI chr 7:130,486,175...130,506,465
Ensembl chr 7:130,486,171...130,506,465
G
MET
MET proto-oncogene, receptor tyrosine kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MET mRNA
CTD
PMID:15336504
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
MFSD6
major facilitator superfamily domain containing 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MFSD6 mRNA
CTD
PMID:15336504
NCBI chr 2:190,407,576...190,502,314
Ensembl chr 2:190,408,355...190,509,205
G
MGLL
monoglyceride lipase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MGLL mRNA
CTD
PMID:15336504
NCBI chr 3:127,689,066...127,823,185
Ensembl chr 3:127,689,062...128,052,190
G
MGP
matrix Gla protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MGP mRNA
CTD
PMID:12766906 PMID:15336504
NCBI chr12:14,880,864...14,885,854
Ensembl chr12:14,880,864...14,885,857
G
MGST2
microsomal glutathione S-transferase 2
decreases response to substance increases expression
ISO
MGST2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MGST2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 4:139,665,819...139,754,618
Ensembl chr 4:139,665,768...139,740,745
G
MGST3
microsomal glutathione S-transferase 3
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of MGST3 mRNA tert-Butylhydroperoxide results in increased expression of MGST3 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 1:165,631,234...165,656,136
Ensembl chr 1:165,631,213...165,661,796
G
MIA
MIA SH3 domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MIA mRNA
CTD
PMID:14729362
NCBI chr19:40,775,160...40,777,490
Ensembl chr19:40,771,648...40,777,490
G
MIA2
MIA SH3 domain ER export factor 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MIA2 mRNA
CTD
PMID:12414654
NCBI chr14:39,233,915...39,388,522
Ensembl chr14:39,230,231...39,388,513
G
MIA3
MIA SH3 domain ER export factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MIA3 mRNA
CTD
PMID:15003993
NCBI chr 1:222,618,097...222,668,007
Ensembl chr 1:222,618,097...222,668,007
G
MID1IP1
MID1 interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MID1IP1 mRNA
CTD
PMID:15003993
NCBI chr X:38,801,459...38,806,532
Ensembl chr X:38,801,440...38,806,537
G
MIR155
microRNA 155
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA]
CTD
PMID:35690295
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR16-2
microRNA 16-2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MIR16 mRNA
CTD
PMID:15336504
NCBI chr 3:160,404,745...160,404,825
Ensembl chr 3:160,404,745...160,404,825
G
MIR184
microRNA 184
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR184 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA]
CTD
PMID:35690295
NCBI chr15:79,209,788...79,209,871
Ensembl chr15:79,209,788...79,209,871
G
MITF
melanocyte inducing transcription factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MITF mRNA
CTD
PMID:15336504
NCBI chr 3:69,739,464...69,968,332
Ensembl chr 3:69,739,456...69,968,336
G
MIXL1
Mix paired-like homeobox
affects expression
EXP
tert-Butylhydroperoxide affects the expression of MIXL1 mRNA
CTD
PMID:23410634
NCBI chr 1:226,223,664...226,227,060
Ensembl chr 1:226,223,618...226,227,060
G
MKKS
MKKS centrosomal shuttling protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MKKS mRNA
CTD
PMID:15336504
NCBI chr20:10,401,009...10,434,222
Ensembl chr20:10,401,009...10,434,222
G
MKNK2
MAPK interacting serine/threonine kinase 2
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of MKNK2 mRNA tert-Butylhydroperoxide results in increased expression of MKNK2 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr19:2,037,471...2,051,244
Ensembl chr19:2,037,465...2,051,244
G
MKRN1
makorin ring finger protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MKRN1 mRNA
CTD
PMID:15336504
NCBI chr 7:140,453,033...140,479,569
Ensembl chr 7:140,453,033...140,479,536
G
MLH1
mutL homolog 1
decreases expression multiple interactions
EXP
tert-Butylhydroperoxide results in decreased expression of MLH1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]
CTD
PMID:12419474 PMID:35690295
NCBI chr 3:36,993,466...37,050,846
Ensembl chr 3:36,993,226...37,050,896
G
MME
membrane metalloendopeptidase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MME mRNA
CTD
PMID:15336504
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
G
MMP11
matrix metallopeptidase 11
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MMP11 mRNA
CTD
PMID:12419474
NCBI chr22:23,772,849...23,784,316
Ensembl chr22:23,768,226...23,784,316
G
MMP3
matrix metallopeptidase 3
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA]
CTD
PMID:35690295
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP9
matrix metallopeptidase 9
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]
CTD
PMID:35690295
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MOB1A
MOB kinase activator 1A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MOB1A mRNA
CTD
PMID:15336504
NCBI chr 2:74,152,528...74,178,879
Ensembl chr 2:74,152,528...74,178,898
G
MOK
MOK protein kinase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MOK mRNA
CTD
PMID:15336504
NCBI chr14:102,214,596...102,305,164
Ensembl chr14:102,224,500...102,305,190
G
MOSPD1
motile sperm domain containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MOSPD1 mRNA
CTD
PMID:15336504
NCBI chr X:134,887,632...134,915,257
Ensembl chr X:134,887,632...134,915,257
G
MOV10
Mov10 RNA helicase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOV10 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:112,674,439...112,700,739
Ensembl chr 1:112,673,141...112,700,756
G
MOXD1
monooxygenase DBH like 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MOXD1 mRNA
CTD
PMID:15336504
NCBI chr 6:132,296,055...132,401,475
Ensembl chr 6:132,296,055...132,401,475
G
MPG
N-methylpurine DNA glycosylase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MPG mRNA
CTD
PMID:15336504
NCBI chr16:77,007...85,846
Ensembl chr16:77,007...85,851
G
MPHOSPH8
M-phase phosphoprotein 8
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MPHOSPH8 mRNA
CTD
PMID:15336504
NCBI chr13:19,633,659...19,673,441
Ensembl chr13:19,633,659...19,673,441
G
MPHOSPH9
M-phase phosphoprotein 9
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MPHOSPH9 mRNA
CTD
PMID:15336504
NCBI chr12:123,152,324...123,244,002
Ensembl chr12:123,152,320...123,244,014
G
MPP1
MAGUK p55 scaffold protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MPP1 mRNA
CTD
PMID:15003993
NCBI chr X:154,778,684...154,805,485
Ensembl chr X:154,778,684...154,821,007
G
MPPE1
metallophosphoesterase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MPPE1 mRNA
CTD
PMID:15336504
NCBI chr18:11,882,622...11,908,317
Ensembl chr18:11,882,622...11,908,366
G
MRPL2
mitochondrial ribosomal protein L2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MRPL2 mRNA
CTD
PMID:15336504
NCBI chr 6:43,054,029...43,059,863
Ensembl chr 6:43,054,029...43,059,438
G
MRPL23
mitochondrial ribosomal protein L23
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL23 mRNA
CTD
PMID:14729362
NCBI chr11:1,947,332...2,014,944
Ensembl chr11:1,947,278...1,984,522
G
MRPL34
mitochondrial ribosomal protein L34
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MRPL34 mRNA
CTD
PMID:15336504
NCBI chr19:17,292,573...17,306,843
Ensembl chr19:17,292,609...17,306,843
G
MRPL48
mitochondrial ribosomal protein L48
increases expression decreases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of MRPL48 mRNA tert-Butylhydroperoxide results in decreased expression of MRPL48 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr11:73,787,874...73,865,133
Ensembl chr11:73,787,872...73,865,133
G
MRPS14
mitochondrial ribosomal protein S14
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MRPS14 mRNA
CTD
PMID:15336504
NCBI chr 1:175,012,958...175,023,425
Ensembl chr 1:175,010,789...175,023,425
G
MSH6
mutS homolog 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MSH6 mRNA
CTD
PMID:15336504
NCBI chr 2:47,783,145...47,810,101
Ensembl chr 2:47,695,530...47,810,063
G
MSLN
mesothelin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MSLN mRNA
CTD
PMID:15336504
NCBI chr16:760,734...768,865
Ensembl chr16:760,734...768,865
G
MSN
moesin
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MSN mRNA
CTD
PMID:15336504
NCBI chr X:65,588,377...65,741,931
Ensembl chr X:65,588,377...65,741,931
G
MSRA
methionine sulfoxide reductase A
decreases response to substance
EXP
MSRA protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15914630
NCBI chr 8:10,054,292...10,428,891
Ensembl chr 8:10,054,292...10,428,891
G
MSRB1
methionine sulfoxide reductase B1
decreases response to substance increases expression
EXP ISO
MSRB1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MSRB1 mRNA
CTD
PMID:15003993 PMID:15914630
NCBI chr16:1,938,229...1,943,199
Ensembl chr16:1,938,229...1,943,199
G
MSRB2
methionine sulfoxide reductase B2
decreases response to substance
EXP
MSRB2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15914630
NCBI chr10:23,095,579...23,122,013
Ensembl chr10:23,095,579...23,122,013
G
MSRB3
methionine sulfoxide reductase B3
decreases response to substance
EXP
MSRB3 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15914630
NCBI chr12:65,278,683...65,466,907
Ensembl chr12:65,278,643...65,491,430
G
MT1G
metallothionein 1G
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MT1G mRNA
CTD
PMID:12414654
NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065
G
MT1H
metallothionein 1H
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MT1H mRNA
CTD
PMID:12414654
NCBI chr16:56,669,814...56,671,129
Ensembl chr16:56,669,814...56,671,129
G
MT1M
metallothionein 1M
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MT1M mRNA
CTD
PMID:15336504
NCBI chr16:56,632,659...56,633,981
Ensembl chr16:56,632,659...56,633,981
G
MT1X
metallothionein 1X
increases expression decreases response to substance affects response to substance
EXP ISO
tert-Butylhydroperoxide results in increased expression of MT1X mRNA MT1 protein results in decreased susceptibility to tert-Butylhydroperoxide MT1 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:7890668 PMID:12414654 PMID:15336504 PMID:16150881
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
G
MT2A
metallothionein 2A
multiple interactions decreases response to substance increases expression affects response to substance
EXP ISO
MT2A protein inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA] MT2A protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MT2A mRNA MT2 protein results in decreased susceptibility to tert-Butylhydroperoxide MT2 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:7890668 PMID:12414654 PMID:16150881 PMID:16402917 PMID:16636651
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
G
MTARC1
mitochondrial amidoxime reducing component 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of MTARC1 mRNA
CTD
PMID:23410634
NCBI chr 1:220,786,913...220,819,659
Ensembl chr 1:220,786,352...220,819,659
G
MTF1
metal regulatory transcription factor 1
increases response to substance
EXP
MTF1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15378601
NCBI chr 1:37,809,574...37,859,592
Ensembl chr 1:37,809,574...37,859,592
G
MTG1
mitochondrial ribosome associated GTPase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MTG1 mRNA
CTD
PMID:15336504
NCBI chr10:133,394,157...133,422,520
Ensembl chr10:133,394,094...133,422,520
G
MTOR
mechanistic target of rapamycin kinase
multiple interactions
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA]
CTD
PMID:35690295
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MTR mRNA
CTD
PMID:27509014
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
G
MTX1
metaxin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MTX1 mRNA
CTD
PMID:14729362
NCBI chr 1:155,208,695...155,213,839
Ensembl chr 1:155,208,695...155,213,824
G
MUC1
mucin 1, cell surface associated
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MUC1 mRNA
CTD
PMID:15336504
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MX1
MX dynamin like GTPase 1
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of MX1 mRNA tert-Butylhydroperoxide results in increased expression of MX1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
G
MXD1
MAX dimerization protein 1
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]
CTD
PMID:20847119
NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MYC mRNA
CTD
PMID:27509014
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYDGF
myeloid derived growth factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MYDGF mRNA
CTD
PMID:15336504
NCBI chr19:4,657,545...4,670,342
Ensembl chr19:4,641,374...4,670,362
G
MYLK
myosin light chain kinase
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of MYLK mRNA tert-Butylhydroperoxide affects the expression of MYLK mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
MYO10
myosin X
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MYO10 mRNA
CTD
PMID:15336504
NCBI chr 5:16,661,907...16,936,288
Ensembl chr 5:16,661,907...16,936,288
G
MYO5A
myosin VA
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of MYO5A mRNA
CTD
PMID:15336504
NCBI chr15:52,307,283...52,529,050
Ensembl chr15:52,307,281...52,529,132
G
MYO5C
myosin VC
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of MYO5C mRNA
CTD
PMID:15336504
NCBI chr15:52,192,322...52,295,804
Ensembl chr15:52,192,322...52,295,804
G
MYO7A
myosin VIIA
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO7A mRNA
CTD
PMID:14729362
NCBI chr11:77,128,246...77,215,241
Ensembl chr11:77,128,246...77,215,241
G
N4BP1
NEDD4 binding protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of N4BP1 mRNA
CTD
PMID:15336504
NCBI chr16:48,538,726...48,610,180
Ensembl chr16:48,538,726...48,620,148
G
N4BP2L2
NEDD4 binding protein 2 like 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of N4BP2L2 mRNA
CTD
PMID:15336504
NCBI chr13:32,432,485...32,538,868
Ensembl chr13:32,432,417...32,538,885
G
NAA15
N-alpha-acetyltransferase 15, NatA auxiliary subunit
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NAA15 mRNA
CTD
PMID:15336504
NCBI chr 4:139,301,505...139,391,384
Ensembl chr 4:139,301,446...139,420,033
G
NAP1L1
nucleosome assembly protein 1 like 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NAP1L1 mRNA
CTD
PMID:15336504
NCBI chr12:76,036,585...76,084,685
Ensembl chr12:76,036,585...76,084,735
G
NAPSA
napsin A aspartic peptidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAPSA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr19:50,358,477...50,365,639
Ensembl chr19:50,358,472...50,365,830
G
NAV3
neuron navigator 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NAV3 mRNA
CTD
PMID:15336504
NCBI chr12:77,571,862...78,213,010
Ensembl chr12:77,324,641...78,213,010
G
NAXD
NAD(P)HX dehydratase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NAXD mRNA
CTD
PMID:15336504
NCBI chr13:110,615,460...110,639,996
Ensembl chr13:110,615,545...110,639,996
G
NCAM1
neural cell adhesion molecule 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NCAM1 mRNA
CTD
PMID:15336504
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
NCAPD2
non-SMC condensin I complex subunit D2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NCAPD2 mRNA
CTD
PMID:15336504
NCBI chr12:6,494,102...6,531,955
Ensembl chr12:6,493,356...6,531,955
G
NCAPG2
non-SMC condensin II complex subunit G2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NCAPG2 mRNA
CTD
PMID:15336504
NCBI chr 7:158,631,169...158,704,804
Ensembl chr 7:158,631,169...158,704,804
G
NCF1
neutrophil cytosolic factor 1
increases expression multiple interactions affects localization
ISO EXP
tert-Butylhydroperoxide results in increased expression of NCF1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide affects the localization of NCF1 protein]
CTD
PMID:22659508 PMID:29111459
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
G
NCF4
neutrophil cytosolic factor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NCF4 mRNA
CTD
PMID:14729362
NCBI chr22:36,861,006...36,878,015
Ensembl chr22:36,860,988...36,878,017
G
NCOR2
nuclear receptor corepressor 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NCOR2 mRNA
CTD
PMID:15336504
NCBI chr12:124,324,415...124,567,612
Ensembl chr12:124,324,415...124,567,612
G
NDC80
NDC80 kinetochore complex component
affects expression
EXP
tert-Butylhydroperoxide affects the expression of NDC80 mRNA
CTD
PMID:23410634
NCBI chr18:2,571,557...2,616,635
Ensembl chr18:2,571,557...2,616,635
G
NDRG1
N-myc downstream regulated 1
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NDRG1 mRNA]
CTD
PMID:20847119
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NDRG3
NDRG family member 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NDRG3 mRNA
CTD
PMID:15336504
NCBI chr20:36,651,771...36,746,090
Ensembl chr20:36,651,766...36,746,090
G
NDRG4
NDRG family member 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NDRG4 mRNA
CTD
PMID:15336504
NCBI chr16:58,463,715...58,515,387
Ensembl chr16:58,462,846...58,513,628
G
NDUFA3
NADH:ubiquinone oxidoreductase subunit A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NDUFA3 mRNA
CTD
PMID:15003993
NCBI chr19:54,102,855...54,107,568
Ensembl chr19:54,102,728...54,109,257
G
NDUFA7
NADH:ubiquinone oxidoreductase subunit A7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NDUFA7 mRNA
CTD
PMID:15336504
NCBI chr19:8,308,595...8,321,375
Ensembl chr19:8,308,768...8,321,375
G
NDUFB2
NADH:ubiquinone oxidoreductase subunit B2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NDUFB2 mRNA
CTD
PMID:15336504
NCBI chr 7:140,696,708...140,706,643
Ensembl chr 7:140,690,777...140,722,790
G
NDUFB7
NADH:ubiquinone oxidoreductase subunit B7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NDUFB7 mRNA
CTD
PMID:15336504
NCBI chr19:14,566,078...14,572,066
Ensembl chr19:14,566,078...14,572,066
G
NDUFS7
NADH:ubiquinone oxidoreductase core subunit S7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NDUFS7 mRNA
CTD
PMID:15336504
NCBI chr19:1,383,907...1,395,584
Ensembl chr19:1,383,527...1,395,589
G
NEAT1
nuclear paraspeckle assembly transcript 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NEAT1 mRNA; tert-Butylhydroperoxide results in increased expression of NEAT1 mRNA alternative form
CTD
PMID:31311324
NCBI chr11:65,422,798...65,445,540
Ensembl chr11:65,422,774...65,445,540
G
NECAP1
NECAP endocytosis associated 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of NECAP1 mRNA
CTD
PMID:23410634
NCBI chr12:8,082,274...8,097,881
Ensembl chr12:8,076,939...8,097,881
G
NEDD4L
NEDD4 like E3 ubiquitin protein ligase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NEDD4L mRNA
CTD
PMID:15336504
NCBI chr18:58,044,226...58,401,540
Ensembl chr18:58,044,226...58,401,540
G
NELFCD
negative elongation factor complex member C/D
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NELFCD mRNA
CTD
PMID:15336504
NCBI chr20:58,981,256...58,995,113
Ensembl chr20:58,981,208...58,995,133
G
NES
nestin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NES mRNA
CTD
PMID:15003993
NCBI chr 1:156,668,763...156,677,407
Ensembl chr 1:156,668,763...156,677,407
G
NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NF2 mRNA
CTD
PMID:12419474
NCBI chr22:29,603,556...29,698,600
Ensembl chr22:29,603,553...29,698,598
G
NFATC1
nuclear factor of activated T cells 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NFATC1 mRNA
CTD
PMID:12419474
NCBI chr18:79,395,930...79,529,323
Ensembl chr18:79,395,856...79,529,325
G
NFATC2IP
nuclear factor of activated T cells 2 interacting protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NFATC2IP mRNA
CTD
PMID:15336504
NCBI chr16:28,950,937...28,967,092
Ensembl chr16:28,950,807...28,967,092
G
NFE2L2
NFE2 like bZIP transcription factor 2
multiple interactions decreases response to substance decreases expression increases expression affects localization
ISO EXP
NFE2L2 protein affects the reaction [3-methylquercetin results in decreased susceptibility to tert-Butylhydroperoxide]; NFE2L2 protein affects the susceptibility to [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] NFE2L2 protein results in decreased susceptibility to tert-Butylhydroperoxide nectandrin-B inhibits the reaction [tert-Butylhydroperoxide affects the localization of NFE2L2 protein]; NFE2L2 mRNA affects the reaction [plumbagin results in decreased susceptibility to tert-Butylhydroperoxide]; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA] tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA; tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein tert-Butylhydroperoxide results in increased expression of NFE2L2 mRNA
CTD
PMID:19647727 PMID:20028456 PMID:20100471 PMID:20932822 PMID:24211276 PMID:27050144 PMID:27509014 PMID:27511913 PMID:28025122 PMID:30273691 More...
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFIC
nuclear factor I C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NFIC mRNA
CTD
PMID:15003993
NCBI chr19:3,359,630...3,469,217
Ensembl chr19:3,314,403...3,469,217
G
NFIX
nuclear factor I X
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NFIX mRNA
CTD
PMID:12419474
NCBI chr19:12,995,475...13,098,796
Ensembl chr19:12,995,475...13,098,796
G
NFKB1
nuclear factor kappa B subunit 1
decreases expression increases expression multiple interactions
EXP ISO
tert-Butylhydroperoxide results in decreased expression of NFKB1 mRNA tert-Butylhydroperoxide results in increased expression of NFKB1 mRNA Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]
CTD
PMID:12419474 PMID:16704919 PMID:24394546
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKBIA
NFKB inhibitor alpha
increases expression increases phosphorylation multiple interactions affects expression
EXP ISO
tert-Butylhydroperoxide results in increased expression of NFKBIA mRNA tert-Butylhydroperoxide results in increased phosphorylation of NFKBIA protein Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of NFKBIA protein] tert-Butylhydroperoxide affects the expression of NFKBIA mRNA
CTD
PMID:15336504 PMID:15879681 PMID:23410634
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NFKBIE
NFKB inhibitor epsilon
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NFKBIE mRNA
CTD
PMID:15336504
NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788
G
NFYB
nuclear transcription factor Y subunit beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NFYB mRNA
CTD
PMID:15336504
NCBI chr12:104,117,086...104,138,210
Ensembl chr12:104,117,086...104,138,241
G
NGF
nerve growth factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NGF mRNA
CTD
PMID:15003993
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NIP7
nucleolar pre-rRNA processing protein NIP7
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NIP7 mRNA
CTD
PMID:15336504
NCBI chr16:69,339,772...69,343,106
Ensembl chr16:69,337,996...69,343,106
G
NISCH
nischarin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NISCH mRNA
CTD
PMID:15336504
NCBI chr 3:52,455,604...52,493,068
Ensembl chr 3:52,455,118...52,493,068
G
NIT1
nitrilase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NIT1 mRNA
CTD
PMID:14729362
NCBI chr 1:161,118,105...161,125,445
Ensembl chr 1:161,118,086...161,125,445
G
NKAIN1
sodium/potassium transporting ATPase interacting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKAIN1 mRNA
CTD
PMID:15003993
NCBI chr 1:31,179,745...31,239,887
Ensembl chr 1:31,179,745...31,239,887
G
NKD1
NKD inhibitor of WNT signaling pathway 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of NKD1 mRNA
CTD
PMID:23410634
NCBI chr16:50,548,396...50,649,249
Ensembl chr16:50,548,396...50,649,249
G
NKIRAS1
NFKB inhibitor interacting Ras like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKIRAS1 mRNA
CTD
PMID:15003993
NCBI chr 3:23,889,951...23,946,562
Ensembl chr 3:23,889,951...23,946,591
G
NKTR
natural killer cell triggering receptor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NKTR mRNA
CTD
PMID:15336504
NCBI chr 3:42,600,612...42,648,735
Ensembl chr 3:42,600,655...42,648,735
G
NKX3-1
NK3 homeobox 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NKX3-1 mRNA
CTD
PMID:15336504
NCBI chr 8:23,678,693...23,682,938
Ensembl chr 8:23,678,697...23,682,938
G
NMD3
NMD3 ribosome export adaptor
affects expression
EXP
tert-Butylhydroperoxide affects the expression of NMD3 mRNA
CTD
PMID:23410634
NCBI chr 3:161,221,102...161,253,532
Ensembl chr 3:161,104,696...161,253,532
G
NME2
NME/NM23 nucleoside diphosphate kinase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NME2 mRNA
CTD
PMID:12419474
NCBI chr17:51,165,536...51,171,744
Ensembl chr17:51,165,435...51,171,744
G
NMNAT3
nicotinamide nucleotide adenylyltransferase 3
decreases response to substance
ISO
NMNAT3 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:18463239
NCBI chr 3:139,560,180...139,678,050
Ensembl chr 3:139,560,180...139,678,017
G
NMRK1
nicotinamide riboside kinase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NMRK1 mRNA
CTD
PMID:15336504
NCBI chr 9:75,060,577...75,088,155
Ensembl chr 9:75,060,573...75,088,217
G
NMT1
N-myristoyltransferase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NMT1 mRNA
CTD
PMID:15336504
NCBI chr17:45,061,317...45,109,016
Ensembl chr17:44,957,992...45,109,016
G
NNT
nicotinamide nucleotide transhydrogenase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NNT mRNA
CTD
PMID:15336504
NCBI chr 5:43,602,675...43,707,396
Ensembl chr 5:43,602,692...43,707,405
G
NOC4L
nucleolar complex associated 4 homolog
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NOC4L mRNA
CTD
PMID:15336504
NCBI chr12:132,144,457...132,152,468
Ensembl chr12:132,144,457...132,152,473
G
NONO
non-POU domain containing octamer binding
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NONO mRNA
CTD
PMID:15336504
NCBI chr X:71,283,635...71,301,168
Ensembl chr X:71,254,814...71,301,522
G
NOS2
nitric oxide synthase 2
multiple interactions increases expression
ISO
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA]; tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD
PMID:10231168 PMID:18812229
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOX4
NADPH oxidase 4
increases expression multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of NOX4 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:29111459
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
G
NPC1
NPC intracellular cholesterol transporter 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NPC1 mRNA
CTD
PMID:15336504
NCBI chr18:23,506,184...23,586,506
Ensembl chr18:23,506,184...23,586,506
G
NPHP4
nephrocystin 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NPHP4 mRNA
CTD
PMID:15336504
NCBI chr 1:5,862,811...5,992,425
Ensembl chr 1:5,862,811...5,992,473
G
NPPB
natriuretic peptide B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NPPB mRNA
CTD
PMID:15336504
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression decreases expression multiple interactions
EXP ISO
tert-Butylhydroperoxide results in increased expression of NQO1 mRNA tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA; tert-Butylhydroperoxide results in decreased expression of NQO1 protein rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]
CTD
PMID:12414654 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NQO2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NQO2 mRNA
CTD
PMID:15336504
NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755
G
NR0B2
nuclear receptor subfamily 0 group B member 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of NR0B2 mRNA
CTD
PMID:23410634
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NR1H4
nuclear receptor subfamily 1 group H member 4
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of NR1H4 mRNA tert-Butylhydroperoxide affects the expression of NR1H4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
G
NR2F6
nuclear receptor subfamily 2 group F member 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NR2F6 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr19:17,231,883...17,245,919
Ensembl chr19:17,231,883...17,245,919
G
NR3C1
nuclear receptor subfamily 3 group C member 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of NR3C1 mRNA
CTD
PMID:23410634
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR4A1
nuclear receptor subfamily 4 group A member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NR4A1 mRNA
CTD
PMID:12414654
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
G
NRBF2
nuclear receptor binding factor 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NRBF2 mRNA
CTD
PMID:15336504
NCBI chr10:63,133,328...63,155,024
Ensembl chr10:63,133,247...63,155,031
G
NSD2
nuclear receptor binding SET domain protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NSD2 mRNA
CTD
PMID:15336504
NCBI chr 4:1,871,393...1,982,192
Ensembl chr 4:1,871,393...1,982,207
G
NSMAF
neutral sphingomyelinase activation associated factor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NSMAF mRNA
CTD
PMID:15336504
NCBI chr 8:58,583,504...58,659,853
Ensembl chr 8:58,583,508...58,659,853
G
NTRK2
neurotrophic receptor tyrosine kinase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NTRK2 mRNA
CTD
PMID:15336504
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
NUCB1
nucleobindin 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NUCB1 mRNA
CTD
PMID:15336504
NCBI chr19:48,900,312...48,923,372
Ensembl chr19:48,900,050...48,923,473
G
NUDT11
nudix hydrolase 11
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NUDT11 mRNA
CTD
PMID:15336504
NCBI chr X:51,490,011...51,496,592
Ensembl chr X:51,490,011...51,496,592
G
NUDT21
nudix hydrolase 21
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NUDT21 mRNA tert-Butylhydroperoxide results in increased expression of NUDT21 mRNA
CTD
PMID:15336504
NCBI chr16:56,429,133...56,451,332
Ensembl chr16:56,429,133...56,452,199
G
NUDT6
nudix hydrolase 6
affects expression
EXP
tert-Butylhydroperoxide affects the expression of NUDT6 mRNA
CTD
PMID:23410634
NCBI chr 4:122,892,577...122,922,968
Ensembl chr 4:122,888,697...122,922,968
G
NUP188
nucleoporin 188
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NUP188 mRNA
CTD
PMID:15336504
NCBI chr 9:128,947,699...129,007,096
Ensembl chr 9:128,947,699...129,007,096
G
NUP205
nucleoporin 205
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NUP205 mRNA
CTD
PMID:15336504
NCBI chr 7:135,557,917...135,648,753
Ensembl chr 7:135,557,917...135,648,757
G
NUP37
nucleoporin 37
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of NUP37 mRNA
CTD
PMID:15336504
NCBI chr12:102,073,103...102,120,114
Ensembl chr12:102,073,103...102,120,120
G
NUP58
nucleoporin 58
increases methylation increases expression
EXP
tert-Butylhydroperoxide results in increased methylation of NUP58 gene tert-Butylhydroperoxide results in increased expression of NUP58 mRNA
CTD
PMID:27509014
NCBI chr13:25,301,625...25,349,800
Ensembl chr13:25,301,524...25,365,390
G
NUSAP1
nucleolar and spindle associated protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of NUSAP1 mRNA
CTD
PMID:15336504
NCBI chr15:41,332,881...41,381,046
Ensembl chr15:41,320,794...41,381,050
G
OAS1
2'-5'-oligoadenylate synthetase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OAS1 mRNA
CTD
PMID:15336504
NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219
G
OAS3
2'-5'-oligoadenylate synthetase 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OAS3 mRNA
CTD
PMID:15336504
NCBI chr12:112,938,474...112,973,251
Ensembl chr12:112,938,051...112,976,460
G
OAZ1
ornithine decarboxylase antizyme 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OAZ1 mRNA
CTD
PMID:15336504
NCBI chr19:2,269,486...2,273,488
Ensembl chr19:2,269,509...2,273,490
G
OBSL1
obscurin like cytoskeletal adaptor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OBSL1 mRNA
CTD
PMID:15336504
NCBI chr 2:219,547,206...219,571,539
Ensembl chr 2:219,550,728...219,571,859
G
OCEL1
occludin/ELL domain containing 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OCEL1 mRNA
CTD
PMID:15336504
NCBI chr19:17,226,226...17,229,219
Ensembl chr19:17,226,213...17,229,219
G
OCLN
occludin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OCLN protein
CTD
PMID:34303734
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
G
ODC1
ornithine decarboxylase 1
increases activity
ISO
tert-Butylhydroperoxide results in increased activity of ODC1 protein
CTD
PMID:2013121
NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
G
OGDH
oxoglutarate dehydrogenase
multiple interactions decreases activity
ISO
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein]; Dithiothreitol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein]
CTD
PMID:12680778
NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,572...44,709,066
G
OGFOD3
2-oxoglutarate and iron dependent oxygenase domain containing 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OGFOD3 mRNA
CTD
PMID:15336504
NCBI chr17:82,389,210...82,418,586
Ensembl chr17:82,389,210...82,418,637
G
OGT
O-linked N-acetylglucosamine (GlcNAc) transferase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OGT mRNA
CTD
PMID:15336504
NCBI chr X:71,533,104...71,575,892
Ensembl chr X:71,533,087...71,575,892
G
OLA1
Obg like ATPase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of OLA1 mRNA
CTD
PMID:15336504
NCBI chr 2:174,072,447...174,248,532
Ensembl chr 2:174,072,447...174,248,599
G
OPN3
opsin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OPN3 mRNA
CTD
PMID:15336504
NCBI chr 1:241,593,124...241,640,369
Ensembl chr 1:241,590,102...241,677,376 Ensembl chr 1:241,590,102...241,677,376
G
OS9
OS9 endoplasmic reticulum lectin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OS9 mRNA
CTD
PMID:15336504
NCBI chr12:57,694,132...57,721,557
Ensembl chr12:57,693,841...57,728,342
G
OSBPL1A
oxysterol binding protein like 1A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OSBPL1A mRNA
CTD
PMID:15336504
NCBI chr18:24,162,045...24,397,824
Ensembl chr18:24,162,045...24,397,880
G
OSER1
oxidative stress responsive serine rich 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OSER1 mRNA
CTD
PMID:15336504
NCBI chr20:44,195,939...44,211,810
Ensembl chr20:44,195,939...44,210,771
G
OSGIN1
oxidative stress induced growth inhibitor 1
increases expression affects expression
EXP
tert-Butylhydroperoxide results in increased expression of OSGIN1 mRNA tert-Butylhydroperoxide affects the expression of OSGIN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,332
G
OSR2
odd-skipped related transciption factor 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OSR2 mRNA
CTD
PMID:15336504
NCBI chr 8:98,944,442...98,952,100
Ensembl chr 8:98,944,403...98,952,104
G
P4HA1
prolyl 4-hydroxylase subunit alpha 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of P4HA1 mRNA
CTD
PMID:15336504
NCBI chr10:73,007,217...73,096,866
Ensembl chr10:73,007,217...73,096,974
G
P4HTM
prolyl 4-hydroxylase, transmembrane
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of P4HTM mRNA
CTD
PMID:15336504
NCBI chr 3:48,989,908...49,007,153
Ensembl chr 3:48,989,889...49,007,153
G
PAFAH1B1
platelet activating factor acetylhydrolase 1b regulatory subunit 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PAFAH1B1 mRNA
CTD
PMID:15336504
NCBI chr17:2,593,183...2,685,615
Ensembl chr17:2,593,183...2,685,615
G
PAFAH2
platelet activating factor acetylhydrolase 2
multiple interactions decreases response to substance affects localization affects response to substance
EXP ISO
PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] PAFAH2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide affects the localization of PAFAH2 protein PAFAH2 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:12406338 PMID:18024956
NCBI chr 1:25,959,767...25,998,063
Ensembl chr 1:25,959,767...25,998,117
G
PALB2
partner and localizer of BRCA2
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of PALB2 intron
CTD
PMID:29432895
NCBI chr16:23,603,165...23,641,310
Ensembl chr16:23,603,160...23,641,321
G
PALLD
palladin, cytoskeletal associated protein
affects expression
EXP
tert-Butylhydroperoxide affects the expression of PALLD mRNA
CTD
PMID:23410634
NCBI chr 4:168,497,052...168,928,441
Ensembl chr 4:168,497,052...168,928,457
G
PAM
peptidylglycine alpha-amidating monooxygenase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PAM mRNA
CTD
PMID:15336504
NCBI chr 5:102,754,783...103,031,105
Ensembl chr 5:102,753,981...103,029,730
G
PAN2
poly(A) specific ribonuclease subunit PAN2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PAN2 mRNA
CTD
PMID:15336504
NCBI chr12:56,316,936...56,334,000
Ensembl chr12:56,316,223...56,334,053
G
PAPOLA
poly(A) polymerase alpha
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PAPOLA mRNA
CTD
PMID:15336504
NCBI chr14:96,502,376...96,567,116
Ensembl chr14:96,501,433...96,567,116
G
PAPSS1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PAPSS1 mRNA
CTD
PMID:15336504
NCBI chr 4:107,613,666...107,720,234
Ensembl chr 4:107,590,276...107,720,234
G
PAPSS2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PAPSS2 mRNA
CTD
PMID:15336504
NCBI chr10:87,659,878...87,747,705
Ensembl chr10:87,659,613...87,747,705
G
PARD3
par-3 family cell polarity regulator
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PARD3 mRNA
CTD
PMID:15336504
NCBI chr10:34,109,561...34,815,296
Ensembl chr10:34,109,560...34,815,325
G
PARP1
poly(ADP-ribose) polymerase 1
multiple interactions increases cleavage decreases expression
ISO EXP
Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; acetovanillone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]
CTD
PMID:15569404 PMID:16753784 PMID:27050144 PMID:27511913 PMID:28733231 PMID:29111459 More...
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PASK
PAS domain containing serine/threonine kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PASK mRNA
CTD
PMID:15336504
NCBI chr 2:241,106,099...241,150,347
Ensembl chr 2:241,106,099...241,150,264
G
PAWR
pro-apoptotic WT1 regulator
affects expression
EXP
tert-Butylhydroperoxide affects the expression of PAWR mRNA
CTD
PMID:23410634
NCBI chr12:79,584,879...79,690,964
Ensembl chr12:79,574,979...79,690,964
G
PAX6
paired box 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PAX6 mRNA
CTD
PMID:15336504
NCBI chr11:31,789,026...31,817,961
Ensembl chr11:31,784,779...31,817,961
G
PAXIP1
PAX interacting protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PAXIP1 mRNA
CTD
PMID:15336504
NCBI chr 7:154,943,690...155,003,411
Ensembl chr 7:154,943,687...155,003,124
G
PBX1
PBX homeobox 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PBX1 mRNA
CTD
PMID:15336504
NCBI chr 1:164,559,184...164,886,047
Ensembl chr 1:164,555,584...164,899,296
G
PBX2
PBX homeobox 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PBX2 mRNA
CTD
PMID:15336504
NCBI chr 6:32,184,733...32,190,202
Ensembl chr 6:32,184,733...32,190,202
G
PBX3
PBX homeobox 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PBX3 mRNA
CTD
PMID:15336504
NCBI chr 9:125,747,373...125,967,377
Ensembl chr 9:125,747,345...125,967,377
G
PCDH9
protocadherin 9
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PCDH9 mRNA
CTD
PMID:15336504
NCBI chr13:66,302,834...67,230,336
Ensembl chr13:66,302,834...67,230,445
G
PCID2
PCI domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PCID2 mRNA
CTD
PMID:15336504
NCBI chr13:113,165,002...113,208,669
Ensembl chr13:113,177,536...113,208,715
G
PCMTD2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PCMTD2 mRNA
CTD
PMID:15336504
NCBI chr20:64,255,748...64,276,226
Ensembl chr20:64,255,695...64,304,820
G
PCOLCE
procollagen C-endopeptidase enhancer
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PCOLCE mRNA
CTD
PMID:15336504
NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,363...100,608,175
G
PCOLCE2
procollagen C-endopeptidase enhancer 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PCOLCE2 mRNA
CTD
PMID:15336504
NCBI chr 3:142,817,874...142,889,083
Ensembl chr 3:142,815,922...142,889,206
G
PCYOX1
prenylcysteine oxidase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PCYOX1 mRNA
CTD
PMID:15336504
NCBI chr 2:70,257,915...70,281,185
Ensembl chr 2:70,257,386...70,281,185
G
PCYOX1L
prenylcysteine oxidase 1 like
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PCYOX1L mRNA
CTD
PMID:15336504
NCBI chr 5:149,358,046...149,369,653
Ensembl chr 5:149,358,037...149,369,653
G
PDAP1
PDGFA associated protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PDAP1 mRNA
CTD
PMID:15336504
NCBI chr 7:99,394,673...99,408,597
Ensembl chr 7:99,392,048...99,408,597
G
PDCD4
programmed cell death 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PDCD4 mRNA
CTD
PMID:15336504
NCBI chr10:110,871,928...110,900,006
Ensembl chr10:110,871,795...110,900,006
G
PDCD5
programmed cell death 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDCD5 mRNA
CTD
PMID:14729362
NCBI chr19:32,581,190...32,587,453
Ensembl chr19:32,581,190...32,587,453
G
PDE4DIP
phosphodiesterase 4D interacting protein
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PDE4DIP mRNA
CTD
PMID:15336504
NCBI chr 1:148,808,434...149,033,016
Ensembl chr 1:148,808,140...149,048,286
G
PDGFA
platelet derived growth factor subunit A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PDGFA mRNA
CTD
PMID:15336504
NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
G
PDHX
pyruvate dehydrogenase complex component X
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PDHX mRNA
CTD
PMID:15336504
NCBI chr11:34,915,920...34,996,128
Ensembl chr11:34,915,829...35,020,591
G
PDIA4
protein disulfide isomerase family A member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA4 mRNA
CTD
PMID:15003993
NCBI chr 7:149,003,051...149,028,505
Ensembl chr 7:149,003,062...149,028,662
G
PDIA5
protein disulfide isomerase family A member 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA5 mRNA
CTD
PMID:15003993
NCBI chr 3:123,067,025...123,162,104
Ensembl chr 3:123,067,025...123,225,227
G
PDIA6
protein disulfide isomerase family A member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA6 mRNA
CTD
PMID:15003993
NCBI chr 2:10,783,391...10,837,712
Ensembl chr 2:10,783,391...10,837,977
G
PDLIM3
PDZ and LIM domain 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PDLIM3 mRNA
CTD
PMID:15336504
NCBI chr 4:185,500,660...185,535,507
Ensembl chr 4:185,500,660...185,535,507
G
PDLIM4
PDZ and LIM domain 4
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PDLIM4 mRNA
CTD
PMID:15336504
NCBI chr 5:132,257,696...132,273,454
Ensembl chr 5:132,257,696...132,273,454
G
PDLIM7
PDZ and LIM domain 7
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PDLIM7 mRNA
CTD
PMID:15336504
NCBI chr 5:177,483,394...177,497,604
Ensembl chr 5:177,483,394...177,497,606
G
PDP1
pyruvate dehydrogenase phosphatase catalytic subunit 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PDP1 mRNA
CTD
PMID:15336504
NCBI chr 8:93,916,923...93,926,068
Ensembl chr 8:93,857,807...93,926,068
G
PDXK
pyridoxal kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PDXK mRNA
CTD
PMID:15336504
NCBI chr21:43,719,129...43,762,299
Ensembl chr21:43,719,094...43,762,307
G
PDZD2
PDZ domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PDZD2 mRNA
CTD
PMID:15336504
NCBI chr 5:31,639,131...32,110,932
Ensembl chr 5:31,639,131...32,110,932
G
PEG10
paternally expressed 10
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PEG10 mRNA
CTD
PMID:15336504
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
G
PERP
p53 apoptosis effector related to PMP22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PERP mRNA
CTD
PMID:21382384
NCBI chr 6:138,088,505...138,107,419
Ensembl chr 6:138,088,505...138,107,419
G
PFDN6
prefoldin subunit 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PFDN6 mRNA
CTD
PMID:15336504
NCBI chr 6:33,289,197...33,290,934
Ensembl chr 6:33,289,302...33,298,401
G
PFKL
phosphofructokinase, liver type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFKL mRNA
CTD
PMID:15003993
NCBI chr21:44,300,053...44,327,373
Ensembl chr21:44,300,051...44,327,376
G
PFKP
phosphofructokinase, platelet
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFKP mRNA
CTD
PMID:15003993
NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718
G
PFN2
profilin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PFN2 mRNA
CTD
PMID:14729362
NCBI chr 3:149,964,904...149,970,895
Ensembl chr 3:149,964,904...150,050,788
G
PGGT1B
protein geranylgeranyltransferase type I subunit beta
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PGGT1B mRNA
CTD
PMID:12414654
NCBI chr 5:115,204,012...115,262,877
Ensembl chr 5:115,204,012...115,262,877
G
PGLS
6-phosphogluconolactonase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PGLS mRNA
CTD
PMID:15336504
NCBI chr19:17,511,649...17,521,288
Ensembl chr19:17,511,636...17,521,288
G
PGM2
phosphoglucomutase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PGM2 mRNA
CTD
PMID:15003993
NCBI chr 4:37,826,686...37,862,937
Ensembl chr 4:37,826,660...37,862,937
G
PHF2
PHD finger protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PHF2 mRNA
CTD
PMID:15336504
NCBI chr 9:93,576,584...93,679,587
Ensembl chr 9:93,576,584...93,679,587
G
PHKA2
phosphorylase kinase regulatory subunit alpha 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PHKA2 mRNA
CTD
PMID:15003993
NCBI chr X:18,892,298...18,984,114
Ensembl chr X:18,892,298...18,984,114
G
PHKB
phosphorylase kinase regulatory subunit beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PHKB mRNA
CTD
PMID:15336504
NCBI chr16:47,461,299...47,701,523
Ensembl chr16:47,461,123...47,701,523
G
PHLDA1
pleckstrin homology like domain family A member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PHLDA1 mRNA
CTD
PMID:15336504
NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
G
PHLDA2
pleckstrin homology like domain family A member 2
increases expression affects expression
EXP
tert-Butylhydroperoxide results in increased expression of PHLDA2 mRNA tert-Butylhydroperoxide affects the expression of PHLDA2 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr11:2,928,273...2,929,420
Ensembl chr11:2,928,273...2,929,420
G
PI4KA
phosphatidylinositol 4-kinase alpha
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PI4KA mRNA
CTD
PMID:15336504
NCBI chr22:20,707,691...20,858,811
Ensembl chr22:20,707,691...20,859,417
G
PIAS1
protein inhibitor of activated STAT 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PIAS1 mRNA
CTD
PMID:15336504
NCBI chr15:68,054,315...68,193,847
Ensembl chr15:68,054,309...68,198,603
G
PID1
phosphotyrosine interaction domain containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PID1 mRNA
CTD
PMID:15336504
NCBI chr 2:229,023,973...229,271,287
Ensembl chr 2:228,850,526...229,271,287
G
PIDD1
p53-induced death domain protein 1
increases expression increases methylation
EXP
tert-Butylhydroperoxide results in increased expression of PIDD1 mRNA tert-Butylhydroperoxide results in increased methylation of PIDD1 gene
CTD
PMID:27509014
NCBI chr11:799,184...809,501
Ensembl chr11:799,179...809,753
G
PIGN
phosphatidylinositol glycan anchor biosynthesis class N
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PIGN mRNA
CTD
PMID:15336504
NCBI chr18:62,017,615...62,187,056
Ensembl chr18:61,905,255...62,187,118
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression multiple interactions
EXP
tert-Butylhydroperoxide results in decreased expression of PIK3R1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
G
PIK3R2
phosphoinositide-3-kinase regulatory subunit 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PIK3R2 mRNA
CTD
PMID:12419474
NCBI chr19:18,153,163...18,170,532
Ensembl chr19:18,153,163...18,170,532
G
PIK3R3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PIK3R3 mRNA
CTD
PMID:15336504
NCBI chr 1:46,040,140...46,174,901
Ensembl chr 1:46,040,140...46,133,036
G
PILRB
paired immunoglobin like type 2 receptor beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PILRB mRNA
CTD
PMID:15336504
NCBI chr 7:100,358,117...100,367,831
Ensembl chr 7:100,352,176...100,367,831
G
PKP4
plakophilin 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PKP4 mRNA
CTD
PMID:15336504
NCBI chr 2:158,456,952...158,681,429
Ensembl chr 2:158,456,952...158,682,879
G
PLA2G4A
phospholipase A2 group IVA
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PLA2G4A mRNA
CTD
PMID:15336504
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
G
PLA2G5
phospholipase A2 group V
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G5 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 1:20,028,408...20,091,911
Ensembl chr 1:20,028,179...20,091,911
G
PLA2G7
phospholipase A2 group VII
increases expression
EXP ISO
tert-Butylhydroperoxide results in increased expression of PLA2G7 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
PLA2R1
phospholipase A2 receptor 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PLA2R1 mRNA
CTD
PMID:12414654
NCBI chr 2:159,923,933...160,062,615
Ensembl chr 2:159,932,006...160,062,615
G
PLAA
phospholipase A2 activating protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PLAA mRNA
CTD
PMID:15336504
NCBI chr 9:26,903,372...26,947,242
Ensembl chr 9:26,903,372...26,947,242
G
PLAGL1
PLAG1 like zinc finger 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PLAGL1 mRNA
CTD
PMID:15336504
NCBI chr 6:143,940,300...144,064,599
Ensembl chr 6:143,940,300...144,064,599
G
PLAUR
plasminogen activator, urokinase receptor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PLAUR mRNA
CTD
PMID:15336504
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PLBD1
phospholipase B domain containing 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PLBD1 mRNA
CTD
PMID:15336504
NCBI chr12:14,503,661...14,567,883
Ensembl chr12:14,503,661...14,567,883
G
PLCD1
phospholipase C delta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLCD1 mRNA
CTD
PMID:15003993
NCBI chr 3:38,007,496...38,029,642
Ensembl chr 3:38,007,496...38,029,642
G
PLCE1
phospholipase C epsilon 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PLCE1 mRNA
CTD
PMID:15336504
NCBI chr10:93,993,931...94,332,823
Ensembl chr10:93,993,931...94,332,823
G
PLEK2
pleckstrin 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PLEK2 mRNA
CTD
PMID:15336504
NCBI chr14:67,386,984...67,412,165
Ensembl chr14:67,386,984...67,412,167
G
PLEKHO1
pleckstrin homology domain containing O1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of PLEKHO1 mRNA
CTD
PMID:23410634
NCBI chr 1:150,149,646...150,160,065
Ensembl chr 1:150,149,183...150,164,720
G
PLIN3
perilipin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PLIN3 mRNA
CTD
PMID:15336504
NCBI chr19:4,838,341...4,867,667
Ensembl chr19:4,838,341...4,867,694
G
PLK1
polo like kinase 1
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of PLK1 mRNA tert-Butylhydroperoxide results in increased expression of PLK1 mRNA
CTD
PMID:12414654 PMID:15003993
NCBI chr16:23,678,889...23,690,367
Ensembl chr16:23,677,656...23,690,367
G
PLK3
polo like kinase 3
affects expression
EXP
tert-Butylhydroperoxide affects the expression of PLK3 mRNA
CTD
PMID:23410634
NCBI chr 1:44,800,377...44,805,990
Ensembl chr 1:44,800,377...44,805,990
G
PLSCR4
phospholipid scramblase 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PLSCR4 mRNA
CTD
PMID:15336504
NCBI chr 3:146,192,335...146,251,105
Ensembl chr 3:146,192,335...146,251,179
G
PLXNA2
plexin A2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PLXNA2 mRNA
CTD
PMID:15336504
NCBI chr 1:208,022,242...208,244,384
Ensembl chr 1:208,022,242...208,244,384
G
PLXNB2
plexin B2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PLXNB2 mRNA
CTD
PMID:15336504
NCBI chr22:50,274,979...50,307,646
Ensembl chr22:50,274,979...50,307,646
G
PMAIP1
phorbol-12-myristate-13-acetate-induced protein 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of PMAIP1 mRNA
CTD
PMID:23410634
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
G
PMS2P1
PMS1 homolog 2, mismatch repair system component pseudogene 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PMS2P1 mRNA
CTD
PMID:15336504
NCBI chr 7:100,320,640...100,336,307
Ensembl chr 7:100,328,836...100,335,860
G
PMS2P2
PMS1 homolog 2, mismatch repair system component pseudogene 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PMS2P2 mRNA
CTD
PMID:15336504
NCBI chr 7:75,343,937...75,358,997
Ensembl chr 7:75,344,015...75,359,550
G
PMS2P3
PMS1 homolog 2, mismatch repair system component pseudogene 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PMS2P3 mRNA
CTD
PMID:15336504
NCBI chr 7:75,507,747...75,528,123
Ensembl chr 7:75,507,747...75,528,148 Ensembl chr 7:75,507,747...75,528,148
G
PNP
purine nucleoside phosphorylase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PNP mRNA
CTD
PMID:15336504
NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094
G
PNPLA6
patatin like phospholipase domain containing 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PNPLA6 mRNA
CTD
PMID:15336504
NCBI chr19:7,534,164...7,561,767
Ensembl chr19:7,534,004...7,561,764
G
POGLUT2
protein O-glucosyltransferase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of POGLUT2 mRNA
CTD
PMID:15336504
NCBI chr13:102,784,281...102,798,976
Ensembl chr13:102,784,281...102,799,040
G
POLD1
DNA polymerase delta 1, catalytic subunit
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of POLD1 mRNA
CTD
PMID:12419474
NCBI chr19:50,384,323...50,418,018
Ensembl chr19:50,384,204...50,418,018
G
POLD4
DNA polymerase delta 4, accessory subunit
increases expression affects expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of POLD4 mRNA tert-Butylhydroperoxide affects the expression of POLD4 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr11:67,350,765...67,353,596
Ensembl chr11:67,350,772...67,356,972
G
POLE2
DNA polymerase epsilon 2, accessory subunit
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of POLE2 mRNA
CTD
PMID:12414654
NCBI chr14:49,643,555...49,688,214
Ensembl chr14:49,643,555...49,688,422
G
POLR2E
RNA polymerase II, I and III subunit E
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of POLR2E mRNA
CTD
PMID:15336504
NCBI chr19:1,086,574...1,095,375
Ensembl chr19:1,086,574...1,095,380
G
POLR2J
RNA polymerase II subunit J
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of POLR2J mRNA
CTD
PMID:15336504
NCBI chr 7:102,473,128...102,478,922
Ensembl chr 7:102,473,128...102,478,922
G
PON2
paraoxonase 2
decreases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of PON2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 7:95,404,862...95,435,028
Ensembl chr 7:95,404,862...95,435,329
G
POPDC3
popeye domain containing 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of POPDC3 mRNA
CTD
PMID:15336504
NCBI chr 6:105,157,900...105,180,014
Ensembl chr 6:105,157,900...105,180,014
G
POT1
protection of telomeres 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of POT1 mRNA
CTD
PMID:15336504
NCBI chr 7:124,822,386...124,929,825
Ensembl chr 7:124,822,386...124,929,983
G
PPARA
peroxisome proliferator activated receptor alpha
multiple interactions decreases expression
ISO
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein] tert-Butylhydroperoxide results in decreased expression of PPARA mRNA; tert-Butylhydroperoxide results in decreased expression of PPARA protein
CTD
PMID:26989860
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARD
peroxisome proliferator activated receptor delta
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PPARD mRNA
CTD
PMID:15336504
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions increases activity
EXP
tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]] tert-Butylhydroperoxide results in increased activity of PPARG protein
CTD
PMID:16417216 PMID:20847119
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPARGC1A
PPARG coactivator 1 alpha
decreases response to substance multiple interactions decreases expression
ISO EXP
PPARGC1A protein results in decreased susceptibility to tert-Butylhydroperoxide AICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]]; dorsomorphin promotes the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]
CTD
PMID:17460188 PMID:25522270
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
PPIP5K1
diphosphoinositol pentakisphosphate kinase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PPIP5K1 mRNA
CTD
PMID:15336504
NCBI chr15:43,533,475...43,590,253
Ensembl chr15:43,533,462...43,590,208
G
PPL
periplakin
increases expression decreases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of PPL mRNA tert-Butylhydroperoxide results in decreased expression of PPL mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr16:4,882,507...4,937,148
Ensembl chr16:4,882,507...4,960,741
G
PPM1D
protein phosphatase, Mg2+/Mn2+ dependent 1D
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PPM1D mRNA
CTD
PMID:12414654
NCBI chr17:60,600,193...60,666,280
Ensembl chr17:60,600,193...60,666,280
G
PPP1CA
protein phosphatase 1 catalytic subunit alpha
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PPP1CA mRNA
CTD
PMID:12419474
NCBI chr11:67,398,183...67,401,858
Ensembl chr11:67,398,181...67,421,183
G
PPP1CB
protein phosphatase 1 catalytic subunit beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PPP1CB mRNA
CTD
PMID:15336504
NCBI chr 2:28,751,604...28,802,940
Ensembl chr 2:28,751,640...28,802,940
G
PPP1R15A
protein phosphatase 1 regulatory subunit 15A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PPP1R15A mRNA
CTD
PMID:15336504
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
G
PPP1R3C
protein phosphatase 1 regulatory subunit 3C
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of PPP1R3C mRNA tert-Butylhydroperoxide affects the expression of PPP1R3C mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071
G
PPP1R7
protein phosphatase 1 regulatory subunit 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PPP1R7 mRNA
CTD
PMID:15336504
NCBI chr 2:241,149,573...241,183,652
Ensembl chr 2:241,149,576...241,183,652
G
PPP1R8
protein phosphatase 1 regulatory subunit 8
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PPP1R8 mRNA
CTD
PMID:12419474
NCBI chr 1:27,830,782...27,851,676
Ensembl chr 1:27,830,782...27,851,676
G
PPP2CB
protein phosphatase 2 catalytic subunit beta
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PPP2CB mRNA
CTD
PMID:12414654
NCBI chr 8:30,785,616...30,812,818
Ensembl chr 8:30,774,457...30,814,314
G
PPP3CA
protein phosphatase 3 catalytic subunit alpha
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PPP3CA mRNA
CTD
PMID:12419474
NCBI chr 4:101,023,418...101,347,526
Ensembl chr 4:101,023,409...101,348,278
G
PPP3CC
protein phosphatase 3 catalytic subunit gamma
affects expression
EXP
tert-Butylhydroperoxide affects the expression of PPP3CC mRNA
CTD
PMID:23410634
NCBI chr 8:22,441,078...22,541,125
Ensembl chr 8:22,440,819...22,541,142
G
PPRC1
PPARG related coactivator 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PPRC1 mRNA
CTD
PMID:15336504
NCBI chr10:102,119,889...102,150,333
Ensembl chr10:102,132,994...102,150,333
G
PRDX1
peroxiredoxin 1
increases expression increases activity multiple interactions decreases expression
EXP ISO
tert-Butylhydroperoxide results in increased expression of PRDX1 protein tert-Butylhydroperoxide results in increased activity of PRDX1 protein Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PRDX1 protein]
CTD
PMID:11295360 PMID:16880205 PMID:20100471
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
G
PRDX2
peroxiredoxin 2
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of PRDX2 mRNA tert-Butylhydroperoxide results in increased expression of PRDX2 protein
CTD
PMID:11295360 PMID:14729362 PMID:15336504
NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800
G
PRDX3
peroxiredoxin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRDX3 protein
CTD
PMID:24394546
NCBI chr10:119,167,720...119,178,812
Ensembl chr10:119,167,720...119,178,812
G
PRDX5
peroxiredoxin 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRDX5 mRNA
CTD
PMID:14729362
NCBI chr11:64,318,121...64,321,811
Ensembl chr11:64,318,121...64,321,811
G
PRDX6
peroxiredoxin 6
increases expression decreases response to substance increases response to substance affects response to substance
EXP ISO
tert-Butylhydroperoxide results in increased expression of PRDX6 protein PRDX6 protein results in decreased susceptibility to tert-Butylhydroperoxide PRDX6 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide PRDX6 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:11295360 PMID:12732627 PMID:14741336 PMID:20627125
NCBI chr 1:173,477,335...173,488,815
Ensembl chr 1:173,477,330...173,488,815
G
PREPL
prolyl endopeptidase like
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PREPL mRNA
CTD
PMID:15336504
NCBI chr 2:44,317,607...44,361,862
Ensembl chr 2:44,316,281...44,361,862
G
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PRKAR1A mRNA
CTD
PMID:15336504
NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
G
PRKCA
protein kinase C alpha
decreases expression affects localization increases activity
EXP ISO
tert-Butylhydroperoxide results in decreased expression of PRKCA mRNA tert-Butylhydroperoxide affects the localization of PRKCA protein tert-Butylhydroperoxide results in increased activity of PRKCA protein
CTD
PMID:15336504 PMID:16716901
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRKCE
protein kinase C epsilon
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PRKCE mRNA
CTD
PMID:27509014
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
PRKCH
protein kinase C eta
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PRKCH mRNA
CTD
PMID:15336504
NCBI chr14:61,187,468...61,550,976
Ensembl chr14:61,187,559...61,550,976
G
PRKCQ
protein kinase C theta
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of PRKCQ mRNA tert-Butylhydroperoxide results in increased methylation of PRKCQ gene
CTD
PMID:27509014
NCBI chr10:6,394,097...6,580,646
Ensembl chr10:6,427,143...6,580,301
G
PRMT3
protein arginine methyltransferase 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PRMT3 mRNA
CTD
PMID:15336504
NCBI chr11:20,387,716...20,509,338
Ensembl chr11:20,387,558...20,509,338
G
PRNP
prion protein (Kanno blood group)
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PRNP mRNA
CTD
PMID:15336504
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
G
PROS1
protein S
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PROS1 mRNA
CTD
PMID:15336504
NCBI chr 3:93,873,051...93,973,896
Ensembl chr 3:93,873,051...93,980,003
G
PRR13
proline rich 13
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRR13 mRNA
CTD
PMID:15003993
NCBI chr12:53,441,734...53,446,638
Ensembl chr12:53,441,678...53,446,645
G
PRRG2
proline rich and Gla domain 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRRG2 mRNA
CTD
PMID:14729362
NCBI chr19:49,580,617...49,591,004
Ensembl chr19:49,580,646...49,591,004
G
PRUNE1
prune exopolyphosphatase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PRUNE1 mRNA
CTD
PMID:15336504
NCBI chr 1:151,008,449...151,035,713
Ensembl chr 1:151,008,420...151,035,713
G
PRUNE2
prune homolog 2 with BCH domain
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PRUNE2 mRNA
CTD
PMID:15336504
NCBI chr 9:76,611,376...76,906,114
Ensembl chr 9:76,611,376...76,906,114
G
PSCA
prostate stem cell antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSCA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 8:142,670,297...142,682,725
Ensembl chr 8:142,670,308...142,682,725
G
PSD3
pleckstrin and Sec7 domain containing 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PSD3 mRNA
CTD
PMID:15336504
NCBI chr 8:18,527,303...19,084,805
Ensembl chr 8:18,527,303...19,084,730
G
PSIP1
PC4 and SRSF1 interacting protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PSIP1 mRNA
CTD
PMID:15336504
NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
G
PSMA6
proteasome 20S subunit alpha 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PSMA6 mRNA
CTD
PMID:15336504
NCBI chr14:35,278,558...35,317,493
Ensembl chr14:35,278,633...35,317,493
G
PSMB9
proteasome 20S subunit beta 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMB9 mRNA
CTD
PMID:15003993
NCBI chr 6:32,854,192...32,859,851
Ensembl chr 6:32,844,136...32,859,851
G
PSMD11
proteasome 26S subunit, non-ATPase 11
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PSMD11 mRNA
CTD
PMID:15336504
NCBI chr17:32,444,510...32,483,319
Ensembl chr17:32,444,379...32,483,319
G
PSMD12
proteasome 26S subunit, non-ATPase 12
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PSMD12 mRNA
CTD
PMID:12414654
NCBI chr17:67,337,916...67,366,577
Ensembl chr17:67,337,916...67,366,605
G
PSRC1
proline and serine rich coiled-coil 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PSRC1 mRNA
CTD
PMID:15336504
NCBI chr 1:109,279,556...109,283,145
Ensembl chr 1:109,279,556...109,283,186
G
PTBP2
polypyrimidine tract binding protein 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PTBP2 mRNA
CTD
PMID:15336504
NCBI chr 1:96,721,784...96,823,739
Ensembl chr 1:96,721,665...96,823,738
G
PTEN
phosphatase and tensin homolog
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PTEN mRNA
CTD
PMID:15336504
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
PTGES
prostaglandin E synthase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PTGES mRNA
CTD
PMID:15336504
NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042
G
PTGR1
prostaglandin reductase 1
increases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of PTGR1 mRNA
CTD
PMID:14729362 PMID:23410634
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
G
PTGS1
prostaglandin-endoperoxide synthase 1
increases activity
ISO
tert-Butylhydroperoxide results in increased activity of PTGS1 protein
CTD
PMID:15604817
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression increases activity
EXP ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]; tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] tert-Butylhydroperoxide results in increased activity of PTGS2 protein
CTD
PMID:14729362 PMID:15604817 PMID:15705740 PMID:16417216 PMID:28063877
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTK2
protein tyrosine kinase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PTK2 mRNA
CTD
PMID:15336504
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
G
PTMA
prothymosin alpha
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PTMA mRNA
CTD
PMID:12419474
NCBI chr 2:231,708,525...231,713,551
Ensembl chr 2:231,706,895...231,713,551
G
PTP4A1
protein tyrosine phosphatase 4A1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PTP4A1 mRNA
CTD
PMID:15336504
NCBI chr 6:63,516,440...63,583,588
Ensembl chr 6:63,521,746...63,583,588
G
PTP4A2
protein tyrosine phosphatase 4A2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PTP4A2 mRNA
CTD
PMID:15336504
NCBI chr 1:31,906,421...31,938,368
Ensembl chr 1:31,906,421...31,944,856
G
PTPRR
protein tyrosine phosphatase receptor type R
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PTPRR mRNA
CTD
PMID:15336504
NCBI chr12:70,638,073...70,920,738
Ensembl chr12:70,638,073...70,920,738
G
PTRH2
peptidyl-tRNA hydrolase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PTRH2 mRNA
CTD
PMID:15336504
NCBI chr17:59,697,308...59,707,430
Ensembl chr17:59,674,636...59,707,626
G
PTTG1
PTTG1 regulator of sister chromatid separation, securin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTTG1 mRNA
CTD
PMID:15003993
NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
G
PUM2
pumilio RNA binding family member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PUM2 mRNA
CTD
PMID:15336504
NCBI chr 2:20,248,691...20,352,253
Ensembl chr 2:20,248,691...20,352,234
G
PVR
PVR cell adhesion molecule
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PVR mRNA
CTD
PMID:15336504
NCBI chr19:44,643,910...44,666,162
Ensembl chr19:44,643,798...44,666,162
G
PXMP2
peroxisomal membrane protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PXMP2 mRNA
CTD
PMID:15336504
NCBI chr12:132,687,587...132,704,985
Ensembl chr12:132,687,587...132,704,985
G
PYGL
glycogen phosphorylase L
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of PYGL mRNA
CTD
PMID:15336504
NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483
G
QSOX1
quiescin sulfhydryl oxidase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of QSOX1 mRNA
CTD
PMID:12419474
NCBI chr 1:180,154,869...180,204,030
Ensembl chr 1:180,154,869...180,204,030
G
R3HDM2
R3H domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of R3HDM2 mRNA
CTD
PMID:15336504
NCBI chr12:57,253,764...57,431,141
Ensembl chr12:57,253,762...57,431,043
G
RAB22A
RAB22A, member RAS oncogene family
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAB22A mRNA
CTD
PMID:15336504
NCBI chr20:58,309,715...58,367,507
Ensembl chr20:58,309,715...58,367,507
G
RAB27A
RAB27A, member RAS oncogene family
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAB27A mRNA
CTD
PMID:15336504
NCBI chr15:55,202,966...55,289,813
Ensembl chr15:55,202,966...55,319,113
G
RAB29
RAB29, member RAS oncogene family
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAB29 mRNA
CTD
PMID:15336504
NCBI chr 1:205,767,986...205,775,482
Ensembl chr 1:205,767,986...205,775,482
G
RAB4A
RAB4A, member RAS oncogene family
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RAB4A mRNA
CTD
PMID:15336504
NCBI chr 1:229,271,111...229,305,894
Ensembl chr 1:229,271,062...229,305,894
G
RAB5C
RAB5C, member RAS oncogene family
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of RAB5C intron
CTD
PMID:29432895
NCBI chr17:42,124,979...42,154,989
Ensembl chr17:42,124,978...42,155,044
G
RAB7A
RAB7A, member RAS oncogene family
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RAB7 mRNA
CTD
PMID:12419474
NCBI chr 3:128,726,183...128,814,798
Ensembl chr 3:128,693,669...128,825,942
G
RAB8A
RAB8A, member RAS oncogene family
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RAB8A mRNA
CTD
PMID:15336504
NCBI chr19:16,111,889...16,134,234
Ensembl chr19:16,111,889...16,134,234
G
RABEP2
rabaptin, RAB GTPase binding effector protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RABEP2 mRNA
CTD
PMID:15336504
NCBI chr16:28,904,421...28,925,238
Ensembl chr16:28,904,421...28,936,526
G
RABGAP1
RAB GTPase activating protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RABGAP1 mRNA
CTD
PMID:15336504
NCBI chr 9:122,931,671...123,104,866
Ensembl chr 9:122,940,833...123,104,866
G
RABGAP1L
RAB GTPase activating protein 1 like
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RABGAP1L mRNA
CTD
PMID:15336504
NCBI chr 1:174,159,520...174,995,308
Ensembl chr 1:174,159,410...174,995,308
G
RAC2
Rac family small GTPase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAC2 mRNA
CTD
PMID:22659508
NCBI chr22:37,225,270...37,244,269
Ensembl chr22:37,225,270...37,259,594
G
RAD23A
RAD23 homolog A, nucleotide excision repair protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RAD23A mRNA
CTD
PMID:15336504
NCBI chr19:12,945,862...12,953,642
Ensembl chr19:12,945,855...12,953,642
G
RAET1L
retinoic acid early transcript 1L
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAET1G mRNA
CTD
PMID:14729362
NCBI chr 6:150,018,334...150,025,532
Ensembl chr 6:150,018,334...150,025,532
G
RALA
RAS like proto-oncogene A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RALA mRNA
CTD
PMID:15336504
NCBI chr 7:39,623,572...39,708,120
Ensembl chr 7:39,623,565...39,708,120
G
RANBP2
RAN binding protein 2
multiple interactions increases expression
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]
CTD
PMID:20847119
NCBI chr 2:108,719,482...109,842,301
Ensembl chr 2:108,719,482...108,785,810
G
RANBP9
RAN binding protein 9
affects expression
EXP
tert-Butylhydroperoxide affects the expression of RANBP9 mRNA
CTD
PMID:23410634
NCBI chr 6:13,621,498...13,711,835
Ensembl chr 6:13,621,498...13,711,835
G
RAP1GAP
RAP1 GTPase activating protein
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAP1GAP mRNA
CTD
PMID:23410634
NCBI chr 1:21,596,221...21,669,357
Ensembl chr 1:21,596,221...21,669,357
G
RAP1GDS1
Rap1 GTPase-GDP dissociation stimulator 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAP1GDS1 mRNA
CTD
PMID:15336504
NCBI chr 4:98,261,384...98,443,858
Ensembl chr 4:98,261,384...98,443,858
G
RAP2A
RAP2A, member of RAS oncogene family
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RAP2A mRNA
CTD
PMID:15336504
NCBI chr13:97,434,169...97,469,128
Ensembl chr13:97,434,169...97,469,128
G
RAPGEF2
Rap guanine nucleotide exchange factor 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAPGEF2 mRNA
CTD
PMID:15336504
NCBI chr 4:159,103,079...159,360,173
Ensembl chr 4:159,103,013...159,360,174
G
RARB
retinoic acid receptor beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RARB mRNA
CTD
PMID:12419474
NCBI chr 3:24,829,321...25,597,932
Ensembl chr 3:24,687,887...25,597,932
G
RASAL1
RAS protein activator like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RASA4 mRNA
CTD
PMID:15003993
NCBI chr12:113,099,278...113,136,756
Ensembl chr12:113,098,819...113,136,239
G
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RASGRF1 mRNA
CTD
PMID:15336504
NCBI chr15:78,959,906...79,090,780
Ensembl chr15:78,959,906...79,090,780
G
RASGRP3
RAS guanyl releasing protein 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RASGRP3 mRNA
CTD
PMID:15336504
NCBI chr 2:33,436,348...33,564,731
Ensembl chr 2:33,436,324...33,564,750
G
RB1
RB transcriptional corepressor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RB1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
G
RBBP8
RB binding protein 8, endonuclease
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RBBP8 mRNA
CTD
PMID:15336504
NCBI chr18:22,914,139...23,026,486
Ensembl chr18:22,798,261...23,026,488
G
RBL2
RB transcriptional corepressor like 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RBL2 mRNA
CTD
PMID:12419474
NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648
G
RBM12
RNA binding motif protein 12
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RBM12 mRNA
CTD
PMID:15336504
NCBI chr20:35,648,925...35,664,900
Ensembl chr20:35,648,925...35,664,956
G
RCN1
reticulocalbin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RCN1 mRNA
CTD
PMID:14729362
NCBI chr11:32,091,074...32,105,722
Ensembl chr11:32,091,074...32,105,722
G
RCN3
reticulocalbin 3
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of RCN3 mRNA tert-Butylhydroperoxide results in increased expression of RCN3 mRNA
CTD
PMID:15336504
NCBI chr19:49,528,003...49,543,633
Ensembl chr19:49,528,003...49,546,962
G
RCOR3
REST corepressor 3
affects expression
EXP
tert-Butylhydroperoxide affects the expression of RCOR3 mRNA
CTD
PMID:23410634
NCBI chr 1:211,259,366...211,316,385
Ensembl chr 1:211,258,377...211,316,385
G
RDH14
retinol dehydrogenase 14
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RDH14 mRNA
CTD
PMID:15336504
NCBI chr 2:18,554,723...18,560,653
Ensembl chr 2:18,554,723...18,560,679
G
RECQL
RecQ like helicase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RECQL mRNA
CTD
PMID:15336504
NCBI chr12:21,468,910...21,501,635
Ensembl chr12:21,468,910...21,501,669
G
REEP3
receptor accessory protein 3
multiple interactions increases expression
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]
CTD
PMID:20847119
NCBI chr10:63,521,401...63,625,128
Ensembl chr10:63,521,401...63,625,128
G
REEP4
receptor accessory protein 4
affects expression
EXP
tert-Butylhydroperoxide affects the expression of REEP4 mRNA
CTD
PMID:23410634
NCBI chr 8:22,138,020...22,141,907
Ensembl chr 8:22,138,020...22,141,951
G
REEP5
receptor accessory protein 5
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of REEP5 mRNA tert-Butylhydroperoxide results in increased expression of REEP5 mRNA
CTD
PMID:15336504
NCBI chr 5:112,876,385...112,922,227
Ensembl chr 5:112,876,385...112,922,289
G
REL
REL proto-oncogene, NF-kB subunit
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of REL mRNA
CTD
PMID:12419474
NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions increases expression affects localization
ISO
Catechin inhibits the reaction [tert-Butylhydroperoxide affects the localization of RELA protein] tert-Butylhydroperoxide results in increased expression of RELA mRNA
CTD
PMID:15879681 PMID:16704919
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RELB
RELB proto-oncogene, NF-kB subunit
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RELB mRNA
CTD
PMID:15336504
NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192
G
RENBP
renin binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RENBP mRNA
CTD
PMID:14729362
NCBI chr X:153,935,269...153,944,643
Ensembl chr X:153,935,269...153,944,687
G
RER1
retention in endoplasmic reticulum sorting receptor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RER1 mRNA
CTD
PMID:15336504
NCBI chr 1:2,391,841...2,405,436
Ensembl chr 1:2,391,775...2,405,442
G
RETSAT
retinol saturase
increases response to substance
ISO
RETSAT protein results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:17664141
NCBI chr 2:85,341,955...85,354,528
Ensembl chr 2:85,341,955...85,354,531
G
RFC3
replication factor C subunit 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RFC3 mRNA
CTD
PMID:15336504
NCBI chr13:33,818,149...33,977,377
Ensembl chr13:33,818,069...33,966,558
G
RFXANK
regulatory factor X associated ankyrin containing protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RFXANK mRNA
CTD
PMID:15336504
NCBI chr19:19,192,258...19,201,866
Ensembl chr19:19,192,229...19,201,869
G
RGN
regucalcin
multiple interactions decreases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RGN protein]
CTD
PMID:16677110 PMID:24394546
NCBI chr X:47,078,443...47,093,313
Ensembl chr X:47,078,355...47,093,314
G
RGS10
regulator of G protein signaling 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RGS10 mRNA
CTD
PMID:15003993
NCBI chr10:119,499,817...119,542,719
Ensembl chr10:119,499,817...119,542,719
G
RGS2
regulator of G protein signaling 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RGS2 mRNA
CTD
PMID:15336504
NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275
G
RGS3
regulator of G protein signaling 3
affects expression
EXP
tert-Butylhydroperoxide affects the expression of RGS3 mRNA
CTD
PMID:23410634
NCBI chr 9:113,444,730...113,597,738
Ensembl chr 9:113,444,731...113,597,743
G
RHD
Rh blood group D antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RHD mRNA
CTD
PMID:15003993
NCBI chr 1:25,272,486...25,330,445
Ensembl chr 1:25,272,393...25,330,445
G
RHEB
Ras homolog, mTORC1 binding
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RHEB mRNA
CTD
PMID:15336504
NCBI chr 7:151,466,012...151,519,895
Ensembl chr 7:151,466,012...151,520,120
G
RHOD
ras homolog family member D
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RHOD mRNA
CTD
PMID:15336504
NCBI chr11:67,056,847...67,072,017
Ensembl chr11:67,056,847...67,072,017
G
RHPN2
rhophilin Rho GTPase binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RHPN2 mRNA
CTD
PMID:14729362
NCBI chr19:32,978,592...33,064,888
Ensembl chr19:32,978,592...33,064,888
G
RICTOR
RPTOR independent companion of MTOR complex 2
multiple interactions increases expression affects expression
EXP
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RICTOR mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA] tert-Butylhydroperoxide affects the expression of RICTOR mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 5:38,937,920...39,074,399
Ensembl chr 5:38,937,920...39,074,402
G
RIOX1
ribosomal oxygenase 1
multiple interactions decreases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA]
CTD
PMID:20847119
NCBI chr14:73,490,933...73,493,394
Ensembl chr14:73,490,933...73,493,394
G
RIPK2
receptor interacting serine/threonine kinase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RIPK2 mRNA
CTD
PMID:15336504
NCBI chr 8:89,757,816...89,791,064
Ensembl chr 8:89,757,806...89,791,064
G
RMND5B
required for meiotic nuclear division 5 homolog B
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RMND5B mRNA
CTD
PMID:15336504
NCBI chr 5:178,131,014...178,150,568
Ensembl chr 5:178,130,996...178,150,568
G
RNASEH2C
ribonuclease H2 subunit C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RNASEH2C mRNA
CTD
PMID:15003993
NCBI chr11:65,717,673...65,720,798
Ensembl chr11:65,714,005...65,720,818
G
RND3
Rho family GTPase 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RND3 mRNA
CTD
PMID:15336504
NCBI chr 2:150,468,193...150,487,695
Ensembl chr 2:150,468,195...150,539,011
G
RNF103
ring finger protein 103
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNF103 mRNA
CTD
PMID:15003993
NCBI chr 2:86,603,393...86,623,877
Ensembl chr 2:86,603,398...86,623,866
G
RNF13
ring finger protein 13
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RNF13 mRNA
CTD
PMID:15336504
NCBI chr 3:149,812,688...149,962,139
Ensembl chr 3:149,812,770...149,962,139
G
RNFT2
ring finger protein, transmembrane 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RNFT2 mRNA
CTD
PMID:15336504
NCBI chr12:116,738,315...116,853,631
Ensembl chr12:116,738,178...116,853,631
G
RNH1
ribonuclease/angiogenin inhibitor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RNH1 mRNA
CTD
PMID:12419474
NCBI chr11:494,515...507,242
Ensembl chr11:494,512...507,300
G
RORA
RAR related orphan receptor A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RORA mRNA
CTD
PMID:15336504
NCBI chr15:60,488,284...61,229,302
Ensembl chr15:60,488,284...61,229,302
G
RPA1
replication protein A1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RPA1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:1,830,005...1,900,082
Ensembl chr17:1,829,702...1,900,082
G
RPGR
retinitis pigmentosa GTPase regulator
affects expression
EXP
tert-Butylhydroperoxide affects the expression of RPGR mRNA
CTD
PMID:23410634
NCBI chr X:38,269,163...38,327,509
Ensembl chr X:38,269,163...38,327,544
G
RPL13A
ribosomal protein L13a
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RPL13A mRNA
CTD
PMID:12419474
NCBI chr19:49,487,608...49,492,308
Ensembl chr19:49,487,510...49,493,057
G
RPL27A
ribosomal protein L27a
affects expression
EXP
tert-Butylhydroperoxide affects the expression of RPL27A mRNA
CTD
PMID:23410634
NCBI chr11:8,682,792...8,689,872
Ensembl chr11:8,682,788...8,714,759
G
RPL5
ribosomal protein L5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RPL5 mRNA
CTD
PMID:15336504
NCBI chr 1:92,831,986...92,841,924
Ensembl chr 1:92,832,013...92,841,924
G
RPS19
ribosomal protein S19
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RPS19 mRNA
CTD
PMID:12419474
NCBI chr19:41,860,255...41,872,925
Ensembl chr19:41,860,255...41,872,925
G
RPS27L
ribosomal protein S27 like
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RPS27L mRNA
CTD
PMID:15336504
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
G
RPS6KA1
ribosomal protein S6 kinase A1
increases phosphorylation multiple interactions
EXP
tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein]
CTD
PMID:17003459
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
G
RPUSD2
RNA pseudouridine synthase domain containing 2
multiple interactions decreases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RPUSD2 mRNA]
CTD
PMID:20847119
NCBI chr15:40,569,299...40,574,949
Ensembl chr15:40,569,299...40,574,949
G
RRAD
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RRAD mRNA
CTD
PMID:15336504
NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,685...66,925,535
G
RRAGD
Ras related GTP binding D
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RRAGD mRNA
CTD
PMID:15336504
NCBI chr 6:89,364,616...89,412,273
Ensembl chr 6:89,364,616...89,412,273
G
RRAS2
RAS related 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RRAS2 mRNA
CTD
PMID:23410634
NCBI chr11:14,277,920...14,364,506
Ensembl chr11:14,277,922...14,364,506
G
RRM1
ribonucleotide reductase catalytic subunit M1
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of RRM1 mRNA tert-Butylhydroperoxide affects the expression of RRM1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr11:4,094,685...4,138,932
Ensembl chr11:4,094,707...4,138,932
G
RRN3
RRN3 homolog, RNA polymerase I transcription factor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RRN3 mRNA
CTD
PMID:29432895
NCBI chr16:15,060,022...15,094,335
Ensembl chr16:15,060,033...15,094,311
G
RSAD2
radical S-adenosyl methionine domain containing 2
increases expression decreases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of RSAD2 mRNA tert-Butylhydroperoxide results in decreased expression of RSAD2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239
G
RSL1D1
ribosomal L1 domain containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RSL1D1 mRNA
CTD
PMID:29432895
NCBI chr16:11,833,850...11,851,542
Ensembl chr16:11,833,850...11,851,580
G
RTN3
reticulon 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RTN3 mRNA
CTD
PMID:15336504
NCBI chr11:63,681,450...63,759,891
Ensembl chr11:63,681,446...63,759,891
G
RTN4R
reticulon 4 receptor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RTN4R mRNA
CTD
PMID:29432895
NCBI chr22:20,241,415...20,268,318
Ensembl chr22:20,241,415...20,283,246
G
RXRA
retinoid X receptor alpha
decreases response to substance
ISO
RXRA protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14978233
NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
G
RXRB
retinoid X receptor beta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of RXRB mRNA
CTD
PMID:12419474
NCBI chr 6:33,193,588...33,200,853
Ensembl chr 6:33,193,588...33,200,665
G
RYBP
RING1 and YY1 binding protein
increases methylation increases expression
EXP
tert-Butylhydroperoxide results in increased methylation of RYBP gene tert-Butylhydroperoxide results in increased expression of RYBP mRNA
CTD
PMID:27509014
NCBI chr 3:72,374,597...72,446,623
Ensembl chr 3:72,371,825...72,446,621
G
S100A3
S100 calcium binding protein A3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of S100A3 mRNA
CTD
PMID:15336504
NCBI chr 1:153,547,329...153,549,258
Ensembl chr 1:153,547,329...153,549,258
G
S100A4
S100 calcium binding protein A4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of S100A4 mRNA
CTD
PMID:15336504
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
G
S100P
S100 calcium binding protein P
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of S100P mRNA
CTD
PMID:12414654
NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
G
S100PBP
S100P binding protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of S100PBP mRNA
CTD
PMID:15336504
NCBI chr 1:32,816,562...32,858,879
Ensembl chr 1:32,816,767...32,858,875
G
SAMD4A
sterile alpha motif domain containing 4A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SAMD4A mRNA
CTD
PMID:15336504
NCBI chr14:54,565,316...54,793,315
Ensembl chr14:54,566,117...54,793,315
G
SAP18
Sin3A associated protein 18
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SAP18 mRNA
CTD
PMID:15336504
NCBI chr13:21,140,119...21,149,097
Ensembl chr13:21,140,119...21,149,097
G
SAP30
Sin3A associated protein 30
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SAP30 mRNA
CTD
PMID:15336504
NCBI chr 4:173,370,954...173,377,532
Ensembl chr 4:173,369,969...173,377,532
G
SAPCD2
suppressor APC domain containing 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SAPCD2 mRNA
CTD
PMID:23410634
NCBI chr 9:137,062,127...137,070,557
Ensembl chr 9:137,062,127...137,070,557
G
SAR1A
secretion associated Ras related GTPase 1A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SAR1A mRNA
CTD
PMID:15336504
NCBI chr10:70,147,289...70,170,514
Ensembl chr10:70,147,289...70,170,523
G
SAR1B
secretion associated Ras related GTPase 1B
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SAR1B mRNA
CTD
PMID:15336504
NCBI chr 5:134,601,149...134,632,828
Ensembl chr 5:134,601,149...134,649,271
G
SARAF
store-operated calcium entry associated regulatory factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SARAF mRNA
CTD
PMID:15003993
NCBI chr 8:30,063,003...30,083,208
Ensembl chr 8:30,063,003...30,083,208
G
SAT1
spermidine/spermine N1-acetyltransferase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SAT1 mRNA
CTD
PMID:15336504
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
G
SATB1
SATB homeobox 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SATB1 mRNA
CTD
PMID:15336504
NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,621
G
SCARB2
scavenger receptor class B member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SCARB2 mRNA
CTD
PMID:15336504
NCBI chr 4:76,158,737...76,234,532
Ensembl chr 4:76,158,737...76,234,536
G
SCD
stearoyl-CoA desaturase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SCD mRNA
CTD
PMID:15336504
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SCG5
secretogranin V
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SCG5 mRNA
CTD
PMID:15336504
NCBI chr15:32,641,710...32,697,092
Ensembl chr15:32,641,676...32,697,098
G
SCML1
Scm polycomb group protein like 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SCML1 mRNA
CTD
PMID:15336504
NCBI chr X:17,737,128...17,754,985
Ensembl chr X:17,737,449...17,754,988
G
SCP2
sterol carrier protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SCP2 mRNA
CTD
PMID:15336504
NCBI chr 1:52,927,276...53,051,698
Ensembl chr 1:52,927,276...53,051,698
G
SDC2
syndecan 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SDC2 mRNA
CTD
PMID:15336504
NCBI chr 8:96,493,813...96,611,790
Ensembl chr 8:96,493,813...96,611,790
G
SEC14L1
SEC14 like lipid binding 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SEC14L1 mRNA
CTD
PMID:15336504
NCBI chr17:77,088,685...77,217,101
Ensembl chr17:77,088,749...77,217,101
G
SEC24B
SEC24 homolog B, COPII coat complex component
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SEC24B mRNA
CTD
PMID:23410634
NCBI chr 4:109,433,815...109,540,896
Ensembl chr 4:109,433,772...109,540,896
G
SECTM1
secreted and transmembrane 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SECTM1 mRNA
CTD
PMID:15336504
NCBI chr17:82,321,024...82,333,959
Ensembl chr17:82,321,024...82,334,074
G
SEL1L3
SEL1L family member 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SEL1L3 mRNA
CTD
PMID:15336504
NCBI chr 4:25,713,964...25,863,566
Ensembl chr 4:25,747,433...25,863,760
G
SELENBP1
selenium binding protein 1
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of SELENBP1 mRNA tert-Butylhydroperoxide results in increased expression of SELENBP1 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
G
SELENOK
selenoprotein K
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SELENOK mRNA
CTD
PMID:15003993
NCBI chr 3:53,884,417...53,891,859
Ensembl chr 3:53,884,417...53,891,885
G
SELENOP
selenoprotein P
multiple interactions decreases response to substance
EXP
dimethyl mercaptosuccinate inhibits the reaction [SELENOP protein results in decreased susceptibility to tert-Butylhydroperoxide]
CTD
PMID:16632112
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
G
SEPHS1
selenophosphate synthetase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SEPHS1 mRNA
CTD
PMID:15336504
NCBI chr10:13,317,428...13,348,293
Ensembl chr10:13,317,428...13,348,298
G
SEPTIN2
septin 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SEPTIN2 mRNA
CTD
PMID:15336504
NCBI chr 2:241,315,355...241,354,027
Ensembl chr 2:241,315,100...241,354,027
G
SEPTIN9
septin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SEPTIN9 mRNA
CTD
PMID:15003993
NCBI chr17:77,281,499...77,500,596
Ensembl chr17:77,280,569...77,500,596
G
SERPINB1
serpin family B member 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SERPINB1 mRNA
CTD
PMID:15336504
NCBI chr 6:2,832,332...2,841,863
Ensembl chr 6:2,832,332...2,841,959
G
SERPINB2
serpin family B member 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SERPINB2 mRNA
CTD
PMID:15336504
NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888
G
SERPINB5
serpin family B member 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SERPINB5 mRNA
CTD
PMID:12414654
NCBI chr18:63,476,958...63,505,085
Ensembl chr18:63,476,958...63,505,085
G
SERPINB8
serpin family B member 8
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SERPINB8 mRNA
CTD
PMID:15336504
NCBI chr18:63,970,081...64,019,779
Ensembl chr18:63,970,029...64,019,779
G
SERPINE1
serpin family E member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SERPINE1 mRNA
CTD
PMID:15336504
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPINE2
serpin family E member 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SERPINE2 mRNA
CTD
PMID:15336504
NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
G
SERPINH1
serpin family H member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SERPINH1 mRNA
CTD
PMID:12766906
NCBI chr11:75,562,253...75,572,783
Ensembl chr11:75,562,056...75,572,783
G
SERPINI1
serpin family I member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINI1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 3:167,735,721...167,825,569
Ensembl chr 3:167,735,243...167,825,569
G
SESN2
sestrin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SESN2 protein
CTD
PMID:32740777
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
G
SETD2
SET domain containing 2, histone lysine methyltransferase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SETD2 mRNA
CTD
PMID:15336504
NCBI chr 3:47,016,436...47,164,840
Ensembl chr 3:47,016,428...47,164,113
G
SETD3
SET domain containing 3, actin N3(tau)-histidine methyltransferase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SETD3 mRNA
CTD
PMID:15336504
NCBI chr14:99,397,748...99,486,458
Ensembl chr14:99,397,748...99,480,889
G
SETDB1
SET domain bifurcated histone lysine methyltransferase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SETDB1 mRNA
CTD
PMID:15336504
NCBI chr 1:150,926,263...150,964,737
Ensembl chr 1:150,926,263...150,964,744
G
SF1
splicing factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SF1 mRNA
CTD
PMID:12419474
NCBI chr11:64,764,606...64,778,542
Ensembl chr11:64,764,606...64,778,786
G
SFPQ
splicing factor proline and glutamine rich
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of SFPQ intron
CTD
PMID:29432895
NCBI chr 1:35,176,380...35,193,145
Ensembl chr 1:35,176,378...35,193,446
G
SGCE
sarcoglycan epsilon
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SGCE mRNA
CTD
PMID:15336504
NCBI chr 7:94,584,980...94,656,133
Ensembl chr 7:94,524,204...94,656,572
G
SGK2
serum/glucocorticoid regulated kinase 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SGK2 mRNA
CTD
PMID:23410634
NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237
G
SH2B3
SH2B adaptor protein 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SH2B3 mRNA
CTD
PMID:15336504
NCBI chr12:111,404,730...111,451,623
Ensembl chr12:111,405,923...111,451,623
G
SH2D4A
SH2 domain containing 4A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SH2D4A mRNA
CTD
PMID:15336504
NCBI chr 8:19,313,693...19,396,218
Ensembl chr 8:19,313,693...19,396,218
G
SH2D5
SH2 domain containing 5
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SH2D5 mRNA
CTD
PMID:23410634
NCBI chr 1:20,719,731...20,732,703
Ensembl chr 1:20,719,731...20,732,837
G
SH3GLB1
SH3 domain containing GRB2 like, endophilin B1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SH3GLB1 mRNA
CTD
PMID:15336504
NCBI chr 1:86,704,576...86,748,184
Ensembl chr 1:86,704,570...86,748,184
G
SHISA5
shisa family member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SHISA5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 3:48,467,876...48,504,810
Ensembl chr 3:48,467,798...48,504,826
G
SHMT1
serine hydroxymethyltransferase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SHMT1 mRNA
CTD
PMID:15336504 PMID:27509014
NCBI chr17:18,327,873...18,363,550
Ensembl chr17:18,327,873...18,363,550
G
SIAH1
siah E3 ubiquitin protein ligase 1
decreases expression affects expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of SIAH1A mRNA tert-Butylhydroperoxide affects the expression of SIAH1 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr16:48,360,531...48,387,246
Ensembl chr16:48,356,364...48,448,402
G
SIK1
salt inducible kinase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SIK1 mRNA
CTD
PMID:15336504
NCBI chr21:43,414,483...43,427,131
Ensembl chr21:43,414,483...43,427,131
G
SIN3A
SIN3 transcription regulator family member A
increases localization
ISO
Tert-butyl hydroperoxide increases localization of Sin3a protein at Ar promoter in hepatoma cells
RGD
PMID:18945670
RGD:2306468
NCBI chr15:75,369,379...75,455,815
Ensembl chr15:75,369,379...75,455,842
G
SIPA1L1
signal induced proliferation associated 1 like 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SIPA1L1 mRNA
CTD
PMID:15336504
NCBI chr14:71,320,476...71,741,209
Ensembl chr14:71,320,449...71,741,229
G
SIRT1
sirtuin 1
decreases expression multiple interactions
EXP
tert-Butylhydroperoxide results in decreased expression of SIRT1 protein hyperoside inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SIRT1 protein]
CTD
PMID:18552516
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SIRT3
sirtuin 3
multiple interactions
EXP
SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]]; SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
CTD
PMID:25522270
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
G
SKA3
spindle and kinetochore associated complex subunit 3
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SKA3 mRNA
CTD
PMID:23410634
NCBI chr13:21,153,595...21,176,552
Ensembl chr13:21,153,595...21,176,552
G
SKP2
S-phase kinase associated protein 2
decreases expression decreases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of SKP2 mRNA tert-Butylhydroperoxide results in decreased methylation of SKP2 intron
CTD
PMID:15336504 PMID:29432895
NCBI chr 5:36,152,111...36,193,530
Ensembl chr 5:36,151,989...36,196,849
G
SLAMF1
signaling lymphocytic activation molecule family member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLAMF1 mRNA
CTD
PMID:12414654
NCBI chr 1:160,608,106...160,647,044
Ensembl chr 1:160,608,106...160,647,044
G
SLC11A2
solute carrier family 11 member 2
increases expression decreases expression
EXP ISO
tert-Butylhydroperoxide results in increased expression of SLC11A2 mRNA tert-Butylhydroperoxide results in decreased expression of SLC11A2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SLC13A3
solute carrier family 13 member 3
decreases methylation
EXP
tert-Butylhydroperoxide results in decreased methylation of SLC13A3 intron
CTD
PMID:29432895
NCBI chr20:46,557,828...46,684,485
Ensembl chr20:46,557,823...46,684,467
G
SLC16A2
solute carrier family 16 member 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLC16A2 mRNA
CTD
PMID:15336504
NCBI chr X:74,421,493...74,533,916
Ensembl chr X:74,421,493...74,533,917
G
SLC17A2
solute carrier family 17 member 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SLC17A2 mRNA
CTD
PMID:23410634
NCBI chr 6:25,912,754...25,930,691
Ensembl chr 6:25,912,754...25,930,691
G
SLC19A2
solute carrier family 19 member 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLC19A2 mRNA
CTD
PMID:15336504
NCBI chr 1:169,463,909...169,485,970
Ensembl chr 1:169,463,909...169,485,944
G
SLC1A1
solute carrier family 1 member 1
decreases expression multiple interactions decreases activity
EXP ISO
tert-Butylhydroperoxide results in decreased expression of SLC1A1 mRNA [Tetradecanoylphorbol Acetate co-treated with Propofol] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of SLC1A1 protein]
CTD
PMID:15336504 PMID:17382927
NCBI chr 9:4,490,468...4,587,469
Ensembl chr 9:4,490,468...4,587,469
G
SLC1A4
solute carrier family 1 member 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SLC1A4 mRNA
CTD
PMID:15336504
NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865
G
SLC20A1
solute carrier family 20 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC20A1 mRNA
CTD
PMID:15003993
NCBI chr 2:112,645,939...112,663,825
Ensembl chr 2:112,645,939...112,663,825
G
SLC22A18
solute carrier family 22 member 18
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SLC22A18 mRNA
CTD
PMID:15336504
NCBI chr11:2,899,691...2,925,246
Ensembl chr11:2,899,721...2,925,246
G
SLC22A3
solute carrier family 22 member 3
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SLC22A3 mRNA
CTD
PMID:23410634
NCBI chr 6:160,348,378...160,452,577
Ensembl chr 6:160,348,378...160,452,577
G
SLC25A10
solute carrier family 25 member 10
multiple interactions increases expression
ISO
[SLC25A10 protein co-treated with Glutathione] results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of SLC25A10 mRNA
CTD
PMID:12388626 PMID:15003993
NCBI chr17:81,712,284...81,721,012
Ensembl chr17:81,712,236...81,721,016
G
SLC25A16
solute carrier family 25 member 16
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLC25A16 mRNA
CTD
PMID:15336504
NCBI chr10:68,477,998...68,527,523
Ensembl chr10:68,477,998...68,527,523
G
SLC27A2
solute carrier family 27 member 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SLC27A2 mRNA
CTD
PMID:23410634
NCBI chr15:50,182,196...50,236,385
Ensembl chr15:50,182,196...50,236,385
G
SLC2A14
solute carrier family 2 member 14
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A14 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A14 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A14 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A14 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A14 mRNA]
CTD
PMID:20847119
NCBI chr12:7,812,514...7,891,196
Ensembl chr12:7,812,512...7,891,148
G
SLC2A3
solute carrier family 2 member 3
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]
CTD
PMID:20847119
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SLC31A1
solute carrier family 31 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC31A1 mRNA
CTD
PMID:14729362
NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492
G
SLC35F2
solute carrier family 35 member F2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLC35F2 mRNA
CTD
PMID:15336504
NCBI chr11:107,790,991...107,858,787
Ensembl chr11:107,790,991...107,928,293
G
SLC35G2
solute carrier family 35 member G2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLC35G2 mRNA
CTD
PMID:15336504
NCBI chr 3:136,819,126...136,855,888
Ensembl chr 3:136,818,647...136,855,888
G
SLC37A4
solute carrier family 37 member 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SLC37A4 mRNA
CTD
PMID:15336504
NCBI chr11:119,024,112...119,030,877
Ensembl chr11:119,023,751...119,030,906
G
SLC39A14
solute carrier family 39 member 14
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLC39A14 mRNA
CTD
PMID:15336504
NCBI chr 8:22,367,278...22,434,129
Ensembl chr 8:22,367,278...22,434,129
G
SLC44A4
solute carrier family 44 member 4
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SLC44A4 mRNA
CTD
PMID:23410634
NCBI chr 6:31,863,192...31,878,997
Ensembl chr 6:31,863,192...31,879,046
G
SLC46A1
solute carrier family 46 member 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SLC46A1 mRNA
CTD
PMID:22956110
NCBI chr17:28,394,642...28,406,592
Ensembl chr17:28,394,642...28,407,197
G
SLC4A1
solute carrier family 4 member 1 (Diego blood group)
increases degradation
EXP
tert-Butylhydroperoxide results in increased degradation of SLC4A1 protein
CTD
PMID:15040847
NCBI chr17:44,248,390...44,268,135
Ensembl chr17:44,248,390...44,268,141
G
SLC4A11
solute carrier family 4 member 11
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLC4A11 mRNA
CTD
PMID:29432895
NCBI chr20:3,227,417...3,239,559
Ensembl chr20:3,227,417...3,239,559
G
SLC6A14
solute carrier family 6 member 14
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SLC6A14 mRNA
CTD
PMID:23410634
NCBI chr X:116,436,606...116,461,458
Ensembl chr X:116,436,606...116,461,458
G
SLC7A11
solute carrier family 7 member 11
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SLC7A11 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLC7A5
solute carrier family 7 member 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SLC7A5 mRNA
CTD
PMID:12419474
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
G
SLPI
secretory leukocyte peptidase inhibitor
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of SLPI mRNA SLPI protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
SLTM
SAFB like transcription modulator
multiple interactions increases expression
EXP
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of SLTM mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]
CTD
PMID:20847119
NCBI chr15:58,879,050...58,933,679
Ensembl chr15:58,879,050...58,933,679
G
SMAD1
SMAD family member 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SMAD1 mRNA
CTD
PMID:12419474
NCBI chr 4:145,480,770...145,559,176
Ensembl chr 4:145,481,194...145,559,176
G
SMAD3
SMAD family member 3
increases expression increases methylation
EXP
tert-Butylhydroperoxide results in increased expression of SMAD3 mRNA tert-Butylhydroperoxide results in increased methylation of SMAD3 gene
CTD
PMID:27509014
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
SMAD5
SMAD family member 5
decreases methylation increases expression
EXP
tert-Butylhydroperoxide results in decreased methylation of SMAD5 gene tert-Butylhydroperoxide results in increased expression of SMAD5 mRNA
CTD
PMID:27509014
NCBI chr 5:136,132,845...136,182,733
Ensembl chr 5:136,132,845...136,188,747
G
SMAD7
SMAD family member 7
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SMAD7 mRNA
CTD
PMID:15336504
NCBI chr18:48,919,853...48,950,965
Ensembl chr18:48,919,853...48,950,965
G
SMAD9
SMAD family member 9
decreases methylation decreases expression
EXP
tert-Butylhydroperoxide results in decreased methylation of SMAD9 gene tert-Butylhydroperoxide results in decreased expression of SMAD9 mRNA
CTD
PMID:27509014
NCBI chr13:36,844,831...36,920,854
Ensembl chr13:36,844,831...36,920,887
G
SMARCA2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SMARCA2 mRNA
CTD
PMID:15336504
NCBI chr 9:2,015,347...2,193,624
Ensembl chr 9:1,980,290...2,193,624
G
SMARCC1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SMARCC1 mRNA
CTD
PMID:15336504
NCBI chr 3:47,585,269...47,781,893
Ensembl chr 3:47,585,269...47,782,106
G
SMARCC2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SMARCC2 mRNA
CTD
PMID:15336504
NCBI chr12:56,162,359...56,189,483
Ensembl chr12:56,162,359...56,189,567
G
SMC4
structural maintenance of chromosomes 4
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of SMC4 mRNA tert-Butylhydroperoxide affects the expression of SMC4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 3:160,399,650...160,434,953
Ensembl chr 3:160,399,274...160,434,954
G
SMIM19
small integral membrane protein 19
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SMIM19 mRNA
CTD
PMID:23410634
NCBI chr 8:42,541,148...42,555,195
Ensembl chr 8:42,541,155...42,555,195
G
SMIM7
small integral membrane protein 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SMIM7 mRNA
CTD
PMID:15336504
NCBI chr19:16,630,751...16,660,144
Ensembl chr19:16,630,751...16,660,442
G
SMNDC1
survival motor neuron domain containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SMNDC1 mRNA
CTD
PMID:15336504
NCBI chr10:110,290,730...110,304,920
Ensembl chr10:110,290,730...110,304,938
G
SMOX
spermine oxidase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SMOX mRNA
CTD
PMID:15336504
NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747
G
SMTN
smoothelin
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SMTN mRNA
CTD
PMID:15336504
NCBI chr22:31,064,118...31,104,624
Ensembl chr22:31,064,105...31,104,757
G
SNAI2
snail family transcriptional repressor 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SNAI2 mRNA
CTD
PMID:15336504
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
G
SNAP23
synaptosome associated protein 23
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SNAP23 mRNA
CTD
PMID:15336504
NCBI chr15:42,491,129...42,533,058
Ensembl chr15:42,491,233...42,545,356
G
SNN
stannin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SNN mRNA
CTD
PMID:15336504
NCBI chr16:11,668,455...11,679,152
Ensembl chr16:11,668,455...11,679,152
G
SNX1
sorting nexin 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SNX1 mRNA
CTD
PMID:15336504
NCBI chr15:64,095,982...64,144,231
Ensembl chr15:64,094,123...64,146,090
G
SNX4
sorting nexin 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SNX4 mRNA
CTD
PMID:15336504
NCBI chr 3:125,446,650...125,520,202
Ensembl chr 3:125,446,650...125,520,202
G
SOAT1
sterol O-acyltransferase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SOAT1 mRNA
CTD
PMID:15336504
NCBI chr 1:179,293,797...179,358,680
Ensembl chr 1:179,293,714...179,358,680
G
SOBP
sine oculis binding protein homolog
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SOBP mRNA
CTD
PMID:15336504
NCBI chr 6:107,490,117...107,661,306
Ensembl chr 6:107,490,106...107,661,306
G
SOCS1
suppressor of cytokine signaling 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOCS1 mRNA
CTD
PMID:15003993
NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
G
SOCS6
suppressor of cytokine signaling 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SOCS6 mRNA
CTD
PMID:15336504
NCBI chr18:70,289,045...70,330,199
Ensembl chr18:70,289,045...70,330,199
G
SOD1
superoxide dismutase 1
decreases response to substance increases activity increases expression multiple interactions
ISO EXP
SOD1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased activity of SOD1 protein tert-Butylhydroperoxide results in increased expression of SOD1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]; LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:15849717 PMID:31627909 PMID:35690295 More...
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
increases response to substance increases activity increases expression affects response to substance multiple interactions decreases expression
ISO EXP
SOD2 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased activity of SOD2 protein tert-Butylhydroperoxide results in increased expression of SOD2 mRNA SOD2 protein affects the susceptibility to tert-Butylhydroperoxide 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD2 mRNA; LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]; SIRT3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]]; tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein
CTD
PMID:15182862 PMID:15336504 PMID:16636651 PMID:16704919 PMID:17003459 PMID:20107204 PMID:25522270 PMID:27050144 PMID:27509014 PMID:29128606 PMID:31627909 PMID:35690295 More...
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SORD
sorbitol dehydrogenase
increases expression increases activity decreases expression
EXP ISO
tert-Butylhydroperoxide results in increased expression of SORD mRNA tert-Butylhydroperoxide results in increased activity of SORD protein tert-Butylhydroperoxide results in decreased expression of SORD protein
CTD
PMID:15336504 PMID:16928893 PMID:24394546
NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
G
SOX9
SRY-box transcription factor 9
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SOX9 mRNA
CTD
PMID:15336504
NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416
G
SP100
SP100 nuclear antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SP100 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:230,416,201...230,545,606
Ensembl chr 2:230,415,942...230,545,606
G
SP2
Sp2 transcription factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SP2 mRNA
CTD
PMID:12419474
NCBI chr17:47,896,236...47,931,731
Ensembl chr17:47,896,150...47,928,957
G
SPAG5
sperm associated antigen 5
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SPAG5 mRNA
CTD
PMID:23410634
NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025
G
SPARC
secreted protein acidic and cysteine rich
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SPARC mRNA tert-Butylhydroperoxide results in increased expression of SPARC mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
G
SPATA20
spermatogenesis associated 20
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SPATA20 mRNA
CTD
PMID:15336504
NCBI chr17:50,547,174...50,555,852
Ensembl chr17:50,543,058...50,555,852
G
SPDL1
spindle apparatus coiled-coil protein 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SPDL1 mRNA
CTD
PMID:23410634
NCBI chr 5:169,583,773...169,604,778
Ensembl chr 5:169,583,636...169,604,778
G
SPHK1
sphingosine kinase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SPHK1 mRNA
CTD
PMID:15336504
NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
G
SPINT2
serine peptidase inhibitor, Kunitz type 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SPINT2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr19:38,264,573...38,292,615
Ensembl chr19:38,244,035...38,292,615
G
SPRED2
sprouty related EVH1 domain containing 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SPRED2 mRNA
CTD
PMID:15336504
NCBI chr 2:65,307,175...65,432,599
Ensembl chr 2:65,310,851...65,432,637
G
SPRR1A
small proline rich protein 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPRR1A mRNA
CTD
PMID:15003993
NCBI chr 1:152,984,081...152,985,814
Ensembl chr 1:152,984,081...152,985,814
G
SPRR2G
small proline rich protein 2G
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPRR2G mRNA
CTD
PMID:15003993
NCBI chr 1:153,149,582...153,203,278
Ensembl chr 1:153,149,582...153,150,890
G
SPRY4
sprouty RTK signaling antagonist 4
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SPRY4 mRNA
CTD
PMID:23410634
NCBI chr 5:142,310,430...142,325,021
Ensembl chr 5:142,310,427...142,326,455
G
SPTA1
spectrin alpha, erythrocytic 1
multiple interactions
EXP
tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]
CTD
PMID:15040847
NCBI chr 1:158,610,704...158,686,715
Ensembl chr 1:158,610,704...158,686,715
G
SPTAN1
spectrin alpha, non-erythrocytic 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SPTAN1 mRNA
CTD
PMID:15336504
NCBI chr 9:128,552,587...128,633,662
Ensembl chr 9:128,552,558...128,633,662
G
SPTB
spectrin beta, erythrocytic
multiple interactions
EXP
tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]
CTD
PMID:15040847
NCBI chr14:64,746,283...64,879,907
Ensembl chr14:64,746,283...64,879,907
G
SPTBN1
spectrin beta, non-erythrocytic 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SPTBN1 mRNA
CTD
PMID:15336504
NCBI chr 2:54,456,327...54,671,446
Ensembl chr 2:54,456,327...54,671,446
G
SPTLC1
serine palmitoyltransferase long chain base subunit 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SPTLC1 mRNA
CTD
PMID:15336504
NCBI chr 9:92,031,147...92,115,413
Ensembl chr 9:92,000,087...92,115,413
G
SPTLC2
serine palmitoyltransferase long chain base subunit 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SPTLC2 mRNA
CTD
PMID:15336504
NCBI chr14:77,505,997...77,616,637
Ensembl chr14:77,505,997...77,616,637
G
SPTSSA
serine palmitoyltransferase small subunit A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SPTSSA mRNA
CTD
PMID:15336504
NCBI chr14:34,432,788...34,462,240
Ensembl chr14:34,432,788...34,462,240
G
SQLE
squalene epoxidase
decreases expression increases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of SQLE mRNA tert-Butylhydroperoxide results in increased expression of SQLE mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
G
SQOR
sulfide quinone oxidoreductase
increases expression affects expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of SQOR mRNA tert-Butylhydroperoxide affects the expression of SQOR mRNA
CTD
PMID:14729362 PMID:15336504 PMID:23410634
NCBI chr15:45,631,148...45,691,281
Ensembl chr15:45,631,148...45,691,281
G
SQSTM1
sequestosome 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SQSTM1 mRNA
CTD
PMID:23410634
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SRF
serum response factor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SRF mRNA
CTD
PMID:12419474
NCBI chr 6:43,171,269...43,181,506
Ensembl chr 6:43,171,269...43,181,506
G
SRGN
serglycin
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SRGN mRNA
CTD
PMID:15336504
NCBI chr10:69,087,603...69,104,811
Ensembl chr10:69,088,103...69,104,805
G
SRPK2
SRSF protein kinase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SRPK2 mRNA
CTD
PMID:15336504
NCBI chr 7:105,114,740...105,399,357
Ensembl chr 7:105,110,704...105,399,308
G
SRPRA
SRP receptor subunit alpha
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SRPRA mRNA
CTD
PMID:15336504
NCBI chr11:126,235,930...126,268,895
Ensembl chr11:126,262,938...126,269,144
G
SRPX
sushi repeat containing protein X-linked
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SRPX mRNA
CTD
PMID:15336504
NCBI chr X:38,149,339...38,220,871
Ensembl chr X:38,149,336...38,220,924
G
SRRD
SRR1 domain containing
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SRRD mRNA
CTD
PMID:15336504
NCBI chr22:26,483,877...26,494,658
Ensembl chr22:26,483,877...26,494,658
G
SRRT
serrate, RNA effector molecule
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SRRT mRNA
CTD
PMID:15336504
NCBI chr 7:100,875,103...100,888,664
Ensembl chr 7:100,875,103...100,888,664
G
SRSF3
serine and arginine rich splicing factor 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SRSF3 mRNA
CTD
PMID:15336504
NCBI chr 6:36,594,362...36,605,600
Ensembl chr 6:36,594,353...36,605,600
G
SRXN1
sulfiredoxin 1
increases expression decreases methylation
ISO EXP
tert-Butylhydroperoxide results in increased expression of SRXN1 mRNA tert-Butylhydroperoxide results in decreased methylation of SRXN1 gene
CTD
PMID:22003191 PMID:23410634 PMID:27509014
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
SS18L1
SS18L1 subunit of BAF chromatin remodeling complex
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SS18L1 mRNA
CTD
PMID:15336504
NCBI chr20:62,143,769...62,182,514
Ensembl chr20:62,143,769...62,182,514
G
SST
somatostatin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SST mRNA
CTD
PMID:12414654
NCBI chr 3:187,668,912...187,670,394
Ensembl chr 3:187,668,912...187,670,394
G
SSX2IP
SSX family member 2 interacting protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SSX2IP mRNA
CTD
PMID:15336504
NCBI chr 1:84,643,706...84,690,745
Ensembl chr 1:84,643,706...84,690,803
G
ST3GAL1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions increases expression
EXP
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]
CTD
PMID:20847119
NCBI chr 8:133,454,848...133,571,887
Ensembl chr 8:133,454,848...133,571,926
G
ST6GALNAC4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ST6GALNAC4 mRNA
CTD
PMID:15003993
NCBI chr 9:127,907,886...127,917,041
Ensembl chr 9:127,907,886...127,917,041
G
ST7
suppression of tumorigenicity 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ST7 mRNA
CTD
PMID:15336504
NCBI chr 7:116,953,501...117,230,176
Ensembl chr 7:116,953,238...117,230,176
G
STAG1
STAG1 cohesin complex component
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of STAG1 mRNA
CTD
PMID:15336504
NCBI chr 3:136,336,236...136,752,378
Ensembl chr 3:136,336,236...136,752,403
G
STAT1
signal transducer and activator of transcription 1
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of STAT1 mRNA tert-Butylhydroperoxide results in increased expression of STAT1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
STAT3
signal transducer and activator of transcription 3
decreases phosphorylation multiple interactions
EXP
tert-Butylhydroperoxide results in decreased phosphorylation of STAT3 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of STAT3 protein]
CTD
PMID:29128606
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STAT5A
signal transducer and activator of transcription 5A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of STAT5A mRNA
CTD
PMID:12766906
NCBI chr17:42,287,439...42,311,943
Ensembl chr17:42,287,547...42,311,943
G
STAT6
signal transducer and activator of transcription 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of STAT6 mRNA
CTD
PMID:12419474
NCBI chr12:57,095,408...57,111,362
Ensembl chr12:57,095,408...57,132,139
G
STC1
stanniocalcin 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of STC1 mRNA
CTD
PMID:15336504
NCBI chr 8:23,841,929...23,854,806
Ensembl chr 8:23,841,929...23,854,806
G
STC2
stanniocalcin 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of STC2 mRNA
CTD
PMID:15336504
NCBI chr 5:173,314,723...173,328,414
Ensembl chr 5:173,314,723...173,328,447
G
STK10
serine/threonine kinase 10
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of STK10 mRNA
CTD
PMID:15336504
NCBI chr 5:172,042,079...172,188,224
Ensembl chr 5:172,042,079...172,188,224
G
STK24
serine/threonine kinase 24
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of STK24 mRNA
CTD
PMID:15336504
NCBI chr13:98,445,185...98,577,107
Ensembl chr13:98,445,185...98,577,940
G
STMN1
stathmin 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of STMN1 mRNA
CTD
PMID:15336504
NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
G
STX7
syntaxin 7
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of STX7 mRNA
CTD
PMID:15336504
NCBI chr 6:132,445,867...132,513,472
Ensembl chr 6:132,445,867...132,513,198
G
SUGP2
SURP and G-patch domain containing 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SUGP2 mRNA
CTD
PMID:15336504
NCBI chr19:18,990,887...19,033,844
Ensembl chr19:18,990,888...19,034,023
G
SUMO3
small ubiquitin like modifier 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SUMO3 mRNA
CTD
PMID:29432895
NCBI chr21:44,805,617...44,818,062
Ensembl chr21:44,805,617...44,818,779
G
SUOX
sulfite oxidase
affects expression
EXP
tert-Butylhydroperoxide affects the expression of SUOX mRNA
CTD
PMID:23410634
NCBI chr12:55,997,276...56,005,525
Ensembl chr12:55,997,180...56,006,641
G
SUSD6
sushi domain containing 6
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SUSD6 mRNA
CTD
PMID:15336504
NCBI chr14:69,611,596...69,715,144
Ensembl chr14:69,611,596...69,715,144
G
SYNJ2
synaptojanin 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of SYNJ2 mRNA
CTD
PMID:15336504
NCBI chr 6:157,981,296...158,099,176
Ensembl chr 6:157,981,863...158,099,176
G
SYT1
synaptotagmin 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of SYT1 mRNA
CTD
PMID:15336504
NCBI chr12:78,863,982...79,452,008
Ensembl chr12:78,863,993...79,452,008
G
TADA3
transcriptional adaptor 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TADA3 mRNA
CTD
PMID:12419474
NCBI chr 3:9,779,967...9,793,011
Ensembl chr 3:9,779,967...9,793,011
G
TAP1
transporter 1, ATP binding cassette subfamily B member
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TAP1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TAPBPL
TAP binding protein like
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TAPBPL mRNA
CTD
PMID:15336504
NCBI chr12:6,451,649...6,472,006
Ensembl chr12:6,451,690...6,466,517
G
TASOR
transcription activation suppressor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TASOR mRNA
CTD
PMID:15336504
NCBI chr 3:56,620,132...56,683,265
Ensembl chr 3:56,620,132...56,683,265
G
TBC1D22A
TBC1 domain family member 22A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TBC1D22A mRNA
CTD
PMID:15336504
NCBI chr22:46,762,650...47,175,699
Ensembl chr22:46,762,617...47,175,699
G
TBL1XR1
TBL1X/Y related 1
affects expression decreases methylation
EXP
tert-Butylhydroperoxide affects the expression of TBL1XR1 mRNA tert-Butylhydroperoxide results in decreased methylation of TBL1XR1 intron
CTD
PMID:23410634 PMID:29432895
NCBI chr 3:177,019,344...177,201,800
Ensembl chr 3:177,019,340...177,228,000
G
TBRG1
transforming growth factor beta regulator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TBRG1 mRNA
CTD
PMID:14729362
NCBI chr11:124,622,864...124,635,926
Ensembl chr11:124,622,836...124,635,926
G
TCAF1
TRPM8 channel associated factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TCAF1 mRNA
CTD
PMID:15336504
NCBI chr 7:143,851,375...143,902,176
Ensembl chr 7:143,851,375...143,902,198
G
TCEA1
transcription elongation factor A1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TCEA1 mRNA
CTD
PMID:12419474
NCBI chr 8:53,966,556...54,022,448
Ensembl chr 8:53,966,552...54,022,448
G
TCF3
transcription factor 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TCF3 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr19:1,609,292...1,652,615
Ensembl chr19:1,609,291...1,652,615
G
TCF4
transcription factor 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TCF4 mRNA
CTD
PMID:15336504
NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787
G
TCFL5
transcription factor like 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TCFL5 mRNA
CTD
PMID:15336504
NCBI chr20:62,841,005...62,861,822
Ensembl chr20:62,841,005...62,861,822
G
TEAD4
TEA domain transcription factor 4
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of TEAD4 mRNA tert-Butylhydroperoxide affects the expression of TEAD4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr12:2,959,397...3,040,676
Ensembl chr12:2,959,330...3,040,676
G
TENM4
teneurin transmembrane protein 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TENM4 mRNA
CTD
PMID:15336504
NCBI chr11:78,652,829...79,441,030
Ensembl chr11:78,652,829...79,441,030
G
TENT2
terminal nucleotidyltransferase 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of TENT2 mRNA
CTD
PMID:23410634
NCBI chr 5:79,612,441...79,688,246
Ensembl chr 5:79,612,120...79,688,246
G
TERF1
telomeric repeat binding factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TERF1 mRNA
CTD
PMID:12419474
NCBI chr 8:73,008,864...73,048,123
Ensembl chr 8:73,008,856...73,048,123
G
TET1
tet methylcytosine dioxygenase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TET1 mRNA
CTD
PMID:27509014
NCBI chr10:68,560,337...68,694,487
Ensembl chr10:68,560,337...68,694,487
G
TEX10
testis expressed 10
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TEX10 mRNA
CTD
PMID:15336504
NCBI chr 9:100,302,084...100,352,942
Ensembl chr 9:100,302,077...100,352,942
G
TFCP2
transcription factor CP2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TFCP2 mRNA
CTD
PMID:15336504
NCBI chr12:51,093,656...51,173,135
Ensembl chr12:51,093,656...51,173,135
G
TFDP1
transcription factor Dp-1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TFDP1 mRNA
CTD
PMID:15336504
NCBI chr13:113,584,688...113,641,473
Ensembl chr13:113,584,721...113,641,473
G
TFPI2
tissue factor pathway inhibitor 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TFPI2 mRNA
CTD
PMID:15336504
NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753
G
TFRC
transferrin receptor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TFRC mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
G
TGFA
transforming growth factor alpha
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TGFA mRNA
CTD
PMID:15336504
NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
G
TGFB1
transforming growth factor beta 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TGFB1 mRNA; tert-Butylhydroperoxide results in increased expression of TGFB1 protein
CTD
PMID:15147944 PMID:15336504 PMID:15963989
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB1I1
transforming growth factor beta 1 induced transcript 1
increases expression affects expression
EXP
tert-Butylhydroperoxide results in increased expression of TGFB1I1 mRNA tert-Butylhydroperoxide affects the expression of TGFB1I1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr16:31,472,152...31,477,960
Ensembl chr16:31,471,585...31,477,960
G
TGM2
transglutaminase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TGM2 mRNA
CTD
PMID:15336504
NCBI chr20:38,127,385...38,168,475
Ensembl chr20:38,127,385...38,166,578
G
TGOLN2
trans-golgi network protein 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TGOLN2 mRNA
CTD
PMID:15336504
NCBI chr 2:85,318,027...85,327,989
Ensembl chr 2:85,318,027...85,328,251
G
THAP1
THAP domain containing 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of THAP1 mRNA
CTD
PMID:23410634
NCBI chr 8:42,836,674...42,843,325
Ensembl chr 8:42,836,674...42,843,325
G
THBD
thrombomodulin
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of THBD mRNA
CTD
PMID:15336504
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
THBS1
thrombospondin 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of THBS1 mRNA
CTD
PMID:29432895
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
THBS3
thrombospondin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBS3 mRNA
CTD
PMID:14729362
NCBI chr 1:155,195,588...155,209,178
Ensembl chr 1:155,195,588...155,209,051
G
THEM6
thioesterase superfamily member 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of THEM6 mRNA
CTD
PMID:15336504
NCBI chr 8:142,727,223...142,736,927
Ensembl chr 8:142,727,223...142,736,927
G
THOC6
THO complex subunit 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of THOC6 mRNA
CTD
PMID:15336504
NCBI chr16:3,024,035...3,027,750
Ensembl chr16:3,024,027...3,027,755
G
TIA1
TIA1 cytotoxic granule associated RNA binding protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TIA1 mRNA
CTD
PMID:15336504
NCBI chr 2:70,209,444...70,248,793
Ensembl chr 2:70,209,444...70,248,660
G
TIAL1
TIA1 cytotoxic granule associated RNA binding protein like 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TIAL1 mRNA
CTD
PMID:15336504
NCBI chr10:119,573,465...119,596,964
Ensembl chr10:119,571,802...119,597,029
G
TIE1
tyrosine kinase with immunoglobulin like and EGF like domains 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TIE1 mRNA
CTD
PMID:15336504
NCBI chr 1:43,300,982...43,323,108
Ensembl chr 1:43,300,982...43,323,108
G
TIMM22
translocase of inner mitochondrial membrane 22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMM22 mRNA
CTD
PMID:15003993
NCBI chr17:997,129...1,003,671
Ensembl chr17:997,129...1,003,671
G
TIMM9
translocase of inner mitochondrial membrane 9
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TIMM9 mRNA
CTD
PMID:15336504
NCBI chr14:58,408,494...58,427,531
Ensembl chr14:58,408,495...58,427,531
G
TIMP3
TIMP metallopeptidase inhibitor 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TIMP3 mRNA
CTD
PMID:15336504
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
G
TINAGL1
tubulointerstitial nephritis antigen like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TINAGL1 mRNA
CTD
PMID:15003993
NCBI chr 1:31,576,515...31,587,686
Ensembl chr 1:31,576,485...31,587,686
G
TIPARP
TCDD inducible poly(ADP-ribose) polymerase
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TIPARP mRNA
CTD
PMID:15336504
NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770
G
TJP1
tight junction protein 1
multiple interactions affects localization
ISO
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Staurosporine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]
CTD
PMID:16716901
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
G
TK1
thymidine kinase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TK1 mRNA
CTD
PMID:12414654
NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233
G
TKFC
triokinase and FMN cyclase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TKFC mRNA
CTD
PMID:15336504
NCBI chr11:61,333,228...61,353,426
Ensembl chr11:61,333,220...61,353,295
G
TLE3
TLE family member 3, transcriptional corepressor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TLE3 mRNA
CTD
PMID:15336504
NCBI chr15:70,047,790...70,097,917
Ensembl chr15:70,047,790...70,098,176
G
TLE4
TLE family member 4, transcriptional corepressor
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TLE4 mRNA
CTD
PMID:15336504
NCBI chr 9:79,571,965...79,726,882
Ensembl chr 9:79,571,773...79,726,882
G
TLE5
TLE family member 5, transcriptional modulator
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of TLE5 mRNA tert-Butylhydroperoxide results in increased expression of TLE5 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr19:3,052,910...3,062,966
Ensembl chr19:3,052,910...3,063,107
G
TLR4
toll like receptor 4
multiple interactions
EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TM4SF1
transmembrane 4 L six family member 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TM4SF1 mRNA
CTD
PMID:12766906 PMID:15336504
NCBI chr 3:149,369,022...149,377,649
Ensembl chr 3:149,369,022...149,377,692
G
TM7SF2
transmembrane 7 superfamily member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TM7SF2 mRNA
CTD
PMID:15336504
NCBI chr11:65,111,872...65,116,230
Ensembl chr11:65,111,845...65,116,384
G
TM9SF2
transmembrane 9 superfamily member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TM9SF2 mRNA
CTD
PMID:15336504
NCBI chr13:99,501,472...99,564,048
Ensembl chr13:99,446,311...99,564,048
G
TM9SF3
transmembrane 9 superfamily member 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TM9SF3 mRNA
CTD
PMID:15336504
NCBI chr10:96,518,110...96,587,012
Ensembl chr10:96,518,110...96,587,452
G
TMCO3
transmembrane and coiled-coil domains 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TMCO3 mRNA
CTD
PMID:15336504
NCBI chr13:113,491,021...113,550,229
Ensembl chr13:113,491,021...113,554,590
G
TMEM106C
transmembrane protein 106C
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TMEM106C mRNA
CTD
PMID:15336504
NCBI chr12:47,963,596...47,968,878
Ensembl chr12:47,963,569...47,968,878
G
TMEM132A
transmembrane protein 132A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TMEM132A mRNA
CTD
PMID:15336504
NCBI chr11:60,924,460...60,937,159
Ensembl chr11:60,924,460...60,937,159
G
TMEM158
transmembrane protein 158
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TMEM158 mRNA
CTD
PMID:15336504
NCBI chr 3:45,224,466...45,226,287
Ensembl chr 3:45,224,466...45,226,287
G
TMEM177
transmembrane protein 177
multiple interactions increases expression decreases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of TMEM177 mRNA] tert-Butylhydroperoxide results in increased expression of TMEM177 mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr 2:119,679,201...119,723,618
Ensembl chr 2:119,679,167...119,686,507
G
TMEM205
transmembrane protein 205
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM205 mRNA
CTD
PMID:14729362
NCBI chr19:11,342,778...11,346,492
Ensembl chr19:11,342,776...11,346,518
G
TMEM248
transmembrane protein 248
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TMEM248 mRNA
CTD
PMID:15336504
NCBI chr 7:66,921,225...66,958,551
Ensembl chr 7:66,921,225...66,958,551
G
TMEM80
transmembrane protein 80
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TMEM80 mRNA
CTD
PMID:15336504
NCBI chr11:695,639...705,028
Ensembl chr11:695,591...705,028
G
TMPO
thymopoietin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TMPO mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr12:98,515,573...98,550,351
Ensembl chr12:98,515,579...98,550,351
G
TMSB10
thymosin beta 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMSB10 mRNA
CTD
PMID:15003993
NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,905,656...84,906,671
G
TMSB15A
thymosin beta 15A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TMSB15A mRNA
CTD
PMID:15336504
NCBI chr X:102,513,682...102,516,739
Ensembl chr X:102,513,682...102,516,739
G
TMT1A
thiol methyltransferase 1A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TMT1A mRNA
CTD
PMID:15336504
NCBI chr12:50,925,015...50,932,508
Ensembl chr12:50,923,472...50,932,510
G
TMX4
thioredoxin related transmembrane protein 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TMX4 mRNA
CTD
PMID:15336504
NCBI chr20:7,977,346...8,019,761
Ensembl chr20:7,977,346...8,019,805
G
TNC
tenascin C
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TNC mRNA
CTD
PMID:15336504
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNF
tumor necrosis factor
multiple interactions increases secretion increases expression
ISO EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; 8-methoxymethyl-3-isobutyl-1-methylxanthine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Verapamil inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; W 7 inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein] tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein] tert-Butylhydroperoxide results in increased expression of TNF mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNF mRNA; acetovanillone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]
CTD
PMID:10231168 PMID:17129690 PMID:17369293 PMID:29111459 PMID:29935159 PMID:35690295 More...
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP3
TNF alpha induced protein 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TNFAIP3 mRNA
CTD
PMID:15336504
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TNFRSF1A
TNF receptor superfamily member 1A
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TNFRSF1A mRNA
CTD
PMID:12419474
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFRSF9
TNF receptor superfamily member 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNFRSF9 mRNA
CTD
PMID:15003993
NCBI chr 1:7,915,871...7,940,839
Ensembl chr 1:7,915,871...7,943,165
G
TNFSF10
TNF superfamily member 10
decreases expression multiple interactions
EXP
tert-Butylhydroperoxide results in decreased expression of TNFSF10 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TNNC1
troponin C1, slow skeletal and cardiac type
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of TNNC1 mRNA tert-Butylhydroperoxide results in increased expression of TNNC1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 3:52,451,100...52,454,041
Ensembl chr 3:52,451,100...52,454,041
G
TNNT1
troponin T1, slow skeletal type
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TNNT1 mRNA
CTD
PMID:15336504
NCBI chr19:55,132,698...55,149,206
Ensembl chr19:55,132,698...55,149,206
G
TNNT2
troponin T2, cardiac type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNNT2 mRNA
CTD
PMID:14729362
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
G
TNPO1
transportin 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TNPO1 mRNA
CTD
PMID:15336504
NCBI chr 5:72,816,661...72,914,388
Ensembl chr 5:72,816,312...72,916,733
G
TNPO2
transportin 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TNPO2 mRNA
CTD
PMID:15336504
NCBI chr19:12,699,201...12,723,932
Ensembl chr19:12,699,201...12,724,011
G
TOM1
target of myb1 membrane trafficking protein
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TOM1 mRNA
CTD
PMID:12414654
NCBI chr22:35,299,275...35,347,973
Ensembl chr22:35,299,275...35,347,992
G
TOP6BL
TOP6B like initiator of meiotic double strand breaks
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TOP6BL mRNA
CTD
PMID:15336504
NCBI chr11:66,744,736...66,843,516
Ensembl chr11:66,744,451...66,843,516
G
TP53
tumor protein p53
multiple interactions decreases expression increases expression increases glutathionylation increases phosphorylation
EXP ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein]; S-ethyl glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein modified form] tert-Butylhydroperoxide results in decreased expression of TP53 mRNA tert-Butylhydroperoxide results in increased glutathionylation of TP53 protein Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of TRP53 protein] tert-Butylhydroperoxide results in increased expression of TRP53 mRNA; tert-Butylhydroperoxide results in increased expression of TRP53 protein
CTD
PMID:12419474 PMID:12782109 PMID:15879681 PMID:17555331 PMID:18619952 PMID:35690295 More...
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TP53BP1
tumor protein p53 binding protein 1
decreases expression decreases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of TP53BP1 mRNA tert-Butylhydroperoxide results in decreased methylation of TP53BP1 gene
CTD
PMID:27509014
NCBI chr15:43,403,061...43,510,640
Ensembl chr15:43,403,061...43,510,728
G
TP53I3
tumor protein p53 inducible protein 3
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TP53I3 mRNA
CTD
PMID:15336504
NCBI chr 2:24,077,433...24,084,834
Ensembl chr 2:24,077,433...24,085,861
G
TP73
tumor protein p73
decreases expression increases methylation
EXP
tert-Butylhydroperoxide results in decreased expression of TP73 mRNA tert-Butylhydroperoxide results in increased methylation of TP73 gene
CTD
PMID:27509014
NCBI chr 1:3,652,516...3,736,201
Ensembl chr 1:3,652,516...3,736,201
G
TPD52L1
TPD52 like 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TPD52L1 mRNA
CTD
PMID:15336504
NCBI chr 6:125,153,773...125,264,407
Ensembl chr 6:125,119,049...125,264,407
G
TPGS2
tubulin polyglutamylase complex subunit 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TPGS2 mRNA
CTD
PMID:15336504
NCBI chr18:36,780,024...36,829,002
Ensembl chr18:36,777,647...36,829,216
G
TPM2
tropomyosin 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TPM2 mRNA
CTD
PMID:15336504
NCBI chr 9:35,681,993...35,690,056
Ensembl chr 9:35,681,992...35,690,056
G
TPP1
tripeptidyl peptidase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TPP1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr11:6,612,768...6,619,422
Ensembl chr11:6,612,768...6,619,448
G
TPSAB1
tryptase alpha/beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPSAB1 mRNA
CTD
PMID:15003993
NCBI chr16:1,240,705...1,242,554
Ensembl chr16:1,239,266...1,242,554
G
TPST2
tyrosylprotein sulfotransferase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TPST2 mRNA
CTD
PMID:15336504
NCBI chr22:26,521,996...26,590,132
Ensembl chr22:26,521,996...26,596,717
G
TRAF1
TNF receptor associated factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRAF1 mRNA
CTD
PMID:15003993
NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
G
TRAF2
TNF receptor associated factor 2
multiple interactions
EXP
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]
CTD
PMID:24394546
NCBI chr 9:136,881,958...136,926,607
Ensembl chr 9:136,881,912...136,926,607
G
TRAF4
TNF receptor associated factor 4
increases expression increases methylation
EXP
tert-Butylhydroperoxide results in increased expression of TRAF4 mRNA tert-Butylhydroperoxide results in increased methylation of TRAF4 gene
CTD
PMID:27509014
NCBI chr17:28,744,011...28,750,956
Ensembl chr17:28,744,011...28,750,956
G
TRAK1
trafficking kinesin protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TRAK1 mRNA
CTD
PMID:15336504
NCBI chr 3:42,013,093...42,225,890
Ensembl chr 3:42,013,802...42,225,890
G
TRAM1
translocation associated membrane protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TRAM1 mRNA
CTD
PMID:15336504
NCBI chr 8:70,573,218...70,608,416
Ensembl chr 8:70,573,218...70,608,416
G
TRAPPC1
trafficking protein particle complex subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRAPPC1 mRNA
CTD
PMID:15003993
NCBI chr17:7,930,345...7,931,999
Ensembl chr17:7,930,345...7,932,123
G
TRIAP1
TP53 regulated inhibitor of apoptosis 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TRIAP1 mRNA
CTD
PMID:15336504
NCBI chr12:120,443,964...120,446,384
Ensembl chr12:120,443,964...120,446,384
G
TRIB1
tribbles pseudokinase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TRIB1 mRNA
CTD
PMID:15336504
NCBI chr 8:125,430,358...125,438,403
Ensembl chr 8:125,430,358...125,438,403
G
TRIB2
tribbles pseudokinase 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TRIB2 mRNA
CTD
PMID:15336504
NCBI chr 2:12,716,936...12,742,734
Ensembl chr 2:12,716,910...12,742,734
G
TRIM21
tripartite motif containing 21
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIM21 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr11:4,384,897...4,393,702
Ensembl chr11:4,384,897...4,393,702
G
TRIM25
tripartite motif containing 25
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIM25 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr17:56,887,909...56,914,049
Ensembl chr17:56,836,387...56,914,080
G
TRIO
trio Rho guanine nucleotide exchange factor
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TRIO mRNA
CTD
PMID:15336504
NCBI chr 5:14,143,342...14,510,204
Ensembl chr 5:14,143,342...14,532,128
G
TRIOBP
TRIO and F-actin binding protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TRIOBP mRNA
CTD
PMID:15336504
NCBI chr22:37,697,048...37,776,556
Ensembl chr22:37,697,048...37,776,556
G
TRIP6
thyroid hormone receptor interactor 6
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TRIP6 mRNA
CTD
PMID:15336504
NCBI chr 7:100,867,387...100,873,454
Ensembl chr 7:100,867,387...100,873,454
G
TRPV2
transient receptor potential cation channel subfamily V member 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TRPV2 mRNA
CTD
PMID:15336504
NCBI chr17:16,415,571...16,437,003
Ensembl chr17:16,415,571...16,437,003
G
TRRAP
transformation/transcription domain associated protein
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TRRAP mRNA
CTD
PMID:15336504
NCBI chr 7:98,878,532...99,013,241
Ensembl chr 7:98,877,933...99,050,831
G
TSC22D2
TSC22 domain family member 2
affects expression
EXP
tert-Butylhydroperoxide affects the expression of TSC22D2 mRNA
CTD
PMID:23410634
NCBI chr 3:150,408,298...150,466,422
Ensembl chr 3:150,408,298...150,466,422
G
TSG101
tumor susceptibility 101
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TSG101 mRNA
CTD
PMID:12419474
NCBI chr11:18,480,311...18,526,942
Ensembl chr11:18,468,336...18,526,951
G
TSHB
thyroid stimulating hormone subunit beta
decreases activity increases oxidation
EXP
tert-Butylhydroperoxide results in decreased activity of TSHB protein tert-Butylhydroperoxide results in increased oxidation of TSHB protein
CTD
PMID:14751029
NCBI chr 1:115,029,826...115,034,309
Ensembl chr 1:115,029,826...115,034,302
G
TSPAN14
tetraspanin 14
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TSPAN14 mRNA
CTD
PMID:15336504
NCBI chr10:80,454,310...80,522,631
Ensembl chr10:80,454,265...80,533,124
G
TSPAN3
tetraspanin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TSPAN3 mRNA
CTD
PMID:15336504
NCBI chr15:77,041,404...77,071,109
Ensembl chr15:77,041,404...77,083,984
G
TSPAN31
tetraspanin 31
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TSPAN31 mRNA
CTD
PMID:12419474
NCBI chr12:57,745,039...57,750,219
Ensembl chr12:57,738,013...57,750,219
G
TSPAN5
tetraspanin 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of TSPAN5 mRNA
CTD
PMID:15336504
NCBI chr 4:98,470,367...98,658,611
Ensembl chr 4:98,470,367...98,658,611
G
TSPAN9
tetraspanin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN9 mRNA
CTD
PMID:15003993
NCBI chr12:3,077,379...3,286,559
Ensembl chr12:3,077,355...3,286,564
G
TTC3
tetratricopeptide repeat domain 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TTC3 mRNA
CTD
PMID:15336504
NCBI chr21:37,073,254...37,203,118
Ensembl chr21:37,073,226...37,203,112
G
TUBA1A
tubulin alpha 1a
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TUBA1A mRNA
CTD
PMID:12414654
NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324
G
TUBA1B
tubulin alpha 1b
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TUBA1B mRNA; tert-Butylhydroperoxide results in decreased expression of TUBA1B protein
CTD
PMID:12419474 PMID:15050405
NCBI chr12:49,127,782...49,131,395
Ensembl chr12:49,127,782...49,131,397
G
TUBB2A
tubulin beta 2A class IIa
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBB2A mRNA
CTD
PMID:14729362
NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
G
TUBB2B
tubulin beta 2B class IIb
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TUBB2B mRNA
CTD
PMID:15336504
NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
G
TUBGCP3
tubulin gamma complex component 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TUBGCP3 mRNA
CTD
PMID:15336504
NCBI chr13:112,485,011...112,605,630
Ensembl chr13:112,485,011...112,588,205
G
TULP3
TUB like protein 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TULP3 mRNA
CTD
PMID:15336504
NCBI chr12:2,890,891...2,941,138
Ensembl chr12:2,877,223...2,941,138
G
TUSC3
tumor suppressor candidate 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of TUSC3 mRNA
CTD
PMID:15336504
NCBI chr 8:15,417,188...15,852,091
Ensembl chr 8:15,417,215...15,766,649
G
TXN
thioredoxin
decreases response to substance
EXP
TXN protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:10754530
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXN2
thioredoxin 2
increases oxidation decreases response to substance
EXP
tert-Butylhydroperoxide results in increased oxidation of TXN2 protein TXN2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:16797630 PMID:18550601
NCBI chr22:36,467,046...36,481,640
Ensembl chr22:36,467,046...36,481,640
G
TXNIP
thioredoxin interacting protein
decreases expression decreases response to substance increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of TXNIP mRNA TXNIP protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of TXNIP mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
G
TXNL1
thioredoxin like 1
increases expression multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of TXNL1 mRNA LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNL1 mRNA]
CTD
PMID:31627909
NCBI chr18:56,597,209...56,638,592
Ensembl chr18:56,597,209...56,651,600
G
TXNRD1
thioredoxin reductase 1
multiple interactions increases expression
EXP
MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA]
CTD
PMID:12414654 PMID:16636651
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
TXNRD2
thioredoxin reductase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TXNRD2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
G
TYMP
thymidine phosphorylase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TYMP mRNA
CTD
PMID:14729362
NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032
G
UBA7
ubiquitin like modifier activating enzyme 7
decreases expression increases expression multiple interactions
EXP ISO
tert-Butylhydroperoxide results in decreased expression of UBA7 mRNA; tert-Butylhydroperoxide results in decreased expression of UBA7 protein tert-Butylhydroperoxide results in increased expression of UBA7 mRNA Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UBA7 protein]
CTD
PMID:15003993 PMID:15336504 PMID:25649257
NCBI chr 3:49,805,209...49,813,953
Ensembl chr 3:49,805,209...49,813,953
G
UBAP2
ubiquitin associated protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBAP2 mRNA
CTD
PMID:14729362
NCBI chr 9:33,921,693...34,049,199
Ensembl chr 9:33,921,693...34,049,388
G
UBE2C
ubiquitin conjugating enzyme E2 C
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of UBE2C mRNA
CTD
PMID:12414654
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
G
UBE2E1
ubiquitin conjugating enzyme E2 E1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of UBE2E1 mRNA
CTD
PMID:15336504
NCBI chr 3:23,805,955...23,891,640
Ensembl chr 3:23,805,955...23,891,640
G
UBE2K
ubiquitin conjugating enzyme E2 K
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of UBE2K mRNA
CTD
PMID:15336504
NCBI chr 4:39,698,136...39,782,792
Ensembl chr 4:39,698,109...39,782,792
G
UBE2L6
ubiquitin conjugating enzyme E2 L6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2L6 mRNA
CTD
PMID:15003993
NCBI chr11:57,551,662...57,567,935
Ensembl chr11:57,551,656...57,568,284
G
UBE3C
ubiquitin protein ligase E3C
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of UBE3C mRNA
CTD
PMID:15336504
NCBI chr 7:157,138,926...157,269,370
Ensembl chr 7:157,138,926...157,269,370
G
UBL5
ubiquitin like 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of UBL5 mRNA
CTD
PMID:15336504
NCBI chr19:9,827,918...9,830,115
Ensembl chr19:9,827,892...9,830,115
G
UBXN7
UBX domain protein 7
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of UBXN7 mRNA tert-Butylhydroperoxide results in increased expression of UBXN7 mRNA
CTD
PMID:15336504
NCBI chr 3:196,347,662...196,432,427
Ensembl chr 3:196,347,662...196,432,430
G
UCK2
uridine-cytidine kinase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of UCK2 mRNA
CTD
PMID:15336504
NCBI chr 1:165,827,614...165,911,618
Ensembl chr 1:165,827,614...165,911,618
G
UMPS
uridine monophosphate synthetase
multiple interactions decreases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UMPS mRNA]
CTD
PMID:20847119
NCBI chr 3:124,730,452...124,749,273
Ensembl chr 3:124,730,433...124,749,273
G
UNG
uracil DNA glycosylase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of UNG mRNA
CTD
PMID:12414654
NCBI chr12:109,097,597...109,110,992
Ensembl chr12:109,097,597...109,126,725
G
UPB1
beta-ureidopropionase 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of UPB1 mRNA
CTD
PMID:29432895
NCBI chr22:24,495,332...24,528,390
Ensembl chr22:24,494,107...24,528,390
G
UPF3A
UPF3A regulator of nonsense mediated mRNA decay
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of UPF3A mRNA
CTD
PMID:15336504
NCBI chr13:114,281,601...114,305,817
Ensembl chr13:114,281,601...114,305,817
G
UPP1
uridine phosphorylase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of UPP1 mRNA
CTD
PMID:15336504
NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736
G
UQCRFS1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
multiple interactions
ISO
[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein; Cyclosporine inhibits the reaction [[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein]
CTD
PMID:16023995
NCBI chr19:29,205,320...29,213,151
Ensembl chr19:29,205,320...29,213,151
G
USP17L5
ubiquitin specific peptidase 17 like family member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP17LA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 4:9,339,403...9,340,995
Ensembl chr 4:9,339,403...9,340,995
G
USP18
ubiquitin specific peptidase 18
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP18 mRNA
CTD
PMID:15003993
NCBI chr22:18,150,170...18,177,397
Ensembl chr22:18,149,843...18,177,397
G
USP21
ubiquitin specific peptidase 21
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of USP21 mRNA
CTD
PMID:15336504
NCBI chr 1:161,159,500...161,165,723
Ensembl chr 1:161,159,450...161,165,723
G
USP22
ubiquitin specific peptidase 22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP22 mRNA
CTD
PMID:15003993
NCBI chr17:20,999,596...21,043,419
Ensembl chr17:20,999,596...21,043,760
G
USP9X
ubiquitin specific peptidase 9 X-linked
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of USP9X mRNA
CTD
PMID:15336504
NCBI chr X:41,085,445...41,236,579
Ensembl chr X:41,085,445...41,236,579
G
UTP14A
UTP14A small subunit processome component
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of UTP14A mRNA
CTD
PMID:15336504
NCBI chr X:129,906,164...129,929,752
Ensembl chr X:129,906,121...129,929,761
G
UTP25
UTP25 small subunit processome component
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of UTP25 mRNA
CTD
PMID:15336504
NCBI chr 1:209,827,972...209,857,565
Ensembl chr 1:209,827,972...209,857,565
G
VAMP1
vesicle associated membrane protein 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of VAMP1 mRNA
CTD
PMID:15336504
NCBI chr12:6,462,237...6,470,677
Ensembl chr12:6,462,237...6,470,677
G
VASN
vasorin
multiple interactions increases expression
EXP
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]
CTD
PMID:20847119
NCBI chr16:4,371,848...4,383,538
Ensembl chr16:4,371,848...4,383,538
G
VCAM1
vascular cell adhesion molecule 1
decreases expression multiple interactions increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of VCAM1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]
CTD
PMID:12419474 PMID:28063877
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
VCAN
versican
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of VCAN mRNA
CTD
PMID:15336504
NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303
G
VDAC2
voltage dependent anion channel 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of VDAC2 mRNA
CTD
PMID:15336504
NCBI chr10:75,210,170...75,231,448
Ensembl chr10:75,210,154...75,231,448
G
VEGFA
vascular endothelial growth factor A
multiple interactions increases secretion increases expression
EXP
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA]; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA] tert-Butylhydroperoxide results in increased secretion of VEGFA protein tert-Butylhydroperoxide results in increased expression of VEGFA mRNA; tert-Butylhydroperoxide results in increased expression of VEGFA protein
CTD
PMID:15336504 PMID:17200665 PMID:20847119 PMID:35690295
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFC
vascular endothelial growth factor C
increases secretion increases expression
EXP
tert-Butylhydroperoxide results in increased secretion of VEGFC protein tert-Butylhydroperoxide results in increased expression of VEGFC mRNA; tert-Butylhydroperoxide results in increased expression of VEGFC protein
CTD
PMID:15336504 PMID:17200665
NCBI chr 4:176,683,538...176,792,922
Ensembl chr 4:176,683,538...176,792,922
G
VGLL4
vestigial like family member 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of VGLL4 mRNA
CTD
PMID:15336504
NCBI chr 3:11,556,067...11,721,815
Ensembl chr 3:11,556,069...11,771,350
G
VIM
vimentin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of VIM protein
CTD
PMID:15050405
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VSNL1
visinin like 1
affects expression
EXP
tert-Butylhydroperoxide affects the expression of VSNL1 mRNA
CTD
PMID:23410634
NCBI chr 2:17,539,972...17,657,018
Ensembl chr 2:17,539,126...17,657,018
G
WBP11
WW domain binding protein 11
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of WBP11 mRNA
CTD
PMID:15336504
NCBI chr12:14,784,582...14,803,478
Ensembl chr12:14,784,582...14,803,486
G
WDR1
WD repeat domain 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of WDR1 mRNA
CTD
PMID:15336504
NCBI chr 4:10,074,339...10,116,799
Ensembl chr 4:10,068,089...10,116,972
G
WDR26
WD repeat domain 26
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of WDR26 mRNA
CTD
PMID:15336504
NCBI chr 1:224,385,146...224,434,797
Ensembl chr 1:224,385,146...224,437,033
G
WDR43
WD repeat domain 43
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of WDR43 mRNA
CTD
PMID:15336504
NCBI chr 2:28,894,667...28,948,219
Ensembl chr 2:28,894,667...28,948,219
G
WDR77
WD repeat domain 77
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of WDR77 mRNA
CTD
PMID:15336504
NCBI chr 1:111,439,890...111,449,256
Ensembl chr 1:111,439,890...111,449,256
G
WEE1
WEE1 G2 checkpoint kinase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of WEE1 mRNA
CTD
PMID:15336504
NCBI chr11:9,573,670...9,589,985
Ensembl chr11:9,573,670...9,593,457
G
WIPI1
WD repeat domain, phosphoinositide interacting 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of WIPI1 mRNA
CTD
PMID:15336504
NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
G
WNT4
Wnt family member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WNT4 mRNA
CTD
PMID:15003993
NCBI chr 1:22,117,313...22,143,097
Ensembl chr 1:22,117,313...22,143,969
G
XCR1
X-C motif chemokine receptor 1
increases methylation
EXP
tert-Butylhydroperoxide results in increased methylation of XCR1 exon
CTD
PMID:29432895
NCBI chr 3:46,017,007...46,085,844
Ensembl chr 3:46,016,990...46,085,825
G
XIST
X inactive specific transcript
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of XIST mRNA
CTD
PMID:15336504
NCBI chr X:73,820,651...73,852,753
Ensembl chr X:73,820,649...73,852,723
G
XPNPEP1
X-prolyl aminopeptidase 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of XPNPEP1 mRNA
CTD
PMID:15336504
NCBI chr10:109,864,766...109,923,511
Ensembl chr10:109,864,766...109,923,553
G
XPNPEP3
X-prolyl aminopeptidase 3
increases expression decreases methylation
EXP
tert-Butylhydroperoxide results in increased expression of XPNPEP3 mRNA tert-Butylhydroperoxide results in decreased methylation of XPNPEP3 gene
CTD
PMID:29432895
NCBI chr22:40,857,148...40,932,815
Ensembl chr22:40,857,077...40,932,815
G
YBX3
Y-box binding protein 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of YBX3 mRNA
CTD
PMID:12419474
NCBI chr12:10,699,089...10,723,323
Ensembl chr12:10,699,089...10,723,323
G
YIPF2
Yip1 domain family member 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of YIPF2 mRNA
CTD
PMID:15336504
NCBI chr19:10,922,193...10,928,639
Ensembl chr19:10,922,185...10,928,681
G
YPEL1
yippee like 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of YPEL1 mRNA
CTD
PMID:15336504
NCBI chr22:21,697,536...21,735,794
Ensembl chr22:21,697,536...21,735,794
G
YTHDF1
YTH N6-methyladenosine RNA binding protein F1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YTHDF1 mRNA
CTD
PMID:15003993
NCBI chr20:63,195,429...63,216,131
Ensembl chr20:63,195,429...63,216,139
G
YWHAH
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of YWHAH mRNA
CTD
PMID:12419474
NCBI chr22:31,944,535...31,957,603
Ensembl chr22:31,944,522...31,957,603
G
ZAP70
zeta chain of T cell receptor associated protein kinase 70
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZAP70 mRNA
CTD
PMID:22659508
NCBI chr 2:97,713,576...97,756,364
Ensembl chr 2:97,713,576...97,739,862
G
ZBTB5
zinc finger and BTB domain containing 5
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ZBTB5 mRNA
CTD
PMID:15336504
NCBI chr 9:37,438,102...37,465,450
Ensembl chr 9:37,438,102...37,465,450
G
ZC3H11A
zinc finger CCCH-type containing 11A
multiple interactions increases expression
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]
CTD
PMID:20847119
NCBI chr 1:203,795,623...203,854,124
Ensembl chr 1:203,795,623...203,854,999
G
ZC3H12A
zinc finger CCCH-type containing 12A
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ZC3H12A mRNA
CTD
PMID:15336504
NCBI chr 1:37,474,580...37,484,377
Ensembl chr 1:37,474,580...37,484,377
G
ZDHHC4
zinc finger DHHC-type palmitoyltransferase 4
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ZDHHC4 mRNA
CTD
PMID:15336504
NCBI chr 7:6,577,454...6,589,374
Ensembl chr 7:6,577,434...6,589,374
G
ZDHHC6
zinc finger DHHC-type palmitoyltransferase 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZDHHC6 mRNA
CTD
PMID:15003993
NCBI chr10:112,424,412...112,447,572
Ensembl chr10:112,424,428...112,447,572
G
ZFP36
ZFP36 ring finger protein
increases expression multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA]
CTD
PMID:20847119
NCBI chr19:39,406,847...39,409,407
Ensembl chr19:39,406,847...39,409,407
G
ZFYVE16
zinc finger FYVE-type containing 16
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ZFYVE16 mRNA
CTD
PMID:15336504
NCBI chr 5:80,407,610...80,483,379
Ensembl chr 5:80,408,013...80,483,379
G
ZMIZ1
zinc finger MIZ-type containing 1
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ZMIZ1 mRNA
CTD
PMID:15336504
NCBI chr10:79,068,966...79,316,519
Ensembl chr10:79,068,966...79,316,519
G
ZMYND19
zinc finger MYND-type containing 19
increases methylation
EXP
tert-Butylhydroperoxide results in increased methylation of ZMYND19 gene
CTD
PMID:29432895
NCBI chr 9:137,582,081...137,590,512
Ensembl chr 9:137,582,081...137,590,512
G
ZNF114
zinc finger protein 114
affects expression
EXP
tert-Butylhydroperoxide affects the expression of ZNF114 mRNA
CTD
PMID:23410634
NCBI chr19:48,270,081...48,287,608
Ensembl chr19:48,270,081...48,287,608
G
ZNF117
zinc finger protein 117
multiple interactions increases expression
EXP
Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZNF117 mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZNF117 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZNF117 mRNA]
CTD
PMID:20847119
NCBI chr 7:64,971,772...64,991,036
Ensembl chr 7:64,970,663...65,006,687
G
ZNF217
zinc finger protein 217
affects expression
EXP
tert-Butylhydroperoxide affects the expression of ZNF217 mRNA
CTD
PMID:23410634
NCBI chr20:53,567,071...53,597,702
Ensembl chr20:53,567,071...53,609,907
G
ZNF227
zinc finger protein 227
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ZNF227 mRNA
CTD
PMID:15336504
NCBI chr19:44,207,547...44,237,268
Ensembl chr19:44,207,547...44,237,268
G
ZNF395
zinc finger protein 395
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ZNF395 mRNA
CTD
PMID:15336504
NCBI chr 8:28,345,590...28,386,460
Ensembl chr 8:28,345,590...28,402,701
G
ZNF593
zinc finger protein 593
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ZNF593 mRNA
CTD
PMID:15336504
NCBI chr 1:26,169,908...26,170,873
Ensembl chr 1:26,169,908...26,170,873
G
ZNF681
zinc finger protein 681
multiple interactions increases expression
EXP
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZNF681 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZNF681 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZNF681 mRNA]
CTD
PMID:20847119
NCBI chr19:23,739,195...23,758,891
Ensembl chr19:23,739,195...23,758,891
G
ZNF91
zinc finger protein 91
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ZNF91 mRNA
CTD
PMID:12419474
NCBI chr19:23,305,004...23,395,471
Ensembl chr19:23,304,991...23,395,471
G
ZNHIT1
zinc finger HIT-type containing 1
decreases expression increases expression
EXP ISO
tert-Butylhydroperoxide results in decreased expression of ZNHIT1 mRNA tert-Butylhydroperoxide results in increased expression of ZNHIT1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:101,218,165...101,224,190
Ensembl chr 7:101,218,165...101,224,190
G
ZPR1
ZPR1 zinc finger
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ZPR1 mRNA
CTD
PMID:15336504
NCBI chr11:116,773,799...116,788,023
Ensembl chr11:116,773,799...116,788,039
G
ZSWIM7
zinc finger SWIM-type containing 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZSWIM7 mRNA
CTD
PMID:15003993
NCBI chr17:15,976,560...15,999,704
Ensembl chr17:15,976,560...15,999,717
G
ZYX
zyxin
decreases expression affects expression
EXP
tert-Butylhydroperoxide results in decreased expression of ZYX mRNA tert-Butylhydroperoxide affects the expression of ZYX mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr 7:143,381,345...143,391,111
Ensembl chr 7:143,381,295...143,391,111
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all